Engineered materials for spatiotemporal regulation of monocyte and macrophage recruitment by Olingy, Claire Eliza
ENGINEERED MATERIALS FOR SPATIOTEMPORAL 




The Academic Faculty 
by 
Claire E. Olingy 
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in the 
Wallace H. Coulter Department of Biomedical Engineering 
Georgia Institute of Technology
Emory University
 August 2017 
COPYRIGHT © 2017 BY CLAIRE E. OLINGY 
ENGINEERED MATERIALS FOR SPATIOTEMPORAL 

























Edward A. Botchwey, PhD 
Wallce H. Coulter Department of 
Biomedical Engineering 
Georgia Institute of Technology 
 Krishnendu Roy, PhD 
Wallce H. Coulter Department of 
Biomedical Engineering 




Luke P. Brewster, MD 
Division of Vascular Surgery,  
Department of Surgery 
Emory University 
 Philip J. Santangelo, PhD 
Wallce H. Coulter Department of 
Biomedical Engineering 




Andrés J. García, PhD 
Woodruff School of Mechanical 
Engineering 
Petite Institute for Bioengineering and 
Bioscience 
Georgia Institute of Technology 
  




If there is one thing I have learned, it is that a PhD cannot be done in isolation. My 
family, mentors, friends, and colleagues have been extremely supportive over the course 
of my graduate education. I would like to begin my thanking my advisor, Edward 
Botchwey, who has pushed me to be the best I can be throughout the course of my PhD. 
On my first day in Ed’s lab, I was immediately at the bench and assisting other graduate 
students. These memories remind me that being in the Botchwey lab has meant you’re a 
part of a team from the very beginning. I remember early conversations with Ed, where I 
was extremely intimidated and did a lot of nodding in agreement. Since then, Ed has taught 
me to have confidence, both in my work and my opinions. Perhaps most importantly, Ed 
has taught me how to communicate science in a way that gets people excited, and makes 
them want to hear more (or fund you). He has taught me not to undervalue myself, to be 
less risk averse, and to treat every exercise or experiment as though it were the final version. 
While Ed and I have very different styles and personalities, this contrast has enabled me to 
become a better scientist and a better thinker. In short, Ed has made me feel like I can tackle 
any problem, and to me, that is what a PhD is truly about. 
I am extremely grateful for the expertise and insight my thesis committee has 
provided, which includes Drs. Luke Brewster, Andrés García, Krishnendu Roy, and Phil 
Santangelo. Their constructive feedback and guidance has focused my thesis work and 
made it better. In particular, I’d like to thank Dr. García for his willingness to provide 
advice, his valuable insight on science and science careers, and encouraging me in ongoing 
collaboration with his lab. I’d also like to thank the professors who I had the opportunity 
 iv 
to work with during my teaching assistantship, Dr. Johnna Temenoff and James Rains. Dr. 
Temenoff taught me many of the traditional aspects of great teaching, while Professor 
Rains taught me the valuable lesson of how to give students good feedback. Both of these 
experiences reinforced my love for teaching. 
My labmates are the primary reason that I consider my time as a PhD student to 
have been both a successful and joyful time in my life. When I joined the Botchwey lab at 
the University of Virginia, Cynthia Huang was the person who first recruited me to join 
the lab. I am extremely grateful for her early guidance and friendship. Dr. Anusuya Das 
was my first mentor in the lab, and I thank her for helping me transition from an 
inexperience undergraduate to an independent graduate student. I can’t imagine where I 
would be today without the mentorship and friendship of Dr. Molly Ogle. I have worked 
collaboratively with Molly more than anyone else in the lab, and I think we make a pretty 
great team. Molly has been one of the most influential people during my PhD, teaching me 
everything from molecular biology techniques and mouse work, to how to be a better writer 
and keep a lab running. She is the best person to provide gentle critique before a talk, gives 
compliments when they are most needed, and provides support to everyone in the lab. I’d 
also like to thank Cheryl San Emeterio, for being both my closest friend in graduate school, 
but also a great co-worker and fellow scientist. She is one of the best listeners I have ever 
met, and always sympathizes and provides great advice. Thanks to Nathan Chiappa for all 
of his help around the lab, broadening my exposure to other fields during my PhD, and 
being a good friend. Thanks to Caitlin Sok for sitting next to me and never making me feel 
like I’m distracting her when I talk to her. Thanks to Jack Krieger for the numerous 
conversations on troubleshooting, experimental design, and data analysis, and also for 
 v 
always being the first person to take a second slice of cake. Thanks to Jada Selma, Tiffany 
Wang, Dr. Tony Awojoodu, Dan Bowers, and Dr. Hannah Song who have made the lab a 
better place to work.  When your co-workers are also your friends, work feels a little bit 
less like work. I would also like to acknowledge Jose Garcia and other members of the 
García lab who I worked collaboratively with throughout my thesis research. I can’t 
imagine what graduate school would have been like without my friends outside the lab, 
particularly Betsy Campbell, Candice Hovell, and Giuli Salazar-Noratto, who provided the 
welcome occasional distraction from work, including oyster happy hours, craft nights, and 
frequent lunches. I will always treasure the memories I made with these friends during 
graduate school.  
 I have worked with many great undergraduates during the course of my PhD, who 
have given me the reward of mentorship and helped me accomplish more than I could have 
alone. Chris Jreige had the best attitude and made friends with everyone in the lab. Brett 
Jordan’s attention to detail, especially when editing our manuscript, was greatly 
appreciated. Shane Chu’s work ethic and independence made him very successful in the 
lab and I appreciated his willingness to help out with anything.  Jerrell Fang has been 
extremely helpful during the last few months of my PhD. He is always willing to contribute 
in whatever way possible, including performing extremely repetitive (but important!) tasks. 
I have also had the opportunity to mentor two high school students, Jovanay Carter and 
Amadou Bah. Watching their development as critical thinkers and young scientists was 
extremely rewarding, especially now that they are attending some of the best colleges in 
the country.  
vi 
Georgia Tech is one of the best places to do research, and that is in no small part 
due to the staff that support our research. I would like to thank Dr. Laura O’Farrell, Dr. 
Richard Noel, Kim Benjamin, Andrea Gibson, Altair Rivas, Ogeda Blue, and all of the 
Physiological Research Lab staff for providing care to the animals that help make our 
research possible. Their expertise and passion for ensuring animal welfare makes the work 
of all Georgia Tech researchers using the PRL easier and more enjoyable. I would also like 
to thank the core facilities staff for their limitless expertise and willingness to be of help. 
In particular, Andrew Shaw is always willing to go above and beyond to help. Additionally, 
thank you Nadia Boguslavsky for her flexibility and always helping me accomplish what I 
need to, as well as Steve Woodard for the support he provides and continuing to make the 
core facilities even better. I’d like to thank the many members of the BME and IBB staff 
who help our community run, as well as make it an enjoyable place to work. In particular, 
Colly Mitchell has been a welcoming resource throughout my time in the Petit Institute 
and during my leadership of BBUGS. Shannon Sullivan has been endlessly supportive, 
both in making BME a better program over the course of PhD, but also in helping me with 
administrative tasks, even when I didn’t do things correctly. I have always appreciated 
Karen Ethier’s willingness to help me with anything I needed, and Michelle Wong’s 
enthusiasm for getting to know the students within the Petit Institute. Other staff including 
Floyd Wood, Allen Echols, Tracy Dinkins, Sandra Powell, Laura Paige, Maria Pinto, and 
Leilani Burkhead have generously helped me during my time at Georgia Tech.  
I have been extremely fortunate to have received external funding that has 
supported my thesis research, including a National Science Foundation Graduate Research 
Fellowship and an American Heart Association Predoctoral Fellowship. Additionally, I 
 vii 
was honored with a P.E.O. Scholar Award, which was a great support for my studies. This 
scholarship also introduced me to the women of P.E.O. Chapter B, who have been my 
greatest cheerleaders and shown me so much support, particularly Ruth Anne Paradice, Jan 
Metcalf, Pat Holbrook, and Becky Battle.   
There are many people in my life who I will be forever grateful to for the love and 
support they have shown me throughout my many years of schooling. My dad inspired me 
from an early age to love math and science, and encouraged me to pursue biomedical 
engineering, even when everyone told me they had never heard of it. My mom has been a 
constant source of love and support, always making me feel like I can do anything and 
encouraging me every step of the way. My sister has always been my best friend and loves 
to brag to others about me or tell me how proud she is. My family has shaped who I am 
today and what I’ve been able to accomplish, for which I am extremely grateful. My new 
in-laws, Jeff and Julie Olingy, have been exceedingly supportive, particularly as my 
husband and I move from our home in Atlanta that is two hours away from them, to our 
new home in California. They have embraced me as one of their own and been extremely 
supportive of my career. Other new family, including Matt Olingy, Autumn Rosser, and 
Jessica, Brian, Jackson, and Brayden Hay have given me many great memories over the 
past 5 years, and I look forward to many more.  
The last person who I would like to thank is my husband, Mike Olingy. Mike has 
supported me since the beginning of my studies in biomedical engineering when we met at 
Washington University in St. Louis. Mike is my biggest supporter and makes me feel like 
I can accomplish anything. Most importantly, he is my constant reminder of what truly 
matters in life. I also can’t end without saying how grateful I am for my hound dog, Vesper, 
 viii 
who is both the cutest and most strong-willed dog I have ever met, but who has provided 
much-needed laughs, playtime, and cuddles during the course of my PhD. Our little family 
makes me excited for the future and I can’t wait to see what the next step holds.   
  
ix 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS iii 
LIST OF TABLES xiii 
LIST OF FIGURES xiv 
SUMMARY xx 
1 . INTRODUCTION AND SPECIFIC AIMS 1	  
2 . THE ROLE OF MONOCYTES AND MACROPHAGES IN TISSUE REPAIR: 
IMPLICATIONS FOR IMMUNOREGENERATIVE BIOMATERIAL DESIGN 5	  
2.1	  The mononuclear phagocyte system 5	  
2.1.1	   Development of the mononuclear phagocyte system 5	  
2.1.2	   Monocyte heterogeneity 7	  
2.1.3	   Macrophage heterogeneity 11	  
2.2	   Functions of monocytes and macrophages in tissue repair 13	  
2.2.1	   Monocytes/macrophages in vascular remodelling 14	  
2.2.2	   Monocytes/macrophages in musculoskeletal repair 17	  
2.3	   Innate immune response to engineered materials 19	  
2.3.1	   Passive inflammatory response to material implantation 20	  
2.3.2	   Physical properties 23	  
2.3.3	   Surface properties 25	  
2.3.4	   Mechanical properties 26	  
2.3.5	   Incorporation of adhesion sites 27	  
2.3.6	   Degradation 28	  
2.3.7	   Biomolecule delivery 29	  
2.4	   Conclusions and future directions 31	  
3 . NON-CLASSICAL MONOCYTES ARE BIASED PROGENITORS OF WOUND 
HEALING MACROPHAGES 32	  
3.1	   Abstract 32	  
 x 
3.2	   Introduction 33	  
3.3	   Results 36	  
3.3.1	   Systemic inflammatory response induced by skin wounding and biomaterial 
implantation 36	  
3.3.2	   Recruitment of labeled Ly6Clo monocytes to injured skin 39	  
3.3.3	   Recruitment of labeled Ly6Chi monocytes to injured skin 41	  
3.3.4	   Reduction of circulating Ly6Clo monocytes impairs CD206+ macrophage 
generation 43	  
3.3.5	   Adoptively transferred Ly6Clo monocytes preferentially differentiate into 
CD301b+CD206+ macrophages 45	  
3.3.6	   Characterization of chemokine receptors on mononuclear phagocytes 47	  
3.4	   Discussion 49	  
3.5	   Materials and Methods 54	  
3.5.1	   Material fabrication 54	  
3.5.2	   Dorsal skinfold window chamber surgery 54	  
3.5.3	   Flow cytometry 55	  
3.5.4	   Cell tracking of Ly6Clo and Ly6Chi monocytes 56	  
3.5.5	   Statistical analysis 57	  
4 . LOCAL DELIVERY OF FTY720 PROMOTES RECRUITMENT OF  
ALTERNATIVELY ACTIVATED MACROPHAGES AND MUSCLE REPAIR 58	  
4.1	   Abstract 58	  
4.2	   Introduction 59	  
4.3	   Results 62	  
4.3.1	   FTY720 promotes perivascular localization of non-classical monocytes 62	  
4.3.2	   Local delivery of FTY720 promotes accumulation of alternatively activated 
macrophages 65	  
4.3.3	   FTY720 increases perivascular accumulation of alternatively activated 
macrophages and promotes vascular network expansion after arteriole ligation 67	  
4.3.4	   Characterization of myeloid cell response to full-thickness defect in the murine 
spinotrapezius muscle 69	  
 xi 
4.3.5	   Local delivery of FTY720 increases the frequency of non-classical monocytes 
in injured muscle 70	  
4.3.6	   Local delivery of FTY720 increases accumulation of CD206+ alternatively 
activated macrophages in injured muscle 73	  
4.3.7	   FTY720 immunomodulation promotes early wound healing and improved 
regenerated muscle quality 74	  
4.4	   Discussion 77	  
4.5	   Materials and Methods 81	  
4.5.1	   Material fabrication 81	  
4.5.2	   Dorsal skinfold window chamber and tracking of monocyte subsets 81	  
4.5.3	   Flow cytometry 82	  
4.5.4	   Intravital image acquisition 83	  
4.5.5	   Angiogenesis assay with monocyte co-culture 84	  
4.5.6	   Spinotrapezius ischemia model 85	  
4.5.7	   Spinotrapezius volumetric muscle loss model and Ly6Clo monocyte labeling 85	  
4.5.8	   Whole mount immunohistochemistry 86	  
4.5.9	   Imaging and quantification of whole mount immunohistochemistry 87	  
4.5.10	   Statistical analysis 89	  
5 . QUANTITATIVE ANALYSIS OF THE TEMPORAL PROGRESSION OF 
INFLAMMATION AROUND ENGINEERED HYDROGELS 91	  
5.1	   Abstract 91	  
5.2	   Introduction 92	  
5.3	   Results 95	  
5.3.1	   Temporal profile of the myeloid response to degradable PEG hydrogels 95	  
5.3.2	   Comparison of recruited cells and cells present in homeostatic subcutaneous 
tissue 98	  
5.3.3	   Pro-inflammatory monocyte and macrophage populations are replaced with 
anti-inflammatory populations over the course of 14 days 99	  
5.3.4	   Myeloid cell recruitment to hydrogels functionalized with cyclic RGD 102	  
5.3.5	   High-dimensional analysis of temporal progression of inflammation around 
PEG hydrogels 103	  
 xii 
5.3.6	   Implantation of PEG hydrogels in mouse cutaneous wounds 106	  
5.3.7	   Intravital imaging of myeloid cell migration around PEG hydrogels 108	  
5.4	   Discussion 113	  
5.5	   Materials and Methods 118	  
5.5.1	   Poly(ethylene glycol) hydrogel fabrication 118	  
5.5.2	   Subcutaneous implant model 118	  
5.5.3	   Dorsal skinfold window chamber model 119	  
5.5.4	   Immunophenotyping by flow cytometry 120	  
5.5.5	   High-dimensional tSNE analysis 121	  
5.5.6	   Intravital confocal microscopy 121	  
5.5.7	   Intravital imaging analysis 122	  
5.5.8	   Statistics 124	  
6 . VASCULAR ENDOTHELIAL GROWTH FACTOR DELIVERY FROM 
DEGRADABLE HYDROGELS ALTERS MYELOID CELL RECRUITMENT 125	  
6.1	   Abstract 125	  
6.2	   Introduction 126	  
6.3	   Results 129	  
6.3.1	   VEGF-tethered PEG hydrogels for on demand angiogenic growth factor 
delivery 129	  
6.3.2	   Effects of VEGF delivery and adhesive ligand presentation on myeloid cell 
recruitment 130	  
6.3.3	   Effects of VEGF delivery and adhesive ligand presentation on accumulation of 
monocyte/macrophage subsets 132	  
6.3.4	   Intravital imaging of myeloid cell migration around VEGF-releasing  
 hydrogels 134	  
6.3.5	   Effects of adhesive ligand incorporation on VEGF-induced vascularization 136	  
6.4	   Discussion 138	  
6.5	   Materials and Methods 142	  
6.5.1	   Hydrogel fabrication 142	  
6.5.2	   Subcutaneous implant model and flow cytometry 142	  
6.5.3	   Dorsal skinfold window chamber model 143	  
 xiii 
6.5.4	   Intravital confocal microscopy and analysis 144	  
6.5.5	   Whole mount immunohistochemistry and quantification 145	  
6.5.6	   Statistics 145	  
7 . CONCLUSIONS AND FUTURE DIRECTIONS 147	  
7.1	   Overall Summary 147	  
7.2	   Engineering smarter immunoregenerative materials 150	  
7.3	   Expansion of macrophage classifications 152	  
7.4	   Innate immune cell interactions with adaptive immunity 154	  
7.5	   Extension of findings to other medical applications 154	  





LIST OF TABLES 
Table 1 Monocyte and macrophage subset characteristics.  8 
   




LIST OF FIGURES 
Figure 1 Mononuclear phagocytes in regenerative medicine. 15 
Figure 2 Biomaterial properties that affect monocytes/macrophages. 30 
Figure 3 Wounding and biomaterial implantation induces acute changes in 
circulating monocytes. 
37 
Figure 4 Bone marrow monocyte composition after wounding. 38 
Figure 5 Latex bead-labeled Ly6Clo monocytes recruited from blood 
circulation remain Ly6Clo in inflamed dorsal tissue. 
40 
Figure 6 Latex bead-labeled Ly6Clo monocytes recruited from blood 
circulation selectively give rise to CD206+ alternatively activated 
macrophages. 
41 
Figure 7 Selective labeling of blood Ly6Chi monocytes. 42 
Figure 8 Tracking of latex bead-labeled Ly6Chi monocytes recruited from 
blood circulation. 
43 
Figure 9 Loss of Ly6Clo monocytes impairs generation of CD206+ 
alternatively activated macrophages. 
44 
Figure 10 Adoptive transfer of Ly6Chi and Ly6Clo monocytes for fate 
tracking. 
46 
Figure 11 Adoptively transferred non-classical Ly6Clo monocytes 
differentiate into CD206+ macrophages within inflamed peri-
implant tissue 3 days post-injury. 
47 
Figure 12 Expression of chemokine receptors in classical and non-classical 
monocytes. 
48 
Figure 13 FTY720 recruits non-classical monocytes to the perivascular 
space. 
64 
Figure 14 In vitro association of monocytes and endothelial cells. 65 




Figure 16 FTY720-induced accumulation of alternatively activated 
macrophages requires circulating Ly6Clo monocytes. 
66 
Figure 17 FTY720 alters monocyte/macrophage accumulation after arteriole 
ligation in the spinotrapezius muscle. 
68 
Figure 18 FTY720 promotes microvascular network expansion after muscle 
arteriole ligation. 
69 
Figure 19 Mouse model of volumetric muscle loss in the murine 
spinotrapezius muscle. 
71 
Figure 20 Delivery of FTY720 increases Ly6Clo, CX3CR1hi monocytes in 
injured muscle. 
72 
Figure 21 FTY720 increases the frequency of CD68+CD206+ cells in injured 
muscle of CX3CR1GFP/+ mice. 
74 
Figure 22 Delivery of FTY720 promotes muscle healing 3 days post-injury 
in CX3CR1GFP/+ mice. 
75 
Figure 23 Local immunomodulation with FTY720 improves muscle repair 7 
days post-injury in wildtype mice.   
76 
Figure 24 Protease-degradable biofunctional PEG hydrogels. 95 
Figure 25 In vivo assessment of inflammatory response to PEG hydrogels 
implanted subcutaneously in mice. 
97 
Figure 26 Myeloid cells recruited to implanted hydrogels are phenotypically 
different from those present in uninjured subcutaneous tissue. 
99 
Figure 27 Temporal evolution of monocytes around PEG hydrogels. 100 
Figure 28 Temporal evolution of macrophages around PEG hydrogels. 102 
Figure 29 Impact of functionalization with cyclic RGD on myeloid cell 
recruitment to PEG hydrogels. 
103 
Figure 30 High-dimensional analysis of temporal progression of 
inflammation around PEG hydrogels. 
105 
Figure 31 High-dimensional analysis of myeloid response to adhesive ligand 
functionalization of PEG hydrogels. 
106 




Figure 33 Intravital assessment of myeloid cell migration around PEG 
hydrogels. 
109 
Figure 34 Migration of CX3CR1+ cells around PEG hydrogels. 110 
Figure 35 Migration of CX3CR1+ cells as a function of distance from 
hydrogel surface. 
112 
Figure 36 Migration of CX3CR1lo and CX3CR1hi cells around PEG 
hydrogels.  
113 
Figure 37 On demand VEGF delivery from protease-degradable PEG 
hydrogels. 
130 
Figure 38 In vivo effect of VEGF delivery from PEG hydrogels on 
inflammatory cell recruitment. 
132 
Figure 39 Temporal evolution of monocytes and macrophages around PEG 
hydrogels delivering VEGF. 
134 
Figure 40 Intravital imaging of CX3CR1+ myeloid cell migration around 
PEG hydrogels delivering VEGF. 
135 
Figure 41 Quantification of myeloid cell migration around PEG hydrogels 
delivering VEGF. 
136 
Figure 42 Effect of RGD incorporation on vascularization in response to 





LIST OF SYMBOLS AND ABBREVIATIONS 
ANOVA Analysis of variance 
BSA Bovine serum albumin 
BMP Bone morphogenetic protein 
CCL CC-chemokine ligand 
CCR CC-chemokine receptor 
cMoP Common monocyte progenitor 
CD Cluster of differentiation 
CO2 Carbon dioxide 
CXCL C-X-C ligand 
CXCR4 C-X-C chemokine receptor 4 
CX3CR1 C-X3-C chemokine receptor 1 
CX3CR1GFP/+ B6.129P-Cx3cr1tm1Litt/J mice 
DC Dendritic cell 
DMEM Dulbecco’s Modified Eagle Media 
DWC Dorsal skinfold window chamber 
ECM Extracellular matrix 
FBGC Foreign body giant cells 
FBS Fetal bovine serum 
FGF Fibroblast growth factor 
GFP Green fluorescent protein 
GM-CSF Granulocyte-macrophage colony stimulating factor 
GTP Guanosine triphosphate 
 xix 
IACUC Institutional Animal Care and Use Committee 
IGF Insulin-like growth factor 
IHC Immunohistochemistry 
IL Interleukin 
iNOS Inducible nitric oxide synthase 
IFN interferon 
i.p. Intraperitoneally 
LFA-1 Lymphocyte function-associated antigen 1 
LPS Lipopolysaccharide 
kDa Kilodalton 
kPa Kilopascal  
Mafia Macrophage fas-induced apoptosis transgenic mice 
MCP-1 Monocyte chemoattractant protein-1 
M-CSF Macrophage colony stimulating factor 
MDP Macrophage-dendritic cell precursor 
MerTK Mer receptor tyrosine kinase 
mg/kg Milogram per kilogram 
MMP Matrix metalloproteinase 
M1 Classically activated inflammatory macrophage 
M2 Alternatively activated macrophages 
NIH National Institutes of Health 
NR4A1 Nuclear receptor subfamily 4 group A member 1 
PBS Phosphate buffered saline 
PCA Principle component analysis 
PEG Poly(ethylene glycol) 
 xx 
PEG-MAL 4-arm poly(ethylene glycol)-maleimide 
PLGA Poly(lactic-co-glycolic acid) 
PDGF Platelet-derived growth factor 
RDG (Argine-aspartic acid-glycine) scrambled peptide 
RELMα  Resistin-like molecular alpha  
RGD (Arginine-glycine-aspartic acid) peptide 
ROS Radical oxygen species 
SSC Side scatter 
SDF-1 Stromal cell-derived factor-1 
S.E.M. Standard error of the mean 
S1P Sphingosine-1-phosphate 
S1PR Sphingosine-1-phosphate receptor 
SPHK Sphingosine kinase 
TIMP Tissue inhibitor of matrix metalloproteinase 
TGF-ß Transforming growth factor-beta 
TH T helper 
TNF- α Tumor necrosis factor-alpha 
VCAM-1 Vascular cell adhesion molecule 1 
VEGF Vascular endothelial growth factor 






Significant advances have been made in the development of materials that better 
mimic native tissues through incorporation of biofunctionality, transplantation of 
exogenous cells, and recapitulation of host tissue mechanical and structural properties. 
While these advances have generated promising pre-clinical results, biomaterial 
implantation still faces several challenges, including proper integration into host tissue, 
vascularization, and circumventing fibrosis and the foreign body response. Successful 
tissue repair requires the activities of myeloid cells such as monocytes and macrophages 
that guide the progression of inflammation and healing outcome. Materials that balance the 
reparative and inflammatory functions of endogenous immune cells represent a promising 
strategy to enhance the efficacy of biomaterial-based regenerative strategies. A deeper 
understanding of innate immune cell function in inflamed tissues and their subsequent 
interactions with implanted materials is necessary to guide the design of these materials. 
Monocytes and macrophages display significant heterogeneity in vivo, enabling 
them to perform extremely varied and tissue-specific functions. Blood monocytes are 
composed of classical and non-classical subsets, while macrophages display many 
phenotypes in response to a wide variety of polarizing cues. Alternatively activated 
macrophages that produce anti-inflammatory mediators and growth factors have been 
associated with repair of muscle, bone, nerve, and skin, as well as with favorable host 
response to material implantation. In the current work, we expanded understanding of the 
relationship between blood monocyte subsets and alternatively activated macrophages, as 
well as identified potential targets by which to modulate monocyte recruitment. 
 xxii 
Subsequently, we explored how biomolecule release and adhesive ligand presentation from 
materials impact myeloid cell recruitment and contributions to post-injury vascularization. 
We demonstrated that circulating non-classical monocytes are directly recruited to 
polymer films implanted in skin injuries, where they generate alternatively activated, 
wound healing macrophages. These results highlight non-classical monocytes as key 
regulators of inflammatory response and motivated the use of materials that selectively 
target their recruitment. Subsequently, we examined the effect of FTY720 delivery from 
poly(lactic-co-glycolic acid) materials on accumulation of monocyte and macrophage 
subsets within injured skin and muscle. We found that local FTY720 delivery promotes 
accumulation of alternatively activated macrophages that are derived at least in part from 
circulating non-classical monocytes. FTY720-mediated immunomodulation enhanced 
vascularization, collagen matrix deposition, and non-fibrotic muscle regeneration in a 
mouse model of volumetric muscle loss.  
We also explored the kinetics of myeloid cell recruitment in response to adhesive 
ligand functionalization and angiogenic growth factor delivery from degradable 
poly(ethylene glycol) hydrogels. The temporal progression of inflammation around 
subcutaneously implanted hydrogels was not significantly affected by the presence of RGD 
adhesive ligand; however real-time intravital imaging revealed that myeloid cells migrate 
faster in the presence of RGD-functionalized materials. Delivery of vascular endothelial 
growth factor (VEGF) enhanced recruitment of monocytes and dendritic cells, but 
decreased the frequency of macrophages. In the presence of RGD, VEGF promoted 
vascular network expansion. Taken together, these findings identify therapeutic targets 
within the innate immune system for overcoming challenges in the field of biomaterials, 
 xxiii 
including proper integration into host tissue, vascularization, and minimizing fibrosis. 
These results provide previously unknown insight into the value of leveraging endogenous 









1. INTRODUCTION AND SPECIFIC AIMS 
Introduction 
Successful tissue repair requires the activities of myeloid cells such as monocytes 
and macrophages that guide the progression of inflammation and healing outcome. 
Materials that leverage the function of endogenous immune cells to orchestrate 
mechanisms of repair represents a promising strategy to enhance the efficacy of 
biomaterial-based regenerative strategies; however, a deeper understanding of the 
trafficking of immune cells and their subsequent interactions with implanted materials is 
necessary to guide the design of these materials.  
 The objective of this work is to engineer materials that tune myeloid cell 
recruitment and function to improve post-injury revascularization and tissue repair. 
Myeloid cells are the primary responders to material implantation and are critical to 
processes such as vascularization, extracellular matrix remodeling, and stimulating local 
progenitor cell activities.  By dynamically modulating monocyte/macrophages recruitment, 
novel roles for these cells in repair of damaged tissues can be revealed. In this work, we 
first expanded understanding of the relationship between blood monocyte subsets and 
alternatively activated macrophages, as well as identified potential targets by which to 
modulate monocyte recruitment. Subsequently, we explored how biomolecule release and 
adhesive ligand presentation impact myeloid cell recruitment and contributions to post-
injury vascularization. 
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Aim 1: Investigate the contribution of circulating monocyte subsets to the pool of 
alternatively activated wound macrophages during traumatic skin injury. 
Alternatively activated macrophages have been associated with improved 
functional outcomes in a variety of injury contexts, including myocardial infarction, 
peripheral nerve injury, and dermal wounds. With these observations in mind, this aim 
sought to identify monocytic precursors of pro-regenerative macrophage populations to 
inform the design of materials that better leverage endogenous immune cell populations. 
We hypothesized that circulation-derived non-classical monocytes selectively differentiate 
into alternatively activated macrophages during soft tissue injury. Using a murine model 
of excisional skin injury, the relationship between circulating monocyte subsets and wound 
macrophages was evaluated. The trafficking and fate of monocyte subsets was tracked 
using complementary in situ bead-based labeling, adoptive transfer of sorted monocyte 
subsets, and monocyte depletion techniques. Flow cytometry-based immunophenotyping 
was used to characterize expression of chemokine receptors on monocyte subsets to 
identify potential therapeutic targets for enhancing recruitment of specific myeloid cell 
populations.  
Aim 2: Examine the effects of biomaterial-based FTY720 delivery on wound 
monocyte/macrophage accumulation, revascularization, and muscle repair.  
Targeting the recruitment and function of endogenous immune cell populations 
represents a promising strategy to enhance the efficacy of biomaterial-guided soft tissue 
repair. We have demonstrated that incorporation of molecules that target sphingosine-1-
phosphate receptor (S1PR) signaling such as FTY720 modulate the inflammatory response 
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and promote microvascular remodeling. We hypothesized that FTY720 delivery from a 
poly(lactic-co-glycolic acid) implant would enhance accumulation of alternatively 
activated macrophages in ischemic and traumatic muscle injuries. Also, we hypothesized 
that FTY720 delivery would promote revascularization and muscle repair. To address these 
hypotheses, we examined the effect of FTY720 delivery on accumulation of pro-
regenerative myeloid subsets after skin and muscle injury, and whether these cells are 
associated with subsequent processes of repair. We utilized a novel mouse model of 
volumetric muscle injury to more closely study tissue repair and investigate 
vascularization, matrix deposition, and muscle fiber regeneration using high power 
confocal microscopy.  
Aim 3: Investigate the impact of adhesive ligand functionalization and vascular 
endothelial growth factor delivery on myeloid cell recruitment to degradable 
poly(ethylene glycol) hydrogels. 
Significant advances have been made in the development of materials that better 
mimic native tissues; however how these materials interact with the host immune system 
after implantation remains incompletely understood. We hypothesized that incorporation 
of bioadhesive ligands and vascular endothelial growth factor (VEGF) into poly(ethylene 
glycol) (PEG) hydrogels would enhance myeloid cell recruitment and promote 
vascularization. To test this hypothesis, we characterized the progression of inflammation 
around protease-degradable PEG hydrogels functionalized with Arg-Gly-Asp (RGD) 
peptide and covalently-tethered VEGF using high-dimensional flow cytometry data paired 
with real-time intravital image acquisition. Using a mouse subcutaneous implantation 
model, the inflammatory response was characterized using flow cytometry-based 
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immunophenotyping. Real-time interactions of myeloid cells with the hydrogel surface 
were visualized using intravital confocal microscopy in mouse dorsal skinfold window 
chambers.  
Significance  
The work presented in this thesis represents a significant contribution to the fields 
of biomaterials and regenerative medicine by demonstrating that modulation of 
mononuclear phagocyte accumulation around biomaterial implants can enhance 
vascularization and tissue repair. By investigating the recruitment of myeloid cells to 
implanted biomaterials, we revealed several key findings: 1) Non-classical monocytes 
differentiate into wound healing macrophages within cutaneous wounds, 2) Biomaterial-
delivered FTY720 enhances wound healing macrophage accumulation, vascularization, 
and non-fibrotic repair during muscle injury, 3) Both PEG hydrogel implantation and RGD 
functionalization enhance the speed of myeloid cells migrating within skin injuries, and 4) 
Degradable PEG hydrogels promote accumulation of alternatively activated macrophages, 
which is further enhanced by VEGF delivery. These findings identify non-classical 
monocytes and alternatively activated macrophages as therapeutic targets for strategies 
attempting to overcome challenges facing biomaterials, including proper integration into 
host tissue, vascularization, and circumventing fibrosis.  Taken together, these results 
provide previously unknown insight into the value of leveraging endogenous populations 
of pro-regenerative monocytes and macrophages during soft tissue repair.   
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2. THE ROLE OF MONOCYTES AND MACROPHAGES IN TISSUE 
REPAIR: IMPLICATIONS FOR IMMUNOREGENERATIVE 
BIOMATERIAL DESIGN1 
2.1   The mononuclear phagocyte system 
2.1.1   Development of the mononuclear phagocyte system 
The innate immune system plays a critical role in tissue development, homeostasis, 
and repair of injured tissues. Monocytes and macrophages are among the first responders 
to tissue injury and are required for successful tissue regeneration [1-7]. The striking 
evolutionary examples of complex tissue regeneration in the salamander limb and zebrafish 
tailfin require the presence of myeloid cells and regeneration fails when macrophages are 
depleted prior to injury [2, 3]. Increasing evidence suggests that division of labor among 
subpopulations of monocytes and macrophages could allow for harnessing regenerative 
functions over inflammatory functions of myeloid cells [7-11]; however, the complex 
balance between necessary functions of inflammatory versus regenerative myeloid cells 
remains to be fully understood [12].  
Monocytes (immunophenotyped as CD115+CD11b+SSClow cells) differentiate from 
hematopoietic stem and progenitor cells in the bone marrow, and traffic to the blood and 
spleen of vertebrates during homeostasis. Monocytes are robustly recruited to tissue injury 
                                                
1Adapted from: Ogle ME, Segar CE, Sridhar S, Botchwey EA, Monocytes and 
macrophages in tissue repair: Implications for immunoregenerative biomaterial design. 
Exp Biol Med (241) pp. 1084-97. Copyright © 2016. Reprinted by permission of SAGE 
publications. 
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or infection as effector cells and as progenitors of macrophages and dendritic cells [1, 13, 
14]. As effectors, monocytes participate in coordinating efforts between the innate and 
adaptive immune response [10, 11, 15, 16], killing microbial pathogens and parasites such 
as Leishmania major [17], and promoting repair of damaged tissues [4, 8, 18, 19]. Myeloid 
cells responding to injuries typically secrete inflammatory cytokines and chemokines, 
phagocytose necrotic debris, secrete proteolytic and matrix remodeling proteins, and 
produce growth factors upon entry to the tissue [1, 20]. 
Macrophages (MerTK+CD64+) [21] have many important tissue functions in 
development, homeostasis, and tissue repair [22-25]. Some macrophages are the 
descendants of circulating monocytes and are replenished at steady state and during 
inflammation by blood-derived monocytes [13, 26]. Considerable evidence also supports 
a model of multiple origins for macrophages, where some macrophages are derived from 
embryonic sources and self-maintain locally in tissues throughout adulthood [14, 27, 28]. 
Specifically, populations of tissue macrophages of the heart, lung, brain, skin, and liver are 
derived prenatally [14, 29-31]. Some injury contexts, such as TH2-linked infection, can 
increase local tissue macrophage populations specifically through proliferation as opposed 
to monocyte recruitment from the blood [27]. Characterization of gene expression 
signatures among macrophage populations from different tissues, species, and activation 
states reveal marked heterogeneity based on these factors [21, 32]. These studies suggest 
that “macrophage” is an umbrella term covering cells that have remarkable diversity in 
gene and protein expression and function [21, 26, 32, 33] (Table 1). Despite the diversity 
of macrophage origin [26], tissue environment [34], and secondary pathologies [12], 
macrophages (tissue resident and monocyte-derived) seem to share the common expression 
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signature of MerTK and CD64 across populations [21]. Like monocytes, macrophage 
functional diversity is described as a continuum from inflammatory to anti-inflammatory 
macrophages and plasticity is believed to be retained in order to rapidly respond to 
microenvironmental changes [33]. As current dogma continues to evolve concerning the 
origin of tissue macrophages, evidence suggests the diversity in macrophage phenotypes 
likely extends beyond stimulating factors to cell ontogeny, tissue residence, and other 
environmental factors.  
2.1.2   Monocyte heterogeneity 
Cell surface markers and functional activities distinguish multiple subsets of 
monocytes that include classical inflammatory and non-classical or patrolling (Table 1). 
Each monocyte subset responds to distinct chemotactic and trophic cues and equivalent 
subsets have been identified across multiple vertebrate species, including human, mouse, 
and rat [16, 35-37]. Dynamic and biphasic recruitment of monocyte subsets is a key feature 
of the early inflammatory response. Monocytes either persist in tissue as monocytes, 
repolarize to a different monocyte subset, or differentiate into macrophages [19]. 
Heterogeneity in the function and differentiation potential of monocyte subsets is important 
to consider in designing therapies to manipulate the innate immune microenvironment, 
particularly which subset to recruit and how to educate the cells upon recruitment to 
perform a desired function. 
Classical monocytes are characterized by high surface expression of Ly6C and 
CCR2, but low expression of CX3CR1 in mice [16]. Low expression of CD43 in rat 
indicates an equivalent population [36]. The human classical inflammatory subset is 
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CD14+CD16- [16, 35] and an intermediate population expressing both CD14 and CD16 [1]. 
Classical monocytes are derived from a dividing macrophage-dendritic cell precursor 
(MDP) or common monocyte progenitor (cMoP) in the bone marrow [38, 39] and have a 
half-life of about 20 hours in the blood during homeostasis [14]. They are elevated in 
circulation following inflammatory injury with a peak concentration near 48 hours, and the 
magnitude of mobilization scales with the severity of the inflammatory injury [40]. 
Table 1. Monocyte and macrophage subset characteristics. 
 













Mouse:   Ly6Chi,   
    CX3CR1lo, CCR2hi 
Human:  CD14+CD16- 
Rat:        CD43lo 





Mouse:   Ly6Clo,   
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Human:  CD14lo/-CD16+ 
Rat:        CD43hi 
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IL1β, TNFα, IL6, 


































CD163, MHCII IL10, MMP9, IL1β,  
[32, 41, 42, 
45] 
TNF, Tumor necrosis factor; IL, interleukin; iNOS, inducible nitric oxide synthase; CCL, CC-chemokine ligand; 
CXCL, C-X-C motif ligand; IFN, interferon; VEGF, vascular endothelial growth factor; FGF, fibroblast growth 
factor; PDGF-BB, platelet-derived growth factor; TIMP, tissue inhibitor of metalloproteinase; YM1, chitinase-
like 3; Fizz1/RELMα, resistin-like molecule alpha1; IGF1, insulin-like growth factor 1; SPHK1, sphingosine 
kinase 1; MMP9, matrix metalloproteinase 9 
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The source of this increase is likely mobilization from primary reservoirs in the bone 
marrow and spleen [46] and requires expression of CCR2 [14]. Early during the innate 
immune response, classical monocytes are recruited from blood to sites of inflammation 
utilizing integrin α4β1 and L-selectin (CD62L) to arrest on the endothelium [47-49] and 
chemokine receptors CCR2 and CCR5 to migrate toward gradients of inflammatory 
cytokines such as monocyte chemoattractant protein-1 (MCP-1) [1, 50]. While classical 
monocytes are sparsely adherent and motile on the endothelium during steady-state, they 
rapidly adhere and transmigrate through the endothelium when the vessel is activated with 
inflammatory cytokines such as tumor necrosis factor α (TNF-α) or interferon gamma 
(IFN-γ) [48]. The MCP-1/CCR2 signaling axis is a major experimental tool for exploring 
the role of classical monocytes in tissue injury and could be utilized in biomaterials to 
specifically target classical monocyte recruitment. 
Non-classical monocytes have recently emerged as pro-regenerative cells that 
support activities such as matrix remodeling, arteriogenesis, and prevention of fibrosis [1, 
8, 9, 20]. Non-classical monocytes are characteristically Ly6Clo, CCR2- and CX3CR1hi in 
mice, CD14loCD16+ and CX3CR1+ in human, and CD43hi in rat [16, 35, 36] (Table 1). In 
addition, these monocytes express a particular signature of adhesion molecules, including 
high lymphocyte function-associated antigen 1 (LFA-1 or αLβ2 integrin) and low CD62L 
[1] that allow them to “patrol” or crawl on blood vessel walls during homeostasis [48, 49]. 
At steady-state, non-classical monocytes maintain a half-life in the blood of greater than 
two days, which is more than double the half-life of their classical counterparts [14]. 
Interestingly, knockout of CCR2  reduces  increases the circulation half-life of non-
classical monocytes to approximately 11 days, suggesting that classical monocytes limit 
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their lifespan of at steady state [14]. Two models exist for the origin of non-classical 
monocytes in blood circulation: they may differentiate from classical monocytes or directly 
from a MDP in the bone marrow [14, 38, 51]. Fate mapping, adoptive transfer, and new 
intravital imaging studies have elegantly shown transition of labeled classical monocytes 
to non-classical monocytes; however, these studies do not exclude the possibility that some 
are derived directly from progenitors in the bone marrow [4, 14, 16, 19, 38, 51]. Further 
evidence suggests that this differentiation is unidirectional [16]. The signals controlling the 
switch from classical to non-classical monocyte are not clear, although recent work 
suggests the transcription factor NR4A1 controls the development of non-classical 
monocytes and NR4A1 knockout mice have fewer non-classical monocytes in blood [51].  
Chemokine receptors that distinguish monocyte subsets may be particularly useful 
in impacting selective recruitment or activity of this subset. Non-classical monocytes 
exhibit higher migration to gradients of CX3CL1 due their higher expression of the cognate 
receptor CX3CR1 than classical monocytes [16, 52]. Additional chemotactic receptors, 
including the sphingosine-1-phosphate receptor 3 (S1PR3) and C-X-C chemokine receptor 
4 (CXCR4), are higher on non-classical monocytes and may contribute to enhanced 
sensitization to regenerative chemotactic signals [9, 16, 53, 54]. We have recently shown 
that localized release of SDF-1α, a CXCR4 ligand, or the S1PR3-targeting small molecule 
FTY720 can increase the recruitment of non-classical monocytes into injured skin tissue 
and position the cells along a gradient from the biomaterial source [9, 53, 54]. SDF-1a may 
also work in tandem with vascular endothelial growth factor (VEGF) to position monocytes 
in a perivascular niche in order to facilitate their role in vascular repair [55, 56]. Localized 
signals from biomaterials provide a powerful in situ opportunity to recruit cells along an 
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engineered gradient and also “educate” or modulate the response of recruited cells without 
impacting systemic inflammatory responses [9, 53, 54, 56, 57]. A clearer understanding of 
the signals that different monocytes respond to in vivo could provide valuable tools for 
engineering their recruitment and activity within injured tissues and biomaterial implants.  
2.1.3   Macrophage heterogeneity 
Inflammatory macrophages (M1) are the classically activated subset of 
macrophage. In vitro, naïve macrophages can be polarized to an M1 phenotype by 
treatment with IFN-γ, microbial stimuli such as lipopolysaccharide (LPS), and/or 
inflammatory cytokines such as TNF-α [42]. These cells produce many inflammatory 
cytokines, reactive oxygen species (ROS), and growth factors such as VEGF and FGF2 
[41, 58] upon stimulation (Table 1). IFN-γ can be provided in inflamed tissue by natural 
killer cells and T helper 1 (TH1) cells to activate or polarize macrophages [10]. The 
inflammatory cytokines produced by M1 macrophages support host defense through 
pathogen clearance, necrotic tissue clearance and activation of additional immune 
populations. Over-stimulation or failure to resolve the M1 response can be detrimental 
through activation and propagation of TH17 cells, which can contribute to tissue damage 
and autoimmune disease pathologies when not properly regulated [10].  
Anti-inflammatory macrophages (M2) are also known as “alternatively activated” 
macrophages due to a different set of activation signals compared to the M1 subset. This 
group of macrophages can be further subdivided into M2a, M2b, and M2c based on 
activation signals, cell surface receptors, and functional diversity (Table 1). In vitro, naïve 
macrophages can be polarized to an M2a phenotype by treatment with IL-4 receptor ligands 
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IL-4 and/or IL-13; an M2b phenotype can be achieved by treatment with immune 
complexes combined with toll-like receptor (TLR) or IL-1R ligands; and M2c 
macrophages are generated by IL-10 stimulation [42]. M2a macrophages, also called 
wound healing macrophages, express high levels of arginase 1 in response to IL-4, which 
allows them to generate precursors for collagen and fibroblast stimulating factors, thus 
supporting their role in extracellular matrix deposition and wound closure [10]. This 
matrix-remodeling role of M2a cells allows them to contribute to wound stabilization; 
however, must be carefully coordinated to avoid creating undesirable fibrotic changes in 
an injured tissue or surrounding a biomaterial implant [10, 45]. M2b and M2c macrophages 
contribute to suppressing inflammation through secretion of IL-10 [10]. M2 macrophages 
retain a great deal of plasticity and are thought to be able to shift through various transition 
states between M2a-c. A greater understanding of their specific functions in vivo has been 
difficult due to the complexity of signal integration and the lack of defined set of 
distinguishing markers for each class of macrophage.  
The monocyte to macrophage transition, particularly the phenotypes each 
monocyte subset produces and under what circumstances is the target of much recent 
investigation. Most studies support a model where classical monocytes are recruited to 
tissues and convert to non-classical monocytes and then to macrophages [4]. Some studies 
contend that non-classical monocytes are directly recruited from blood to supply 
monocyte-derived macrophages [8, 9, 59]. This distinction could be attributed to 
differences in tissue injury context; however, experiments to directly test this idea in injury 
models have not been performed [26]. Additionally, tissue monocytes that are 
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phenotypically similar to non-classical monocytes in terms of surface marker expression 
may differ significantly in function. 
2.2   Functions of monocytes and macrophages in tissue repair 
The site of tissue injury can be functionally equated to a niche, or “injury niche,” 
based on localized complex signaling that orchestrates the progression of inflammation and 
healing. After injury, rapid, spatially-controlled changes occur within the tissue through 
the evolutionarily-conserved endogenous program of clean-up, repair, and regeneration. 
The tissue microenvironment becomes rich with signals to recruit, position, and 
functionally instruct cells of the inflammatory system to program repair and inflammation 
resolution. Recruited cells further propagate the response by releasing their own paracrine 
signals that continue to guide inflammation even after their apoptotic clearance, as well as 
guide the activities of stem and progenitor cells present in the damaged tissue.  
Each tissue injury niche has a unique set of damage, recruitment, and education 
signals coordinating the repair response that arise from specialization within the tissue 
composition and the type of injury. Unique microenvironmental cues are created by sterile 
inflammation versus pathogen-mediated inflammation due to the damage-associated 
molecular patterns recognized by inflammatory cells rather than pathogen-associated 
molecular patterns. Similarly, ischemic injury can activate signaling divergent from 
traumatic injury based on induction of hypoxia signaling and ROS. Upon recruitment from 
the vasculature, monocytes differentiate into macrophages based on signals they encounter 
within the injury niche. Physiology/biology of the particular tissue also significantly 
impacts the way the injury niche orchestrates repair. For example, repair of a bony structure 
 14 
requires vastly different activities than regeneration of skeletal muscle. The local stromal 
cell and tissue resident macrophage populations, mechanical properties and organization 
of the tissue, and extent of vascularization and oxygenation could all contribute to 
differential engagement of immune cell populations in situ.  
2.2.1   Monocytes/macrophages in vascular remodelling 
Vasculature is a universal necessity for the delivery of oxygen and nutrients to 
tissue and vascular damage is a common feature of many injury sites. Ischemic and 
traumatic injuries produce vascular damage and induce the two major processes of post-
developmental vascular remodeling: angiogenesis and arteriogenesis. Regenerative 
therapies, including biomaterials or tissue engineered constructs, similarly must ensure 
proper oxygen and nutrient supply through remodeling or expansion of existing vascular 
networks [60]. Monocytes and macrophages have been implicated in supporting vascular 
network remodeling and growth in development, homeostasis, and repair [7, 23, 53-55, 61-
63] (Figure 1). During development, embryonic macrophages similar to an M2 phenotype 
physically associate with sprouting angiogenic tip cells to guide connections between 
fusing vessels in both murine and zebrafish models [23]. This direct association of 
macrophage and endothelial cell suggests that the positioning of myeloid cells relative to 
vessels is important for their pro-angiogenic function and highlights the potential 
importance of spatially guiding recruited myeloid cells with immunoregenerative material 
strategies. Genetic mutation of colony stimulating factor receptor 1 (CSFR1) in the 
osteopetrotic (op/op) mouse, which is essential to normal myeloid development, causes not 
only a reduction in circulating monocytes and tissue macrophages, but also aberrant and 
immature vascular networks [7, 23].  
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Figure 1. Mononuclear phagocytes in regenerative medicine. During injury, 
subpopulations of monocytes (classical and non-classical) are recruited from circulation, 
where they can persist transiently as monocytes or differentiate into macrophages ranging 
in phenotype from M1-type to M2-type. Within the specific injury niche, monocytes and 
macrophages can guide tissue repair by promoting angiogenesis and arteriogenesis, 
secreting growth factors that guide progenitor cell differentiation and proliferation, 
regulating the secretome of parenchymal cells, and releasing inflammatory mediators that 
guide other immune cells. 
 
Monocyte recruitment to sites of vessel injury and their ability to adhere to the 
endothelium [64] have been correlated with the extent of collateral arterial growth [9, 54, 
62, 65] and effective angiogenesis [66]. In a typical biphasic injury response, classical 
monocytes are the first monocytic responders, followed by the appearance of non-classical 
monocytes around 3 days later. Loss of CCR2, which leads to removal of classical 
monocytes from the blood and decreased tissue myeloid cells [14], impairs the 


































MCP-1 infusion into the ischemic hindlimb increases total monocyte accumulation in 
parallel with increased density of collateral arteries and number of sprouting capillaries 
[63]. MCP-1 is a key chemotactic molecule for classical monocytes, so this suggests a role 
in arteriogenesis following ischemic damage. Constitutive overexpression of MCP-1 in 
heart tissue leads to severe damage to the myocardium that is related to persistent monocyte 
infiltration and macrophage tunneling within cardiac tissue [68]. Collectively these studies 
suggest that pro-inflammatory mononuclear cells may be essential for effective 
vascularization, although overzealous activation of these cells can lead to tissue damage.  
The precise roles of classical and non-classical monocyte subsets during vascular 
remodeling remains unknown; however, some studies suggest that inflammatory myeloid 
cells are the primary producers of VEGF [41, 69]. Pathologically, VEGF can be 
upregulated by endothelial cells or pericytes in a stress response to hypoxia to stimulate 
angiogenesis. Transgenic organ-specific VEGF induction causes robust tissue infiltration 
of circulating monocytes [55]. Increased transgenic VEGF expression causes perivascular 
cells to produce the chemotactic factor SDF-1α, which positions monocytes in close 
proximity to vascular structures, allowing for reciprocal paracrine signaling between the 
monocytes and the vasculature [55]. While this study did not characterize the subset of 
monocyte that was recruited, the expression of CX3CR1 and CXCR4 suggest that these 
cells may be non-classical monocytes [54]. Release of SDF-1α from a biomaterial implant 
in a dermal inflammatory wound causes an increase in the early recruitment of non-
classical monocytes, which correlated with later parameters of vascular network expansion 
[54]. Intravascularly, non-classical monocytes patrol the endothelial layer for signs of 
damage and assist in clearing apoptotic endothelial cells [18]. Loss of IL-4 receptor α, 
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which plays a major role in M2a polarization, leads to massive hemorrhage and delayed 
epithelialization in a skin injury model, highlighting the critical role these cells play in 
supporting repair [45]. Monocyte/macrophage subset discrimination analysis has 
suggested that enhancing the number of anti-inflammatory monocytes/macrophages 
correlates with increased vascular remodeling [9, 54]. The precise mechanisms by which 
each subset of myeloid cell contributes to vessel development and stabilization remains to 
be fully elucidated; however, secretion of soluble factors [4], matrix deposition/remodeling 
[70], and stabilization of nascent endothelial sprouts [23] are likely to mediate the process. 
2.2.2   Monocytes/macrophages in musculoskeletal repair 
Repair of the damaged musculoskeletal system has been a major focus in tissue 
engineering and regenerative medicine, which can be broadly divided into therapies that 
target injured muscle and those that target bone repair. Muscle tissue maintains the ability 
to regenerate in the adult through maintenance of a quiescent resident stem cell population 
known as satellite cells or myogenic precursor cells. Macrophages in injured muscle can 
produce pro-regenerative growth factors such as IGF-1 to stimulate the activity of muscle-
resident stem cell population- satellite cells (Figure 1). CCR2-deficient muscle displays a 
significant healing defect accompanied by a dampened macrophage response, which can 
be partially rescued by exogenous IGF-1 [25]. During skeletal muscle toxin-induced injury, 
the myeloid response is characterized by an early infiltration of inflammatory 
monocytes/macrophages for the first 4 days after injury, followed by the appearance of 
anti-inflammatory monocytes/macrophages beginning around 4 days after injury [4]. This 
switch appears to be due to in situ differentiation of classical monocytes into anti-
inflammatory monocytes/macrophages [4]. Similar biphasic kinetics of early M1 cells 
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followed by M2 cells in the muscle tissue have been observed in other skeletal muscle 
injury models [71, 72]. In vitro, M1 macrophages stimulate proliferation of myogenic 
precursor cells, while M2a and M2c cells increase myotube formation [4, 73]. Blockade of 
M2 polarization by transgenic knockout of IL-10 causes an increased/sustained M1 
response and poor regeneration in an injured muscle [71]. Most work exploring the role of 
myeloid cells in skeletal muscle repair has not been performed using traumatic models of 
muscle loss; consequently, additional studies are needed to determine whether the cellular 
immune response is similar across different types of muscle injuries.   
While a role for monocytes and macrophages in bone repair is just beginning to be 
appreciated [74], bone has received significant attention in the field of regenerative 
medicine. During homeostasis, osteal macrophages form a canopy structure along the 
endosteal bone surface, and their depletion either with clodronate liposomes or 
macrophage-Fas-induced apoptosis (Mafia) transgenic mice rapidly eliminates bone-
forming osteoblasts [75, 76]. Macrophages appear to directly signal to osteogenic cells, as 
they promote mineralization during in vitro co-culture through soluble cues [75]. Long-
term depletion of macrophages in the Mafia mouse results in severe osteopenia [77], and 
genetic depletion of macrophages results in shorter bone length and reduced bone density 
by three months of age [78]. During bone injury, monocytes and macrophages play diverse 
roles in repair, modulating the acute inflammatory response [22], producing growth factors 
such as bone morphogenetic protein (BMP)-2 [79] and PDGF-BB [80], and inducing 
ostegeonesis of mesenchymal progenitor cells [75, 78] (Figure 1). Impaired monocyte 
trafficking induced by genetic knockout of CCR2 does not affect osteoclast numbers, but 
impairs vascular remodeling and delays bone repair [81]. Macrophages are also required 
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for callous formation after fracture and they localize to regions undergoing early 
endochondral ossification [82]. Depletion of macrophages significantly impairs 
intramembranous bone repair [83] and prevents fracture repair, resulting in fibrotic tissue 
formation instead of endochondral bone [78]. These studies indicate that monocytes and 
macrophages are multi-faceted cellular regulators of the healing response after bone injury, 
and likely represent a powerful target for immunoregenerative therapies. 
2.3   Innate immune response to engineered materials 
Biomaterials afford many advantages as a system to exploit the repair functions of 
monocytes/macrophages; however, foreign materials unavoidably elicit a biological 
response when implanted in vivo. The immune response must be carefully considered in 
the material design in order to avoid unwanted cell recruitment/adhesion, excessive 
secretion of inflammatory cytokines, fibrous encapsulation, or chronic inflammation [84, 
85]. Immunomodulatory or immunoregenerative materials seek to tune this inflammatory 
response typically through biomolecule or small molecule delivery. As the innate immune 
response is highly dynamic, spatial and temporal control over delivery may be critical to 
target specific phases of inflammation and repair in vivo. Localized release can be utilized 
to generate a gradient of a particular compound, which is important for providing spatial 
information to innate immune cells in order to recruit them to the desired site. Materials 
can also be used to provide a substrate or scaffold to organize complex tissue 
reconstruction, however, can face challenges such as proper integration into host tissue, 
vascularization, and circumventing fibrosis and the foreign body response [85]. By 
engineering material properties and biomolecule delivery, the biological response can be 
controlled to maximally promote repair, but not prolong the inflammatory response. 
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2.3.1   Passive inflammatory response to material implantation 
Implantation of a foreign material induces a physiological response that is both 
spatially and temporally regulated, and varies widely depending on the material properties 
[86]. Within 5 seconds of contact with whole blood, protein adsorption and platelet 
activation occurs on titanium oxide surfaces [87]. The composition and bioactivity of 
adsorbed proteins evolves over time and depends on the concentration of proteins in the 
surrounding microenvironment, their affinity for the material surface, and their 
conformation on the surface [88]. Adsorbed plasma proteins include albumin, extracellular 
matrix proteins such as fibronectin and vitronectin, and complement proteins. While in vivo 
studies on the precise composition and magnitude of adsorbed proteins are limited, some 
measurements have been made. Mass spectrometry analysis of adsorbed proteins collected 
from PEG hydrogels revealed that albumin is the most abundant protein after 30 minutes 
of subcutaneous implantation in mice [89].  
Implantation of a material is believed to induce an inflammatory response that 
mimics many of the cell recruitment patterns observed in response to other inflammatory 
stimuli, but may also represent a unique context. Neutrophils are recruited within 16 hours 
after material implantation during the acute inflammatory phase [90] and may persist for 
as long as two weeks, as is the case for non-degradable microparticles implanted in the 
mouse peritoneum [91]. Neutrophil recruitment may be mediated by histamine released 
during mast cell degranulation in response to material implantation [90]; however, damage-
associated molecular patterns recognized by tissue resident macrophages are also known 
to initiate neutrophil recruitment by producing inflammatory mediators such as TNF-α and 
IL-6 [92].  Neutrophil activation and degranulation results in the release of proteolytic 
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enzymes and ROS that may contribute to material degradation [93], as well as initiate 
subsequent phases of inflammation [92]. 
Monocytes are recruited from circulation in response to mediators released from 
neutrophil granules that alter local chemokine production by endothelial cells and resident 
macrophages, as well as induce expression of intercellular adhesion molecules. For 
example, proteinase-3 release from neutrophil secondary granules induces MCP-1 
production by endothelial and upregulates ICAM-1 and VCAM-1 [94]. Extravasated 
monocytes differentiate into macrophages or dendritic cells in response to M-CSF or GM-
CSF, respectively [95]. Crosstalk with other immune cells, including apoptotic neutrophils 
[96] and paracrine signals derived from T helper cells [97], regulate the phenotype of 
macrophages. Macroscale biomaterials induce a unique response in macrophages that 
involves cell fusion and formation of foreign body giant cells (FBGC) that are believed to 
be the result of frustrated phagocytosis [85]. While these cells are not fully characterized 
at the transcriptional and protein level, they are induced by IL-4 and IL-13 signaling [98], 
similar to alternatively activated macrophages, but can also produce both TNF-α and TGF-
β [99]. The role of FBGC in the inflammatory response to degradable materials such as 
natural matrices or synthetic matrices with engineered degradation sites remains unknown.  
Immune cells recruited to the material interact with the surface through integrin 
ligation to adsorbed proteins such as complement proteins, fibrinogen, and fibronectin 
[100, 101]. Integrins are heterodimeric proteins composed of an alpha and beta chain that 
pair in a cell type-specific manner to enable cell-matrix and cell-cell interactions [102]. 
Phagocytes (including neutrophils, monocytes, and macrophages) can express the β1, β2, 
and β3 chains, which dimerize to form integrins that include αLβ2 (LFA-1), αMβ2 (Mac-1), 
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α5β1, and αVβ3 [102]. The affinity of specific integrins for their ligand may be dependent 
on cell activation, as is the case for α4, which undergoes a conformational change after 
exposure to SDF-1 or the complement protein C5a that enhances subsequent binding to 
VCAM-1 [103]. Integrin expression can also be activation-dependent, as local 
administration of TNF-αto the vasculature increases expression of Mac-1, but not LFA-
1, on neutrophils and monocytes [104]. Integrin signaling typically modulates Rho GTPase 
activity, which subsequently induces cytoskeletal remodeling [105]. While formation of 
focal adhesions and cell migration are initiated on short time scales (minutes to hours), 
integrin signaling can alter transcriptional programs that impact longer-term processes such 
as cell survival and differentiation [106, 107].  
Integrin signaling appears to play different roles in leukocyte migration, depending 
on the context in which the cell is migrating. For example, monocytes utilize integrins 
(particularly LFA-1) to crawl along the endothelium and extravasate across the endothelial 
barrier [49, 108]. Conversely, leukocyte migration through interstitial space that does not 
involve interactions with 2D surfaces is not integrin-dependent and instead involves 
amoeboid-like flowing and squeezing motions [108]. Integrins (particularly Mac-1) are 
required for macrophage adhesion to complement proteins adsorbed to biomaterial surfaces 
[100]. Additionally, integrins appear to play key roles in mediating the function of 
biomaterial-associated leukocytes, as blockade of Mac-1 in macrophages reduces pro-
inflammatory cytokine production and reduces fibrous encapsulation [109]. Mac-1 
signaling is also critical for macrophage fusion and subsequent FBGC formation [110, 
111]. Consequently, integrins appear to be the key molecular tool that leukocytes use to 
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interact with a material surface, and integrin signaling can significantly impact 
inflammatory cascade.  
  While many steps in the inflammatory cascade are conserved across tissues, the 
precise host response is also dictated by the implantation site. For example, PEG hydrogels 
displayed differences in the magnitude and composition of the inflammatory cells when 
implanted subcutaneously versus in the abdominal cavity or muscle [112]. The properties 
of the material, either those inherent to the selected material or those introduced by design, 
significantly alter the behavior of immune cells interacting with the material [101]. 
Physical properties such as geometry, topography, and porosity and biochemical properties 
such as surface chemistry, ligand functionalization, and degradation mode are critical 
factors in the host response to the material (Figure 2). 
2.3.2   Physical properties 
Material geometry on the bulk, micro, and nano scale, can greatly impact material-
host interactions and presents an opportunity to design features of a material to best hone 
the inflammatory response. Phagocytic cells like monocytes and macrophages are primary 
responders to foreign materials and the ability of these cells to interact with the material is 
greatly impacted by the shape and size. Pathophysiologically, myeloid cells use size and 
shape of microbes they encounter to dictate the immune response they signal [113]. 
Geometry can influence the ability of cells to adhere to a surface, phagocytose, or align 
with one another.  Spherical materials appear to induce far less fibrous encapsulation than 
cylindrical or materials containing sharp angles [114]. Moreover, a spherical diameter 
around 1.5mm is superior to smaller spheres across a wide range of materials (including 
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alginate hydrogels, stainless steel, and glass) for reducing foreign body response perhaps 
due to reduced cell attachment to the particle surface [114]. Macrophages are most able to 
phagocytose microspheres around 2µm in diameter, both in terms of the number of 
microspheres internalized and their total volume [115]. Microsphere shape is equally 
important, as macrophages detect a “local shape” at the initial point of contact that 
determines whether they will spread along or initiate phagocytosis of the material [116]. 
Interestingly, a wide range of shapes can be engulfed by macrophages if the initial 
orientation is correct and total size primarily affects completion of phagocytosis. Further, 
the sub-micron size of particles can determine whether a particle is engulfed by endocytosis 
(~150nm) versus phagocytosis (~500nm), a distinction that could impact the extent of 
macrophage activation [117]. Liposomal material strategies can take advantage of the 
phagocytic nature of monocytes and macrophages to specifically target drug delivery to 
myeloid cells. Phagocytosis of unilamellar nano-liposomes (~200nm) has been exploited 
experimentally as a tool to specifically deplete mononuclear phagocytes with clodronate-
loaded liposomes [2].  
Topographical cues at the micro or nano scale direct macrophage responses to 
materials after implantation, including adhesion, spreading, migration, and activation. 
Murine macrophages appear unable to detect nano-topographical features less than 150nm, 
whereas cells such as fibroblasts and endothelial cells are able to detect smaller 
topographies and display decreased spreading as feature size increases from 55nm to 
200nm [118]. Parallel gratings made of different polymers ranging from 250-2000 nm 
promote spreading and elongation of unpolarized macrophages and impact secretion of 
M1-associated cytokines such as TNF-α, MCP-1, and VEGF [119]. Electrospun fibers, 
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which can create scaffolds mimicking natural extracellular matrix, support differing 
macrophage responses based on diameter, packing, and alignment features [120-122]. The 
topographical orientation appears to also be important, as randomly-oriented nanofibers 
reduce fibrous encapsulation in vivo compared to aligned nanofibers or non-patterned 
substrates [122]. Material geometry and topography can be used to engineer desired 
inflammatory outcomes. For example, micro-patterned lines of fibronectin (20µm in width) 
promote macrophage elongation, reduce inflammatory cytokine production, and prime 
these cells for differentiation into M2 macrophages compared to larger patterns or no 
patterning [123]. Generally, porous implants are more readily vascularized and can exhibit 
lower fibrous encapsulation than their non-porous counterparts [124, 125]. 
Polytetrafluoroethylene materials with pores 4.4µm in width increase secretion of IL-1β 
by human monocytes in vitro compared to non-porous materials or those with smaller pores 
(1.2 or 3.0µm), but reduce fibrous encapsulation in vivo [126]. Consequently, single 
outputs measured during in vitro screens may not directly correlate with in vivo outcomes, 
particularly due to the complexity of the inflammatory response. 
2.3.3   Surface properties 
The chemical makeup of the material impacts properties such as surface charge and 
hydrophobicity. For small cellulose microspheres, macrophages are less able to 
phagocytose non-ionic hydrophilic particles, demonstrating an 8-fold increase in 
phagocytosis for particles that are highly anionic or a 4-fold increase for highly cationic 
particles [115]. Negatively charged particles induce apoptotic clearance of classical 
monocytes following scavenger receptor-dependent uptake in the circulation. A negative 
charge was required for therapeutic efficacy in preventing classical monocyte 
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accumulation and reducing disease symptoms during myocardial infarction, encephalitis, 
colitis, and other experimental inflammatory diseases [127]. The surface properties of 
macro-materials impact the foreign body response, with hydrophilic or anionic surfaces 
causing macrophage apoptosis and inhibiting macrophage fusion in vivo compared to 
unmodified, cationic, or hydrophobic surfaces [128]. Effects on macrophage function by 
surface properties of the material may be due to variations in the type [129] and 
conformation [107] of adsorbed proteins or related to the charged regions on macrophage 
membranes [130]. 
2.3.4   Mechanical properties 
Like many other cell types, macrophages are able to detect mechanical properties 
of their substrate such as stiffness [131-133]. Soft PEG hydrogels (modulus of 130 
kilopascals (kPa)) prevent macrophage spreading and formation of actin stress fibers, as 
well as prevent inflammatory gene expression in vitro and fibrous encapsulation in vivo 
[132]. Stiffer hydrogels (up to 840 kPa) prime macrophages for higher expression of IL-1β 
and IL-6, and promote generation of thicker fibrous capsules in vivo. A decrease in 
inflammatory response with decreasing material stiffness applies to even softer substrates 
such as polyacrylamide hydrogels below 150 kPa [131]. Interestingly, inflammatory 
mediators such as IFN-γ or LPS increase the elasticity of the macrophages [131]. 
Consequently, cellular mechanics can be regulated both by substrate properties and through 
biochemical cues in macrophages. 
  
 27 
2.3.5   Incorporation of adhesion sites  
The emergence of chemical conjugation strategies that enable biomaterials 
scientists to have precise control over material bioactivity has paved the way for the next 
generation of biomaterials. For example, bioorthogonal click chemistry has increased 
opportunities to develop diverse and complex materials that are both biocompatible and 
biofunctional. Hydrogels have been increasingly utilized in tissue engineering for their ease 
of tunability to specific applications, relative inertness in vivo, and compatibility for cell 
and biomolecule delivery. Inflammatory cell interactions with materials are mediated by 
adsorption of proteins such as albumin, fibrinogen, and components of the complement 
system [89, 134], which is dictated by properties such as surface chemistry and 
hydrophobicity. Due to their protein-fouling nature, hydrogels often must be functionalized 
with adhesive ligands such as the integrin recognition site arginylglycylaspartic acid 
(RGD) to induce cell attachment to their surface. Poly(ethylene glycol) (PEG) hydrogels 
with functionalized with RGD adsorb less protein than unfunctionalized hydrogels 
following subcutaneous implantation in vivo, although the relative composition of 
adsorbed protein remains approximately 90% the same [89]. Functionalization with RGD 
reduces inflammatory gene expression by macrophages in vitro [135], and reduces the 
inflammatory response to non-degradable PEG hydrogels in vivo [136]. Interestingly, a 
delay in RGD presentation via in vivo light-triggered activation reduces the fibrous capsule 
thickness surrounding implanted PEG hydrogels [61], highlighting the potential 
importance of spatiotemporal control of biomaterial features. Components of the 
extracellular matrix may inherently be immunomodulatory, as coating polypropylene 
meshes with various types of extracellular matrices shifts the macrophage response from 
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M1 to M2 and reduces the foreign body response [137]. Taken together, adhesive ligands 
enable better integration with surrounding tissue, which may reduce the material-mediated 
inflammatory response. 
2.3.6   Degradation 
Incorporation of degradation sites has enabled more precise control over the 
kinetics and mechanism of degradation, as well as release rates of embedded biomolecules 
that are diffusion-limited. Protease-sensitive linkers allow a material to be 
environmentally-responsive in the sense that degradation depends on the abundance of 
proteases surrounding the material. Proteases such as MMP-2, MMP-9, and cathepsins are 
upregulated during the early stages of inflammation. Materials that degrade in response to 
MMP activity promote better integration with host tissue and healing compared to non-
degradable materials [138]. The rate of degradation can be further controlled by tuning the 
affinity, avidity, and protease specificity of crosslinkers used [139]. Growth factor delivery 
can be engineered to be environmentally-responsive through conjugation to PEG 
monomers with a protease-sensitive linker [140]. While protease-sensitive materials, as 
well as similar pH-sensitive materials, are able to dynamically respond to their 
environment, they are not able to respond to user-defined stimuli. Consequently, an 
emerging field in biomaterials that will likely be a critical component of 
immunoregenerative therapies, is the application of materials that can be regulated 
temporally be external stimuli such as light, ultrasound, and heat [141]. For example, 
macrophage and neutrophil adhesion to hydrogels can be activated by transdermal 
application of ultraviolet light due to functionalization with “caged” adhesive ligands. Non-
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invasive adhesive ligand activation 7 days post-implantation reduces fibrous encapsulation, 
providing control over the inflammatory response in both space and time [61].  
2.3.7   Biomolecule delivery 
Delivery of synthetic and natural molecules from implanted materials can be used 
to further modulate the host response. Generally, biomolecules embedded to regulate 
monocyte and macrophage function can target the following biological processes: 1) 
recruitment of monocytes and macrophages from blood or surrounding tissue, 2) 
monocyte/macrophage polarization state, and 3) macrophage proliferation. Recruitment 
can be controlled by locally delivery of chemokines that selectively target monocytes and 
macrophages, such as MCP-1, SDF-1, CX3CL1, or bioactive sphingolipids. This strategy 
can be further fine-tuned by selecting biomolecules that target monocyte/macrophage 
subsets. For example, SDF-1 delivery from heparin-PEG hydrogels can selectively 
enhance recruitment of non-classical monocytes, but not classical monocytes, by exploiting 
their relative overexpression of CXCR4 [54]. Delivery of MCP-1, which broadly recruits 
monocytes through CCR2, increased the frequency of arginase-positive M2 macrophages 
and improved endothelial cell transplantation [142]. Delivery of M-CSF from PEG 
hydrogels enhances macrophage accumulation in the cornea and better supports 
vascularization than VEGF [143], further indicating that targeting macrophages can 
improve repair. Polarizing cytokines can also be released to condition the local 
macrophages to a particular phenotype. Delivery of IL-4 from an agarose-based scaffold 
enhanced M2 macrophage bias in the local tissue and correlated with increase in peripheral 
nerve regeneration [144]. Sequential delivery of IFN-γ and IL-4 can be used to guide the 
kinetics of macrophage polarization on decellularized bone matrices to achieve a biphasic 
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inflammatory to regenerative macrophage profile [57]. Delivery of macrophage polarizing 
factors has been investigated silk matrices, either through adsorption or direct conjugation 
[145]. Inflammation-induced macrophage proliferation has only recently been appreciated 
and may provide a new therapeutic target, given that tissue macrophage expansion depends 
on IL-4 and M-CSF [146]. Material-based biomolecule delivery has the unique advantage 
of the ability to control both the spatial and temporal profiles of released molecules, both 
of which are critical aspects of the immunological response after injury. 
 
Figure 2. Biomaterial properties that affect monocytes/macrophages. The fate of 
monocytes and macrophages surrounding implants can be greatly affected by material 
properties, both those inherent to the selected material and those engineered to confer 
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additional functionality. Properties with effects on macrophages include topographical 
cues, mechanical properties such as elasticity and stiffness, porosity, functionalization with 
adhesive ligands, and release of biomolecules. 
2.4   Conclusions and future directions 
Proof-of-principle experiments have demonstrated that changes to specific material 
properties alter the biological response to implanted materials, but this may become more 
complicated when multiple parameters are simultaneously varied. For example, the foreign 
body response to materials varying significantly in surface chemistry, stiffness, and 
topography (polymers, ceramics, metals, and plastics) is most controlled by the material 
size [114], despite previous studies demonstrating that each of these properties can impact 
the inflammatory response. Consequently, high-throughput and empirical studies may be 
required when optimizing material design. While a set of unified principles describing the 
impact that material properties have on inflammatory cell response have yet to be 
developed, the design of next-generation immunomodulatory materials will likely rely on 






3. NON-CLASSICAL MONOCYTES ARE BIASED PROGENITORS 
OF WOUND HEALING MACROPHAGES2 
3.1   Abstract 
Successful tissue repair requires the activities of myeloid cells such as monocytes 
and macrophages that guide the progression of inflammation and healing outcome. 
Immunoregenerative materials leverage the function of endogenous immune cells to 
orchestrate complex mechanisms of repair; however, a deeper understanding of innate 
immune cell function in inflamed tissues and their subsequent interactions with implanted 
materials is necessary to guide the design of these materials. Blood monocytes exist in two 
primary subpopulations, characterized as classical inflammatory or non-classical. While 
classical monocytes extravasate into inflamed tissue and give rise to macrophages, the 
recruitment kinetics and functional role of non-classical monocytes remains unclear. Here, 
we demonstrate that circulating non-classical monocytes are directly recruited to polymer 
films within skin injuries, where they generate alternatively activated, wound healing 
macrophages. Utilizing selective labeling of blood monocyte subsets, we demonstrate that 
that non-classical monocytes are directly recruited to soft tissue injury and selectively give 
rise to alternatively activated macrophages. Reduction of non-classical monocytes with 
clodronate liposomes impairs generation of alternatively activated macrophages, while 
adoptive transfer of non-classical monocytes increases the frequency of donor-derived 
                                                
2 Adapted from: Olingy CE, San Emeterio CL, Ogle ME, Krieger JR, Bruce AC, Pfau DD, 
et al. Non-classical monocytes are biased progenitors of wound healing macrophages 
during soft tissue injury. Sci Rep. 2017;7:447. Published under Creative Commons license. 
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wound healing macrophages compared to adoptive transfer of classical monocytes. These 
results elucidate a previously unknown role for blood-derived non-classical monocytes as 
contributors to alternatively activated macrophages, highlighting them as key regulators of 
inflammatory response and regenerative outcome. 
3.2   Introduction 
The mononuclear phagocyte system plays a multi-faceted role in maintaining tissue 
homeostasis and responding to pathological processes such as autoimmune diseases, 
cancer, and aberrant wound healing. Monocytes circulate in the bloodstream during steady 
state and are robustly recruited to sites of inflammation, where they exert functions that 
include clearance of cellular debris, promotion of angiogenesis, and restoration of tissue 
integrity [95]. Circulating blood monocytes are considered a highly plastic and dynamic 
system of innate immune cells that initiate processes of organ and tissue remodeling [2, 95, 
147]. Immunologically smart interventions that exploit the division of labor between 
different monocyte and macrophage populations require an understanding of the roles that 
these cells play in promoting repair, as unchecked activity of innate immune cells can 
perpetuate tissue damage through chronic inflammation and fibrosis.   
Two distinct subpopulations of monocytes have been identified in mouse and 
human blood, which can be distinguished by well-characterized surface protein expression 
profiles. Classical inflammatory monocytes are identified by Ly6ChiCX3CR1loCD43lo 
expression in mice (CD14hiCD16- in human), whereas non-classical alternative monocytes 
are Ly6CloCX3CR1hiCD43hi in mice (CD14+CD16+ in human) [148]. A third population 
of intermediate monocytes characterized by intermediate expression of Ly6C in mice 
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(CD14hiCD16+ in humans) are thought to complement the functions of non-classical 
monocytes and may preferentially differentiate into dendritic cells within inflamed tissues 
[149, 150]. Under homeostasis, classical monocytes in blood decrease Ly6C expression 
and become non-classical Ly6Clo monocytes [14, 37], which patrol the luminal side of 
resting endothelium [49]. Classical monocytes also survey steady-state tissues and can 
traffic to lymph nodes without differentiating into macrophages [151]. During 
inflammation, monocytes exit peripheral blood and extravasate into tissue, where they may 
transiently persist as monocytes without differentiation and exert a host of functions within 
the damaged tissue [19, 56, 58, 151, 152]. Classical inflammatory monocytes present in 
the acute phases of injury secrete pro-inflammatory cytokines such as IL-6, iNOS, and 
TNF-α [152] and exhibit high levels of matrix metalloproteinase (MMP) and cathepsin 
production [8]. Conversely, Ly6Clo monocytes present later during inflammation secrete 
high levels of vascular endothelial growth factor (VEGF) and IL-10 and can induce 
endothelial cell proliferation to promote arteriogenesis [4, 8, 56]. We have previously 
shown that strategies that enhance the early recruitment of Ly6Clo monocytes correlate 
with later increases in arteriolar expansion and angiogenic activity [9, 54]. Recruited 
monocytes primarily differentiate into macrophages or dendritic cells, serving as an 
alternative source of wound macrophages to those derived from in situ proliferation of 
tissue resident populations [27]. 
Macrophages are highly responsive to cues within the injury niche, enabling them 
to dynamically modify their behavior in response to changes in the microenvironment and 
display extremely varied phenotypes. Classically activated (“M1”) macrophages are 
primary players in pathogen destruction, secretion of inflammatory cytokines, and driving 
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TH1-type responses [10]. Conversely, alternatively activated wound healing (“M2”) 
macrophages (of which a number of subtypes have been described [10]) are associated with 
pro-regenerative activities such as angiogenesis [153, 154], extracellular matrix 
remodeling [70], secretion of anti-inflammatory cytokines [10], and resolution of 
inflammation [155]. The highly complex and heterogeneous nature of inflamed tissue 
microenvironments has rendered a general description of macrophage origin and function 
challenging. Within toxin-induced muscle injury [4], liver fibrosis [156], infection [157], 
and autoimmune disease [158], classical Ly6Chi monocytes are recruited from circulation 
and undergo in situ  differentiation to be the primary contributors of injury Ly6Clo 
monocytes/macrophages. In contrast, sequential recruitment of classical Ly6Chi followed 
by non-classical Ly6Clo monocyte subsets after myocardial infarction [8], and direct 
recruitment of adoptively transferred Ly6Clo monocytes within excisional skin injury [9] 
and during the development of inflammatory arthritis [59] have been reported.  
Harnessing myeloid cell functions for regenerative medicine applications requires 
an understanding of the cues that direct the localization and fate of these cells. 
Immunoregenerative materials seek to leverage the function of endogenous immune cells 
to guide the progression of inflammation and repair damaged tissue [86]. For example, 
local delivery of stromal-derived factor-1 (SDF-1) from desulfated heparin-containing 
poly(ethylene glycol) (PEG) hydrogels increases the frequency of CXCR4hiLy6Clo 
monocytes, which promotes capillary network expansion [54]. Moreover, co-delivery of 
macrophage colony-stimulating factor (M-CSF) with VEGF from PEG hydrogels increases 
the density of macrophages and the maturity of corneal blood vessels compared to VEGF 
alone [143]. However, whether specific populations of blood monocytes give rise to 
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defined macrophage phenotypes surrounding implanted materials remains unknown. In the 
present study, we utilized fate mapping strategies including bead-based in situ labeling and 
adoptive transfer of monocyte subsets to demonstrate that non-classical monocytes 
preferentially give rise to CD206+ M2-like macrophages in response to biomaterial 
implantation within cutaneous wounds. These results shed light on the fate of specific 
monocyte populations following biomaterial implantation after injury and indicate that 
non-classical monocytes are a promising therapeutic target for harnessing pro-regenerative 
inflammation to promote repair.  
3.3   Results  
3.3.1   Systemic inflammatory response induced by skin wounding and biomaterial 
implantation  
The dorsal skinfold window chamber (DWC) model (Figure 3a) is a partial 
thickness excisional skin injury model that involves removing the epidermis and dermis to 
reveal the underlying sub-reticular vasculature (Figure 3b). We have previously used this 
model to investigate the recruitment of distinct monocyte subsets to inflamed tissue 
surrounding biomaterial implants [9, 54, 159]. In this study, the fate of monocytes that are 
recruited in response to cutaneous wounding and material implantation was tracked. 
Monocytes can be identified both in blood circulation and extravascular tissue space by 
gating out neutrophils (Ly6G+), and subsequently gating on CD11b+SSClo cells. Ly6C is 
differentially expressed by monocyte subsets within this population (Figure 3c).  
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Figure 3. Wounding and biomaterial implantation induces acute changes in 
circulating monocytes. (a) Dorsal skinfold window chambers were implanted on C57/Bl6 
mice and excisional wounding was induced by removing the outer layers of the dermis. (b) 
PLGA polymer films were placed on the exposed subcutaneous layer. Scale bar, 500µm. 
(c) Blood was collected for flow cytometry analysis. White blood cells were gated on 
CD11b+SSClo expression and categorized as Ly6Chi, Ly6Cint, and Ly6Clo monocytes based 
on Ly6C expression. Ly6G+, dead blood cells were excluded from analysis. (d) 
CD11b+SSClo monocytes and (e) Ly6Chi, (f) Ly6Cint, and (g) Ly6Clo monocytes per 
milliliter of blood 1 and 3 days post-injury. (h) Proportion of each monocyte subset 
expressed out of total CD11b+SSClo monocytes. Data presented as mean ± S.E.M. *p<0.05 
relative to Day 0 blood by one-way ANOVA. n=5 animals per group. 
 
DWC surgery and implantation of a polymeric poly(lactic-co-glycolic acid) 
(PLGA) thin film 1mm in diameter decreased the frequency of blood monocytes by nearly 
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four-fold 1 day post-injury, followed by a three-fold elevation by 3 days post-injury 
compared to blood taken at day 0 prior to surgery (Figure 3d). A three-fold decrease in the 
frequency of circulating classical Ly6Chi monocytes was observed in the first day post-
injury, followed by a five-fold increase by day 3 (Figure 3e). Ly6Cint monocytes were 
similarly decreased at day 1 by three-fold fold following injury but returned to baseline 
levels by day 3 (Figure 3f). Non-classical Ly6Clo monocytes also initially decreased (by 
five-fold), but then increased by five-fold relative to day 0 (Figure 3g) and were the most 
abundant type of monocyte in blood for the duration of the study (Figure 3h).  
These changes in circulating myeloid cell populations were accompanied by 
corresponding relative changes in bone marrow cell populations. At 3 days post-injury, 
higher frequencies of total, Ly6Chi, and Ly6Cint monocytes were detected in bone marrow, 
while the frequency of Ly6Clo monocytes decreased (Figure 4a-d). These results indicate 
that DWC surgery and biomaterial implantation induces systemic inflammation that 
involves alteration of blood monocyte composition and concomitant changes in bone 
marrow monocyte composition.  
 
Figure 4. Bone marrow monocyte composition after wounding. Frequency of (a) 
CD11b+SSClo monocytes and (b) Ly6Chi, (c) Ly6Cint, and (d) Ly6Clo monocytes within 
bone marrow 3 days post-injury. Data presented as mean ± S.E.M. *p<0.05 by two-tailed 
t-test. n=4-10 animals per group. 
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3.3.2   Recruitment of labeled Ly6Clo monocytes to injured skin 
To further probe the fate of blood myeloid populations that were altered after injury, 
in situ labeling techniques to track blood monocytes were used. Circulating monocyte 
subsets were labeled in vivo prior to DWC surgery to facilitate cell tracking of each 
monocyte population as they entered inflamed dorsal tissue surrounding polymer implants. 
Non-classical Ly6Clo monocyte labeling was performed by intravenous administration of 
fluorescent latex beads [160, 161] (Figure 5a). Within two hours of intravascular 
administration, latex beads are phagocytosed and equally distribute within Ly6Clo and 
Ly6Chi blood monocyte populations. However, by 24 hours after injection, latex beads 
primarily label Ly6Clo monocytes due to physiological conversion of labeled Ly6Chi 
monocytes and this labeling is sustained for up to 1 week [160].  Utilizing this strategy, 
blood Ly6Clo monocytes were selectively labeled compared to classical Ly6Chi monocytes 
after DWC (83.4 ± 9.7% Ly6Clo monocytes vs. 14.5 ± 9.3% Ly6Cint monocytes and 0.0 ± 
0.0% Ly6Chi monocytes, day 1 post-injury) and the label was retained at similar 
proportions during the study (Figure 5b,c). Analysis of digested explanted dorsal skin 
tissue showed labeled cells originating from Ly6Clo monocytes primarily remained Ly6Clo 
within tissue (Figure 5d). The lower frequency of Ly6Chi monocytes carrying the label in 
the tissue (9.6 ± 2.6% of LX+CD11b+SSClo cells) compared to the frequency of labeled 
Ly6Clo cells (44.3 ± 8.2% of LX+CD11b+SSClo cells) indicates that circulating Ly6Clo 
monocytes do not become Ly6Chi post-extravasation (Figure 5e).  
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Figure 5. Latex bead-labeled Ly6Clo monocytes recruited from blood circulation 
remain Ly6Clo in inflamed dorsal tissue. (a) Latex (LX) beads were injected 1 day prior 
to DWC surgery to selectively label blood Ly6Clo monocytes. (b) Representative flow 
cytometry dot plot and (c) quantification of labeled blood LX+CD11b+SSClo cells shows 
selective Ly6Clo monocyte labeling 1 day post-injury. (d) Representative flow cytometry 
dot plot of labeled monocytes collected from digested dorsal tissue 3 days post-injury and 
(e) quantification of labeled Ly6Chi and Ly6Clo monocytes. Data presented as mean ± 
S.E.M. *p<0.05 by one-way ANOVA or two-tailed t-test. n=4-11 animals per group.   
 
To explore whether non-classical monocytes differentiate into macrophages, 
expression of markers associated with macrophage differentiation and polarization on 
bead-labeled cells was measured (Figure 6a). Approximately half of labeled cells 
expressed F4/80, indicating that around half of recruited Ly6Clo monocytes convert into 
macrophages or are phagocytosed by macrophages by 3 days post-injury (Figure 6b). 
About half of total F4/80+CD11b+ cells expressed CD206 (Figure 6c), whereas labeled 
cells were more likely to be immunophenotyped as CD206+ macrophages (91.0±3.4% of 
LX+F4/80+CD11b+ cells) than CD206- macrophages (Figure 6d). These data suggest that 
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blood-derived Ly6Clo monocytes preferentially give rise to CD206+ wound macrophages 
in inflamed tissue surrounding material implants. 
 
Figure 6. Latex bead-labeled Ly6Clo monocytes recruited from blood circulation 
selectively give rise to CD206+ alternatively activated macrophages. (a) Gating 
strategy for tissue macrophages at 3 days post-injury. Tissue cells were gated on 
CD11b+F4/80+ cells to identify macrophages and subsequently assessed for CD206 
expression for macrophage subpopulation analysis. (b) Frequency of bead-labeled F4/80+ 
cells in animals with labeled blood Ly6Clo monocytes. (c) Frequency of CD206+ and 
CD206- cells out of total F4/80+CD11b+ cells. (d) Frequency of bead-labeled CD206+ 
cells out of total F4/80+CD11b+ cells. Data presented as mean ± S.E.M. *p<0.05 by two-
tailed t-test. n=4-11 animals per group. 
 
3.3.3   Recruitment of labeled Ly6Chi monocytes to injured skin 
Circulating Ly6Chi blood monocytes were tracked in complementary bead-based 
labeling studies to explore whether these cells adopted similar fates during inflammation. 
Ly6Chi monocytes were labeled by sequential administration of clodronate-loaded 
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liposomes 2 days prior to injury followed by latex beads 16 hours later (Figure 7a), as 
previously described [160, 161]. Clodronate liposomes administered intravascularly 
transiently deplete all blood monocytes, resulting in accumulation of latex beads in bone 
marrow cells that reappear in circulating Ly6Chi monocytes 2 days later [160]. Pre-
administration of clodronate liposomes before latex bead injection preferentially labeled 
Ly6Chi monocytes (70.8 ± 13.3% Ly6Chi monocytes vs. 26.9 ± 12.9% Ly6Cint monocytes 
and 2.7 ± 0.9% Ly6Clo monocytes, day 1 post-surgery) during the study (Figure 7b,c).  
 
Figure 7. Selective labeling of blood Ly6Chi monocytes. (a) Blood Ly6Chi monocytes 
were selectively labeled by first depleting blood monocytes with intravascular clodronate 
liposome (Clod Lip) administration 2 days prior to injury, followed by LX bead-based 
labeling 16h later. (b) Representative flow cytometry dot plot and (c) quantification of 
labeled blood LX+CD11b+SSClo cells shows selective Ly6Chi monocyte labeling 1 day 
post-injury. Data presented as mean ± S.E.M. *p<0.05 by one-way ANOVA. n=4 animals 
per group. 
 
A relatively low frequency of labeled Ly6Chi monocytes was detected in digested 
tissue (Figure 8a), confirming previous reports [4, 56, 58] that recruited Ly6Chi monocytes 
do not persist as Ly6Chi monocytes post-extravasation. Ly6Chi monocytes likely rapidly 
convert in situ into Ly6Clo monocytes, as a significantly greater frequency of labeled 
Ly6Clo monocytes than Ly6Chi monocytes were detected (Figure 8b). The frequency of 
F4/80+ cells within the latex bead-positive (LX+) population was not different between 
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Ly6Chi monocyte and Ly6Clo monocyte labeling (47.5± 17.3% vs. 48.0 ± 6.2% of LX+ 
cells), suggesting that both monocyte populations are equally capable of acquiring a 
macrophage phenotype after extravasation (Figure 8c). Labeled Ly6Chi monocytes showed 
no preference for acquiring CD206 expression within 3 days of injury (Figure 8d), 
indicating that although blood-derived Ly6Chi monocytes can contribute to CD206+ 
macrophages, they do so at a lower frequency than Ly6Clo monocytes after clodronate 
liposome administration.  
 
Figure 8. Tracking of latex bead-labeled Ly6Chi monocytes recruited from blood 
circulation. (a) Representative flow cytometry dot plot of labeled monocytes collected 
from digested dorsal tissue 3 days post-injury and (b) quantification of labeled Ly6Chi and 
Ly6Clo monocytes. (c) Frequency of bead-labeled F4/80+ cells in animals with labeled 
blood Ly6Chi monocytes. (d) Frequency of bead-labeled CD206+ cells out of total 
F4/80+CD11b+ cells.  Data presented as mean ± S.E.M. *p<0.05 by two-tailed t-test. n=4 
animals per group.   
 
3.3.4   Reduction of circulating Ly6Clo monocytes impairs CD206+ macrophage 
generation  
Intravascular administration of clodronate liposomes transiently depletes all 
circulating monocytes; however, because blood Ly6Clo monocytes are primarily derived 
from the conversion of Ly6Chi monocytes, there is a delay in the repopulation of circulating 
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Ly6Clo monocytes [14, 37]. This tool was employed to examine how decreasing the 
quantity of circulating non-classical monocytes impacts the generation of CD206+ 
macrophages during wound healing. As expected, a deficit in blood Ly6Clo monocytes, but 
not Ly6Chi monocytes, was observed 5 days after clodronate administration (Figure 9a). 
No differences in either monocyte subtype (Figure 9b), total F4/80+ macrophages (Figure 
9c), or CD206- macrophages (Figure 9d) were observed in digested tissue 3 days post-
injury; however, a lower frequency of CD206+ macrophages was observed (Figure 9e). 
These findings suggest that circulating Ly6Clo monocytes are likely major contributors to 
the population of CD206+ wound macrophages.  
 
Figure 9. Loss of Ly6Clo monocytes impairs generation of CD206+ alternatively 
activated macrophages. (a) Clodronate liposome (Clod Lip) administration two days 
before DWC surgery reduced the frequency in blood of Ly6Clo monocytes, but not Ly6Chi 
or Ly6Cint  monocytes. (b) Frequency of Ly6Clo, Ly6Cint, Ly6Chi monocytes after Clod Lip 
administration in digested dorsal tissue 3 days post-injury. (c) Total CD11b+F4/80+ 
macrophages, (d) CD206- macrophages, and (e) CD206+ alternatively activated 
macrophages 3 days post-injury. Data presented as mean ± S.E.M. *p<0.05 by two-tailed 
t-test. n=4-11 animals per group. 
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3.3.5   Adoptively transferred Ly6Clo monocytes preferentially differentiate into 
CD301b+CD206+ macrophages  
To complement in vivo bead-based labeling strategies and further investigate the 
role that blood monocytes play in macrophage generation during inflammation, CD45.1+ 
Ly6ChiCD43lo or Ly6CloCD43hi monocytes were sorted and adoptively transferred into 
CD45.2 mice at the time of DWC surgery (Figure 10a). While Ly6CloCD43hi are a slightly 
more restricted population of Ly6Clo monocytes, these two populations primarily overlap 
and the same is true for Ly6ChiCD43lo monocytes (Figure 10b). At 3 days post-injury, a 
very low frequency of CD45.1+CD45.2- cells were detected in digested dorsal (Figure 
10c), indicating that few donor cells are present 3 days post-injury. A modest, but 
insignificant increase in the average number of total donor cells (normalized to tissue mass) 
originating as Ly6CloCD43hi relative to those adoptively transferred as Ly6ChiCD43lo was 
detected (Figure 10d).  
Donor cells collected from dorsal tissue 3 days post-injury were assayed for 
expression of monocyte and macrophage markers by flow cytometry (Figure 11a). 
CD301b marks a population of macrophages that appear in the midphase of skin wound 
healing and are required for effective cutaneous repair [162]. While F4/80 is present on all 
macrophages, co-expression of CD64 and MerTK exclusively distinguishes macrophages 
from monocytes [21]. These two populations significantly overlap, as 25.3 ± 2.1%  of total 
F4/80+CD11b+ cells are also CD64+MerTK+, but nearly all CD64+MerTK+ cells are 
F4/80+ (Figure 11a) and all F4/80+ donor-derived cells also expressed CD64 and MerTK 
(Figure 11b). We detected no difference in the overall number of CD64+MerTK+ 
macrophages in animal receiving adoptively transferred Ly6ChiCD43lo or Ly6CloCD43hi 
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Figure 10. Adoptive transfer of Ly6Chi and Ly6Clo monocytes for fate tracking. (a) 
CD45.1+ Ly6Chi or Ly6Clo monocytes sorted from pooled bone marrow, blood, and spleen 
were adoptively transferred by i.v. injection to CD45.2+ mice at the time of DWC surgery. 
(b) Monocytes were sorted based on CD11b+SSCloLy6G-Zombie- expression and 
Ly6ChiCD43lo expression or Ly6CloCD43hi expression. (c) Donor-derived cells were 
identified in dorsal tissue 3 days post-injury as CD45.1+CD45.2-. (d) Total donor cells per 
milligram of tissue in mice receiving Ly6Chi or Ly6Clo monocytes. Data presented as mean 
± S.E.M. n=5-6 animals per group. 
 
monocytes (Figure 11c).  However, a greater frequency of donor-derived wound healing 
CD301b+CD206+ macrophages was detected in animals receiving adoptively transferred 
Ly6CloCD43hi monocytes compared to those that received Ly6ChiCD43lo monocytes 
(Figure 11d). No differences in the frequency of CD301b-CD206+CD64+MerTK+  
(Figure 11e) or CD301b-CD206+F4/80+ macrophages (data not shown) were detected 
between the two grafts. These results further support the hypothesis that circulating non-
classical monocytes differentiate into wound repair macrophages.    
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Figure 11. Adoptively transferred non-classical Ly6Clo monocytes differentiate into 
CD206+ macrophages within inflamed peri-implant tissue 3 days post-injury. (a) 
Expression of F4/80, CD301b, and CD206 in MerTK+CD64+ macrophages. (b) Donor-
derived F4/80+CD11b+ cells are also primarily MerTK+CD64+ (representative dot plot 
taken from animal receiving Ly6Clo monocyte graft).  (c) Number of donor-derived 
macrophages (MerTK+CD64+) 3 days post-injury in mice receiving adoptive transfer 
Ly6Chi monocytes compared to mice receiving Ly6Clo monocytes. (d) Frequency of donor-
derived CD301b+CD206+ macrophages and (e) donor-derived CD301b-CD206+ 
macrophages. Data presented as mean ± S.E.M. *p<0.05 by two-tailed t-test. n=5-6 animals 
per group. 
 
3.3.6   Characterization of chemokine receptors on mononuclear phagocytes 
Our findings indicate that non-classical monocytes selectively give rise to 
alternatively activated macrophages, which play key roles in tissue repair [97, 144, 163]. 
In order to inform therapeutic targets for regulating recruitment of non-classical 
monocytes, we assessed the expression of the chemokine receptors sphingosine-1-
phosphate receptor 3 (S1PR3) and VEGF receptors 1 and 2 (VEGFR1 and VEGFR2). 
Peripheral blood was collected from mice expressing green fluorescent protein (GFP) 
under the CX3CR1 promoter (CX3CR1GFP/+ mice). CX3CR1hi monocytes primarily 
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overlap with the Ly6Clo monocyte population, and conversely, CX3CR1lo monocytes are 
primarily Ly6Chi (Figure 12a). Use of CX3CR1GFP/+ as a readout for monocyte subset 
substantially minimizes the use of antibodies, which is particular useful for detection of 
S1PR3, which does not have available fluorophore-conjugated antibodies.  S1PR3 surface 
expression is selectively higher on CX3CR1hi blood monocytes (Figure 12b,c). While a 
modest shift in VEGFR1 expression occurred in CX3CR1hi monocytes, we did not detect 
a significant difference in VEGFR1 expression between monocyte subsets (Figure 12d,e). 
VEGFR2 surface staining was higher on CX3CR1hi monocytes compared to CX3CR1lo 
monocytes (Figure 12f,g). These measurements indicate that elevated S1PR3 and 
VEGFR2 surface expression is a signature of non-classical monocytes. 
 
Figure 12. Expression of chemokine receptors in classical and non-classical 
monocytes. (a) Ly6C expression in CX3CR1hi monocytes and CX3CR1lo monocytes 
obtained from the blood of CX3CR1GFP/+ mice, which identify Ly6Clo monocytes and 
Ly6Chi monocytes, respectively. (b,c) S1PR3 surface staining in blood CX3CR1hi cells and 
CX3CR1lo cells. (d,e) VEGFR1 surface staining in blood CX3CR1hi cells and CX3CR1lo 
cells. (f,g) VEGFR2 surface staining in blood CX3CR1hi cells and CX3CR1lo cells. Data 




3.4   Discussion 
Monocytes are blood-borne mononuclear phagocytes that support tissue 
homeostasis and exit the vasculature at increased rates to differentiate into macrophages 
during inflammation. The precise relationship of circulating classical and non-classical 
monocyte subsets to defined macrophage populations remains unknown. We have shown 
that after skin wounding and biomaterial implantation, circulating non-classical monocytes 
extravasate into inflamed tissue and serve as biased progenitors of CD206+CD301b+ 
wound healing macrophages. Previous work has demonstrated that classical monocytes 
directly convert to non-classical monocytes and macrophages within inflamed tissue [4, 
19]. Therefore, these studies elucidate a complementary role for non-classical monocytes 
and argue that these cells primarily differentiate into alternatively activated macrophages.  
Non-classical Ly6Clo monocytes patrol resting endothelium during homeostasis 
[49], and are present in circulation at a slightly higher frequency than classical Ly6Chi 
monocytes (Figure 3h, 54.8±7.5% Ly6Clo monocytes vs. 30.4±5.6% Ly6Chi monocytes 
out of CD11b+SSClo cells). Interestingly, there was a transient reduction of circulating 
monocyte populations 1 day post-surgery, which could be due to acute cell recruitment 
from the blood to injured tissue, as monocytopoiesis occurs over several days [164]. As 
previously reported [8], circulating myeloid cells were elevated 3 days post-injury, 
including total CD11b+Ly6G-SSClo cells and Ly6Chi  and Ly6Clo subpopulations (Figure 
3e-g). Though a decrease in Ly6Cint monocytes was detected 1 day post-injury, there was 
no elevation at 3 days post-injury, indicating that the size of this population may not be 
altered by inflammatory stimuli. The observed changes in circulating cell populations 
during inflammation are likely due in part to alterations in myeloid cell trafficking from 
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the bone marrow, which displayed parallel changes in myeloid composition (Figure 4). 
These systemic changes in blood myeloid populations are likely a result of DWC surgery 
and not material implantation, as we have previously demonstrated that the number of 
rolling and adherent CX3CR1+ cells within dorsal skin vasculature is not significantly 
different between animals undergoing only DWC surgery and those that also received a 
PLGA implant [9].  
Intravascular non-classical Ly6Clo monocytes orchestrate the disposal of necrotic 
endothelial cells after activation with TLR7-targeted danger signals during inflammation 
[18, 49], whereas extravascular Ly6Clo monocytes can promote angiogenesis and matrix 
remodeling via secretion of VEGF and matrix metalloproteinases [8]. The unique protein 
signature of non-classical monocytes, characterized by higher VEGF, TGF-β, and IL-10, 
and lower TNF-α and IL-1β expression compared to classical monocytes has resulted in 
the suggestion that these cells may constitute a class of “anti-inflammatory” monocytes [4, 
8]. Previous studies have indicated that Ly6Clo monocytes in inflamed tissues such as 
skeletal muscle and focal hepatic injury are derived from cells recruited as Ly6Chi 
monocytes from the blood and are converted in situ to Ly6Clo monocytes to promote wound 
healing and tissue repair [4, 19]. Other reports suggest that Ly6Clo monocytes are directly 
and robustly recruited from the blood, leading to extravascular accumulation during 
inflammation [8, 49, 59]. While we observed that blood-derived Ly6Chi monocytes enter 
inflamed tissue, reduce Ly6C expression (Figure 8b), and differentiate into macrophages 
(Figure 8c, Figure 11c), our studies indicate that Ly6Clo monocytes are also directly 
recruited from circulation to injured tissues and able to give rise to macrophages (Figure 
11c-e). Previous studies have indicated that adoptively transferred Ly6CloMHCII- 
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monocytes do not infiltrate the skin [151], but this may be a result of differences in the 
grafted cell population (Ly6CloMHCII- monocytes vs. Ly6CloCD43hi monocytes in the 
current studies) or inflammatory stimuli (LPS injection vs. excisional skin injury in the 
current studies). Though Ly6Clo blood monocytes were decreased after clodronate 
liposome administration, no difference in the frequency of Ly6Clo monocytes was detected 
within injured skin (Figure 9b). Many studies have shown that Ly6Chi monocytes can 
convert to Ly6Clo monocytes in the blood or tissue [4, 37, 157]. Similarly, the presented 
data may reflect that, in the absence of Ly6Clo monocytes, circulation-derived Ly6Chi 
monocytes compensate and increase their rate of conversion into Ly6Clo monocytes in 
inflamed tissue. 
An important finding of this work is that circulating Ly6Clo monocytes 
preferentially contribute to the CD206+ wound macrophage pool within skin injury 
compared to Ly6Chi monocytes. Analysis of peri-implant tissue for recruited latex bead-
labeled Ly6Clo monocytes shows that this subset is predisposed to acquire a CD206+ 
alternatively activated M2-like [165] macrophage phenotype (Figure 5e, Figure 11d). 
Administration of clodronate liposomes enables selective labeling of Ly6Chi monocytes, 
while simultaneously reducing the frequency of Ly6Clo monocytes for 2-7 days after 
administration [37, 160]. Clodronate liposome-treated animals displayed no change in the 
frequency of overall macrophages within the skin injury after 3 days, but exhibited a 
decrease in the proportion of CD206+ macrophages (Figure 9e). Because tissue monocyte 
composition was unaffected by clodronate liposomes, these results may reflect a delay in 
generation of CD206+ macrophages. Additionally, the possibility that transient monocyte 
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depletion alters myeloid cell responses during inflammation cannot be excluded, as 
monocyte subsets are known to communicate with each other [14].  
Latex bead-based labeling strategies are useful because they overcome many of the 
limitations of adoptive transfer, including ex vivo cell manipulation, pooling of donor cells, 
and low sensitivity due to poor cell recovery [50]. Importantly, there is no evidence that 
these labeling techniques alter monocyte recruitment or systemic inflammation [50].  
However, interpretation of these studies relies on retention of latex beads within the cell 
that was originally labeled and no transfer to other cells. Therefore, cell tracking is best 
performed by use of complimentary tracking methods, including adoptive transfer, 
selective labeling techniques, and transgenic or knockout mice. Adoptive transfer of 
5.55x105 CD45.1+ Ly6Chi or Ly6Clo monocytes was performed by intravascular injection 
into CD45.2 mice at the time of DWC surgery (Figure 10). No differences were detected 
in the total number of CD45.1+ donor-derived cells per milligram of dorsal tissue between 
the two monocytes grafts, and further probed for markers of macrophage differentiation 
and polarization within donor cells. CD301b+CD206+ macrophages drive midstage skin 
regeneration by promoting fibroblast repopulation, cellular proliferation, and re-
epithelialization [162]. In these adoptive transfer studies, a higher frequency of donor 
Ly6Clo monocytes acquired a CD301b+CD206+ macrophage phenotype compared to 
donor Ly6Chi monocytes (Figure 11d), indicating that circulation-derived Ly6Clo 
monocytes may be intrinsically predisposed to convert to dermal wound healing 
macrophages. Conversely, there was no difference in the frequency of donor-derived 
CD301b-CD206+ or number of total macrophages between mice receiving Ly6Chi or 
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Ly6Clo monocytes. Taken together, these data support the hypothesis that non-classical 
monocytes undergo local conversion into alternatively activated macrophages. 
 Monocytes utilize chemokine receptors to migrate towards chemokine gradients 
produced during inflammation. Both VEGF and S1P are elevated after injury and are 
chemotactic for leukocytes [53, 166-168]. Blood-derived non-classical monocytes express 
higher levels of S1PR3 and VEGF2 on their surface compared to classical monocytes 
(Figure 12). We have previously demonstrated that non-classical monocytes also express 
higher levels of CXCR4 and are selectively recruited by heparin-PEG hydrogels delivering 
CXCR4’s chemokine ligand, SDF-1 [54]. Consequently, biomaterial-mediated strategies 
that increase recruitment of non-classical monocytes through S1PR or VEGF signaling 
may be a promising strategy to increase accumulation of pro-regenerative subsets of 
mononuclear phagocytes within injured tissue. 
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3.5   Materials and Methods 
3.5.1   Material fabrication 
Films were fabricated as previously described[9]. Briefly, 350 mg PLGA (50:50 
DLG 5E – Evonik Industries) was dissolved in 2ml dichloromethane in a glass scintillation 
vial via high-speed vortexing. Polymer solutions were poured into Teflon-coated petri 
dishes and allowed to dry at -20°C for 7 days. Before use, films were lyophilized overnight 
to remove any traces of solvent. 
3.5.2   Dorsal skinfold window chamber surgery  
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology or University of Virginia Institutional Animal Care and 
Use Committee. Male C57BL/6J mice (8-12 weeks) were fitted with sterile dorsal skinfold 
window chambers (APJ Trading Co) as previously described [9]. Briefly, mice were 
anesthetized with an intraperitoneal (i.p.) injection of ketamine/xylanzine (100/10 mg/kg) 
in sterile saline. Dorsal skin was shaved, depilated, and sterilized with three alternating 
washes of 70% ethanol and chlorhexidine. A double-layered skin fold was elevated off the 
back of the mouse and fitted with the titanium frame of the window chamber on the 
underside. The epidermis and dermis were removed from the top side of the skinfold in a 
~12mm diameter circular area via surgical microscissors to reveal underlying vasculature. 
Exposed tissue was superfused with sterile saline to prevent desiccation. The titanium 
frame was then mounted on the top side of the skinfold, attached to the underlying frame 
counterpart, and sutured to the surrounding tissue. Two films were placed on top of the 
exposed subreticular dermis layer immediately after surgery (day 0) and exposed tissue 
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was sealed with a sterile glass window. Mice were euthanized 72 hours after surgery via 
CO2 asphyxiation. The vasculature was immediately flushed with intracardiac infusion of 
saline follow by an intracardiac infusion of 4% paraformaldehdyde, prior to whole 
mounting of tissue and immunohistochemistry. 
3.5.3   Flow cytometry 
Peripheral blood was collected via cardiac puncture and bone marrow was collected 
via centrifugation (1000g for 5 mins) of isolated tibiae. The dorsal tissue circumscribing 
films was punched out with 6mm biopsy punches and pooled from both films within one 
animal for most studies. For adoptive transfer studies, all inflamed dorsal tissue was 
collected for analysis. Tissue was digested with collagenase (1mg/ml) at 37°C for 30 
minutes and further disaggregated with a cell strainer to create a single cell suspension. 
Single cell suspensions of tissues were stained for flow cytometry analysis according to 
standard procedures and analyzed on a FACS-AriaIIIu flow cytometer (BD Biosciences). 
The following antibodies were used for cell phenotyping: APC-Cy7- or BV421-conjugated 
anti-CD11b (BioLegend), APC- or BV510-conjugated anti-Ly6C (BioLegend), PerCP-
Cy5.5-conjugated CD43 (Biolegend), PE-Cy7-conjugated anti-GR-1 (BioLegend), APC-
Cy7-conjugated anti-Ly6G (Biolegend), APC-conjugated anti-F4/80 (BioLegend), PE-
Cy7- or FITC-conjugated anti-CD206 BioLegend), PE-Cy7-conjugated anti-CD301b, 
BV711-conjugated anti-CD64 (BioLegend), PE-conjugated anti-MerTK (Biolegend), 
BV605-conjugated anti-CD45.1, BV785-conjugated anti-CD45.2, PerCP-eFluor710 
conjugated anti-CD115 (eBioscience), APC-conjugated anti-VEGFR1 (Biolegend), or 
APC-conjugated VEGF2 (Biolegend). Dead cells were excluded by staining with Zombie 
NIRTM (Biolegend) in protein-free buffer prior to antibody staining. Staining using BV 
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dyes was performed in the presence of Brilliant Stain Buffer (BD Biosciences). Positivity 
was determined by gating on fluorescence minus one controls. Absolute quantification of 
cell numbers in blood and tissue was performed by adding 25µL of AccuCheck counting 
beads to flow cytometry samples (Thermo Fisher Scientific). S1PR3 flow cytometry was 
performed by first performing Fc block (Biolegend), followed by staining cells with 
primary unconjugated anti-S1PR3 antibody (Alomone Labs) and secondary staining with 
DyLight 650 anti-rabbit IgG (Abcam). Positivity was determined by staining CX3CR1GFP/+ 
cells with the secondary body only (no primary S1PR3 antibody). 
3.5.4   Cell tracking of Ly6Clo and Ly6Chi monocytes 
For selective labeling of Ly6Clo monocytes, mice were administered 250µL of 
Fluoresbrite® Polychromatic Red latex beads intravenously one day prior to surgery 
(0.5µm, Polysciences -  diluted 1:25 in sterile saline) via jugular vein injection. For 
selective labeling of Ly6Chi monocytes, mice were administered 100µL of clodronate 
liposomes per 10g of mouse body weight (Dr. Nico van Rooijen, 
clodronateliposomes.com) intravenously two days prior to surgery, followed by 
administration of latex beads 16 hours later (one day prior to surgery). Labeling was 
confirmed by retro-orbital blood draw days 1 and 3 post-surgery. For adoptive transfer 
studies, white blood cells from bone marrow, spleen, and blood were collected from mice 
expressing the CD45.1 allelic variant and enriched for monocytes using an EasySep Mouse 
Monocyte Isolation Kit (Stem Cell Technologies). Cells were further purified by 
fluorescence activated cell sorting on a BD FACS AriaII cell sorter using the following 
markers: Ly6Chi monocytes (SSCloCD11b+Ly6ChiCD43lo) or Ly6Clo monocytes 
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(SSCloCD11b+Ly6CloCD43hi). Mice received 555,000 Ly6Chi or Ly6Clo monocytes via 
jugular vein injection on the day of surgery.  
3.5.5   Statistical analysis 
Data are presented as mean ± standard error of the mean (S.E.M.). All statistical 
analysis was performed in GraphPad Prism software. Comparisons of two groups were 
made using a two-tailed unpaired t-test, with Welch’s correction if standard deviations 
were not equal. For studies with two independent variables, two-way ANOVA with Sidak’s 









4. LOCAL DELIVERY OF FTY720 PROMOTES RECRUITMENT 
OF ALTERNATIVELY ACTIVATED MACROPHAGES AND 
MUSCLE REPAIR3, 4 
4.1   Abstract 
Regeneration of soft tissue injuries requires the synchronized behavior of multiple 
cells that participate in repair. Deposition of a vascular network is one of the first steps 
during new tissue formation, both developmentally and after injury. We examined the role 
that myeloid cells play during revascularization and healing of skin and skeletal muscle 
injuries. We explored the effect of biomaterial-delivered FTY720, a sphingosine-1-
phosphate receptor agonist, on myeloid cell infiltration and tissue repair. Local delivery of 
FTY720 promoted perivascular accumulation of non-classical monocytes and CD206+ 
alternatively activated macrophages in non-healing cutaneous wounds during the acute 
phase of inflammation. Treatment of ischemic or volumetric muscle injuries with FTY720-
loaded materials enhanced accumulation of alternatively activated macrophages and 
promoted revascularization. In the later stages of repair, FTY720 improved muscle fiber 
regeneration and reduced fibrotic collagen deposition.  These results indicate that 
biomaterials delivering factors such as FTY720 to enhance accumulation of pro-
                                                
3 Portions of this chapter adapted from: Olingy CE, San Emeterio CL, Ogle ME, Krieger 
JR, Bruce AC, Pfau DD, et al. Non-classical monocytes are biased progenitors of wound 
healing macrophages during soft tissue injury. Sci Rep. 2017;7:447. Published under 
Creative Commons license. 
4 Portions of this chapter adapted from: San Emeterio CL, Olingy CE, Chu Y, Botchwey 
EA. Selective recruitment of non-classical monocytes promotes skeletal muscle repair. 
Biomaterials. 2017;117:32-43. License No. 4098910025385  
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regenerative myeloid subsets are a promising approach to improve repair of soft tissue 
injuries.  
4.2   Introduction 
Insufficient vascularization is a primary obstacle to recovery of tissues after 
traumatic injury, with regenerative therapies often seeking to enhance post-injury 
angiogenic and arteriogenic processes [169].  Deposition of a vascular network is one of 
the first steps during new tissue formation, both developmentally and after injury [170]. 
Consequently, successful biomaterial-based regenerative therapies must ensure proper 
oxygen and nutrient supply to recruited or transplanted cells through expansion of existing 
vascular networks [169]. Adult vascular remodeling is governed by a complex series of 
molecular and cellular events, with the recruitment and participation of leukocytes being 
necessary for successful angiogenesis [23]. Monocyte recruitment kinetics in particular 
have been implicated in a broad spectrum of therapeutic applications, including skeletal 
and myocardial muscle regeneration [4, 8], as well as the inflammatory response to 
biomedical implants [58].  
Monocytes and macrophages play key roles in post-injury microvascular 
remodeling, as they are the predominant source of VEGF during the early phases of wound 
healing  [69]. Classical and non-classical monocytes are sequentially recruited to ischemic 
injury through coordinated chemokine expression, exploiting the phagocytic and 
proteolytic activities of classical monocytes in early stages and the anti-inflammatory and 
pro-angiogenic properties of non-classical monocytes in the later phase of inflammation 
[8, 164, 171]. Non-classical monocytes promote microvascular remodeling through 
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secretion of soluble growth factors [58], extracellular matrix production, and mural support 
for newly developed vasculature [172]. Following extravasation from blood, recruited 
monocytes may transiently remain monocytes [56] or differentiate into macrophages or 
dendritic cells that persist through the resolution of inflammation [4, 58, 73]. Macrophages 
designated as classical inflammatory “M1” macrophages predominate early after injury, 
while alternatively activated “M2” macrophages orchestrate the later phases of tissue 
repair. Inflammatory macrophages respond to tissue damage signals and upregulate genes 
associated with alarmins and acute inflammatory-phase proteins [173], while alternatively 
activated macrophages begin the processes of inflammation resolution and wound healing 
[147]. Alternatively activated macrophages support angiogenesis [41, 174] and 
arteriogenesis [175], distinct processes that regulate post-injury vascular remodeling. 
Mononuclear phagocytes also coordinate other processes of repair, including 
directing the activities of progenitor and parenchymal cells and regulating extracellular 
matrix deposition. For example, multiple studies have shown that depletion of circulating 
monocytes before toxin-induced muscle injury results in incompletely healed, fibrotic 
muscle [4, 176, 177]. Macrophages can regulate the response of progenitor cell populations 
after injury, promoting muscle satellite cell proliferation [73], osteogenesis of 
mesenchymal stem cells [178], and survival of irradiation-exposed hematopoietic stem 
cells [179]. Later during the inflammatory response, alternatively activated macrophages 
express genes encoding extracellular matrix (ECM) and ECM-remodeling proteins [173], 
control collagen fibril formation [45], and promote ECM deposition by fibroblasts [180]. 
However, unchecked activity of alternatively activated macrophages during chronic 
 61 
inflammation can perpetuate fibrosis [181], which can impair restoration of a tissue’s 
native structural and mechanical properties [182].  
Sphingosine-1-phosphate (S1P) is a pleiotropic bioactive signaling lipid that is 
produced endogenously by red blood cells, platelets, and endothelial cells [183]. S1P 
activates signaling through five known G protein-coupled receptors, S1PR1-5, which are 
differentially expressed in almost every cell type. Local delivery of FTY720, a small 
molecule agonist of S1P1 and S1PR3-5, selectively recruits non-classical Ly6Clo 
monocytes upon local delivery to inflamed skin injuries and promotes arteriogenic 
microvascular growth in an S1PR3-dependent manner [9]. Release of FTY720 from 
polymer nanofibers to mandibular bone defects increases the frequency of alternatively 
activated macrophages, promotes  defect site revascularization, and facilitates 
mineralization [184]. Thus, S1PR signaling is a promising therapeutic target to modulate 
the inflammatory response and subsequent healing of soft tissue injuries. 
In this work, we explored the immunomodulatory effects of FTY720 delivered 
from a biomaterial implant on monocyte and macrophage subsets associated with 
vascularization and tissue repair. Delivery of FTY720 induced homing of extravasated 
non-classical monocytes to peri-implant vasculature and accumulation of wound healing 
macrophages 3 days post-injury in the murine dorsal skinfold window chamber model. 
FTY720 promoted perivascular accumulation of alternatively activated macrophages 
within ischemic skeletal muscle and expansion of vascular networks. To explore whether 
FTY720-mediated immunomodulation improves muscle repair after traumatic injury, a 
novel model of volumetric muscle injury within the murine spinotrapezius muscle was 
used. FTY720 increased the frequency of non-classical monocytes and alternatively 
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activated macrophages 3 days post-injury, which correlated with enhanced defect site 
vascularization and collagen deposition. FTY720 improved regrowth of muscle fibers and 
the overall collagen architecture within regenerated tissue 7 days post-injury.  These results 
indicate that immunomodulatory biomaterials that target specific mononuclear phagocyte 
populations can improve both revascularization and overall tissue quality after injury. 
4.3   Results 
4.3.1   FTY720 promotes perivascular localization of non-classical monocytes. 
We have previously demonstrated that localized delivery of the small molecule 
FTY720 from PLGA thin films enhances recruitment of Ly6Clo monocytes to inflamed 
peri-implant tissue and supports arteriogenesis [9, 159]. FTY720 is a synthetic analog of 
sphingosine that acts as an agonist at S1PR1 and S1PR3-5. To further investigate the 
function and spatial distribution of monocytes recruited to inflamed tissue through S1PR 
signaling, we performed mouse dorsal skinfold window chambers (DWC), which enable 
utilization of intravital imaging modalities. The DWC model involves partial thickness 
excisional skin injury that removes the epidermis and dermis, with a transparent window 
placed over the exposed subreticular vasculature. We have previously used this model to 
investigate the inflammatory response and vascular remodeling around biomaterial 
implants in real time [9, 54, 159]. We performed intravital confocal microscopy of tissue 
surrounding FTY720-loaded PLGA implants 1 day post-surgery in mice expressing green 
fluorescent protein (GFP) under the CX3CR1 promoter (CX3CR1GFP/+ mice). CX3CR1 is 
primarily expressed in monocytes and monocyte-derived cells, with CX3CR1 being highly 
expressed in non-classical monocytes and lowly expressed in classical monocytes [16]. 
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CX3CR1hi and CX3CR1lo cells were distinguished within intravital images based on 
maximum fluorescence intensity. Delivery of FTY720 from implanted films increased the 
frequency of non-classical CX3CR1hi monocytes 1 day post-surgery and decreased the 
distance of CX3CR1hi monocytes to the nearest blood vessel (Figure 13a-c). CX3CR1lo 
cells were located farther from the nearest blood vessel in the presence of FTY720 (Figure 
13d).  Additionally, CD68+CD206+ macrophages visualized by immunofluorescence 
adopted an elongated morphology along the vasculature surrounding FTY720 implants 3 
days post-injury (Figure 13e). 
To investigate whether perivascular localization is a signature of non-classical 
monocytes, we compared the spatial positioning of monocyte subsets in vitro. CX3CR1hi 
and CX3CR1lo monocytes sorted from bone marrow of CX3CR1GFP/+ mice were co-
cultured with murine endothelial cell networks on Matrigel. A significantly higher 
frequency of CX3CR1hi non-classical monocytes compared to CX3CR1lo classical 
monocytes localized to in vitro-forming vessel networks (Figure 14a,b). To determine 
whether monocytes positioned themselves in proximity to the vessels, we compared the 
proportion of cells within 20µm from the vessel to the positions of a computer-generated 
random distribution of cells. Random distributions were generated by stochastically 
positioning the same quantity of CX3CR1hi or CX3CR1lo monocytes on images of in vitro 
endothelial networks. The randomly-generated distributions were indistinguishable from 
the experimental distribution of CX3CR1lo monocytes with respect to the proportion of 
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Figure 13. FTY720 recruits non-classical monocytes to the perivascular space. (a) 
Intravital imaging of DWCs in CX3CR1GFP/+ transgenic mice 1 day post-injury. CX3CR1hi 
cells preferentially accumulated around peri-implant arterioles (white arrows) (b) 
Representative surface renderings of CX3CR1+ cells, color-coded according to distance 
from the closest blood vessel with red cells being closest to blood vessels and purple cells 
being the farthest away. Vessels were labeled with i.v. injection of rhodamine-dextran. (c) 
Distance to the nearest blood vessels of CX3CR1hi cells in animals treated with FTY720 
compared to unloaded PLGA controls. (d) Distance to the nearest blood vessels of 
CX3CR1lo cells. Statistical analyses were conducted using two-tailed Mann-Whitney test. 
*p<0.05, n>100 cells, across 3-4 animals per group. (e) Immunostaining of CD68+CD206+ 
macrophages and vasculature. In animals treated with unloaded PLGA, perivascular 
CD68+CD206+ macrophages were circular (open arrow), while in FTY720-treated 
animals, CD68+CD206+ macrophages associated closely with inflamed vasculature and 
adopted an elongated morphology (solid white arrows). Scale bars, 100µm. 
 
cells in close proximity (less than 20µm) to the endothelial network (Figure 14b). 
Conversely, the frequency of CX3CR1hi monocytes in close proximity to the endothelial 
network was significantly higher than the random position distributions (Figure 14b). 
These results indicate that non-classical monocytes preferentially localize near endothelial 
cells, which may prime them for differentiation into macrophages [185] or enable them to 
exert effects on the microvasculature [56, 154, 186]. 
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Figure 14. In vitro association of monocytes and endothelial cells. (a) Sorted CX3CR1lo 
and CX3CR1hi mouse monocytes associate with murine endothelial cell networks in vitro 
(solid white arrows) (b) The proportion of experimental CX3CR1hi monocytes within 
20µm of the vessel network compared to CX3CR1lo monocytes and a model-simulated 
random distribution of cells. Data presented as mean ± S.E.M. *p<0.05 by two-way 
ANOVA. n=3 independent experiments. 
 
4.3.2   Local delivery of FTY720 promotes accumulation of alternatively activated 
macrophages 
We further explored the fate of specific blood monocyte populations in response to 
localized S1PR stimulation by selectively labeling Ly6Clo and Ly6Chi monocytes with 
latex beads (Chapter 3, Figure 5) followed by implantation of FTY720-loaded PLGA films 
in the DWC. No differences in the overall frequency of blood-derived Ly6Clo monocytes 
was observed with FTY720 delivery compared to blank implant (Figure 15a,c). However, 
FTY720 increased the frequency of CD206+ macrophages within injured tissue 3 days 
post-surgery (Figure 15b). The conversion efficiency of labeled blood-derived Ly6Clo 
monocytes into CD206+ macrophages was similar between groups, suggesting that 
FTY720 does not enhance the rate at which monocytes convert to CD206+ macrophages 
(Figure 15d).  
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Figure 15. FTY720 promotes accumulation of alternatively activated macrophages. 
PLGA films loaded with FTY720 were implanted immediately after DWC surgery. (a) 
Proportion of latex bead-positive (LX+) Ly6Clo monocytes derived from blood in tissue 3 
days post-injury following labeling of Ly6Clo monocytes. (b) Frequency of CD206+ 
macrophages in the presence of FTY720. (c) LX+ cells in tissue surrounding unloaded or 
FTY720-loaded implants. (d) Conversion efficiency of circulation-derived Ly6Clo 
monocytes into CD206+F4/80+CD11b+ cells. Scale bars, 500µm. Data presented as mean 
± S.E.M. *p<0.05 by two-tailed t-test. n=10-12 animals per group.  
 
Selective labeling of Ly6Chi monocytes (Chapter 3, Figure 7) demonstrates that 
FTY720 does not recruit circulation-derived Ly6Chi monocytes to tissue when Ly6Clo 
blood monocytes are reduced with clodronate liposomes (Figure 16a,c). We observed no 
changes in the frequency of total CD206+F4/80+CD11b+ cells (Figure 16b), suggesting 
that FTY720 is unable to increase the number of alternatively activated macrophages after 
reduction of circulating Ly6Clo monocytes.  
 
Figure 16. FTY720-induced accumulation of alternatively activated macrophages 
requires circulating Ly6Clo monocytes. (a) Proportion of LX+ Ly6Chi monocytes that 
were derived from blood following labeling of Ly6Chi monocytes with Clod Lip. (b) 
Overall frequency of CD206+ macrophages in the presence of FTY720 after Clod Lip 
administration. (c) LX+ cells in tissue surrounding unloaded or FTY720-loaded PLGA 
implants. Scale bars, 500µm. Data presented as mean ± S.E.M. n=4 animals per group.  
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4.3.3   FTY720 increases perivascular accumulation of alternatively activated 
macrophages and promotes vascular network expansion after arteriole ligation  
The recruitment kinetics, fate, and function of myeloid cells during inflammation 
is heavily dependent on the specific type of tissue injury [8, 156]. Consequently, we sought 
to determine whether application of FTY720-loaded materials to ischemic muscle injury 
produces similar patterns of immunomodulation. Feeder arteriolar vessels within the 
murine spinotrapezius muscle were ligated in CX3CR1GFP/+ mice. The spinotrapezius 
muscle is a stabilizing muscle in the mouse dorsum that is extremely thin (60-200µm) [187, 
188], enabling the use of three-dimensional (3D) confocal microscopy to examine tissue 
microstructures. Unloaded or FTY720-loaded PLGA films were implanted over the muscle 
immediately after injury and whole mount immunohistochemistry and confocal 
microscopy were performed. We observed a decrease in the overall area of CX3CR1hi cells 
in FTY720-treated animals 3 days post-injury (Figure 17a, b). We observed no difference 
in the total number of CD206+ cells (Figure 17c), but an overall increase in the area ratio 
of CD206+ cells to CX3CR1hi cells in FTY720-treated animals (Figure 17d).  
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Figure 17. FTY720 alters monocyte/macrophage accumulation after arteriole ligation 
in the spinotrapezius muscle. (a) Immunofluorescence of muscle tissue 3 days after 
ligation of spinotrapezius muscle arterioles in CX3CR1GFP/+ mice shows accumulation of 
CX3CR1hi monocytes (top) and CD206+ macrophages (bottom) to lectin-stained 
vasculature 3 days post-ligation. (b) Area of CX3CR1hi cells and (c) CD206+ cells in 
muscle tissue treated with unloaded  FTY720-loaded PLGA 3 days post-ligation. (d) Area 
ratio of CD206+ to CX3CR1hi cells. Data presented as mean ± S.E.M. *p<0.05 by two-
tailed t-test. n=25-27 FOVs from 5 animals per group. Scale bars, 100µm. 
 
Previous work has demonstrated that monocytes differentiate into alternatively 
activated macrophages in vascular niches [185]. We investigated the localization of 
CX3CR1hi and CD206+ cells with respect to lectin-stained vasculature.  No significant 
difference in CX3CR1hi cells (Figure 18a), but more CD206+ cells (Figure 18b) were 
found within 50µm of blood vessels in FTY720-treated animals. Additionally, FTY720-
treated animals had a greater vessel density and total length of arterioles 3 days after 




Figure 18. FTY720 promotes microvascular network expansion after muscle arteriole 
ligation. (a) Number of CX3CR1hi cells and (b) CD206+ cells within 50µm of blood 
vessels. (c, d) Total density of lectin+ blood vessels and (e) the length of arterioles in the 
spinotrapezius muscle treated with FTY720 3 days post-ligation. Data presented as mean 
± S.E.M. Statistical analyses performed using two-tailed t-tests. *p<0.05, n=25-27 FOVs 
from 5 animals per group. Scale bars, 100µm. 
 
4.3.4   Characterization of myeloid cell response to full-thickness defect in the murine 
spinotrapezius muscle  
 In order to better study repair of traumatic tissue injuries and model clinical muscle 
loss, we developed a novel model of volumetric muscle loss (VML) in the murine 
spinotrapezius (Figure 19a). A 1mm circular defect in the spinotrapezius muscle heals 
over the course of 7 days, as quantified from desmin immunostaining of muscle fibers 
(Figure 19b). Consequently, removal of a 1mm diameter muscle defect is not critical-
sized, but enables investigations into the mechanisms, rate, and quality of muscle repair. 
We then investigated the kinetics of myeloid cell trafficking in response to spinotrapezius 
VML injury. Within injured spinotrapezius muscle tissue, neutrophils peaked at 3 days 
post-injury (0.7±0.2% of all cells) and quickly decreased to baseline levels by 7 days post-
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injury (Figure 19c). Ly6Chi monocytes decreased from days 1 (0.7±1.2%) to 7 (0.3±0.5%), 
while Ly6Clo monocytes peaked at day 3 (1.5±0.9%) post-injury and were retained at a 
similar frequency at day 7 (Figure 19d). MerTK and CD64 exclusively identify 
macrophages (MerTK+CD64+) [21], which steadily increase from day 1 (0.5±0.6%) to 
day 7 (3.0±1.0%) (Figure 19e). CD206+ macrophages also increase over time (0.4±0.6% 
at day 1 to 2.8±1.0% at day 7) (Figure 19f). These measurements indicate that neutrophils 
and Ly6Chi monocytes accumulate in the acute inflammatory phase of VML injury, while 
macrophages, particularly CD206+ macrophages, predominate in the later phases of 
muscle injury and healing.  
4.3.5   Local delivery of FTY720 increases the frequency of non-classical monocytes in 
injured muscle. 
Given the immunomodulatory effects of FTY720 observed in wounded skin 
(Figure 15) and ischemic muscle (Figure 17), we sought to determine whether this strategy 
could be leveraged after VML injury to enhance accumulation of pro-regenerative myeloid 
cells. Implantation of a FTY720-loaded PLGA thin film over the muscle defect increased 
the frequency of Ly6Clo, but not Ly6Chi, monocytes compared to PLGA only or no implant 
controls, as determined by flow cytometry (Figure 20a). VML injury was induced in 
CX3CR1GFP/+ mice to visualize recruitment of monocyte subsets distinguished by CX3CR1 
expression. Very few CX3CR1-GFP+ cells were detected in the uninjured contralateral 




Figure 19. Mouse model of volumetric muscle loss in the murine spinotrapezius 
muscle. (a) A 1mm circular volumetric defect made in the spinotrapezius of wildtype mice 
heals over 7 days, as (b) quantified by desmin immunostaining. Statistical analyses were 
performed using two-tailed t-tests. *p<0.05, n=4-5 animals per group. (c) Neutrophils in 
injured muscle tissue peak at day 3 and decrease by day 7 post-injury (tissue neutrophils 
gated on MerTK-CD64-CD11c-CD11b+SSChiLy6Ghi). (d) Ly6Chi monocytes in injured 
muscle tissue decrease from day 1 to day 7 post-injury, while Ly6Clo monocytes increase 
from day 1 to 3 and decrease by day 7 (tissue monocytes gated on CD11b+SSCloMerTK-
CD64-CD11c-). (e) MerTK+CD64+ macrophages increase from day 1 to 7 post-injury. (f) 
CD206+ macrophages increase from day 1 to 7 post-injury. Data presented as mean ± 
S.E.M. †p<0.05 compared to Day 0 for Ly6Clo monocytes or *p<0.05 compared to Day 0 
for all other cell types by one-way ANOVA. n=4 animals per group.  
 
Qualitative assessment of whole mount tissues shows that delivery of FTY720 
increased accumulation of CX3CR1hi cells in the peri-defect muscle tissue (Figure 20c), 
which is consistent with the flow cytometry data that shows increased Ly6Clo monocyte 
frequency following FTY720 treatment. Previous studies have indicated that Ly6Clo 
monocytes present during toxin-induced muscle inflammation are derived from Ly6Chi 
monocytes rather than direct recruitment of circulating Ly6Clo monocytes [4]. Using in situ 
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LX bead-based labeling (Chapter 3, Figure 5), Ly6Clo blood monocytes were labeled in 
CX3CR1GFP/+ mice 1 day prior to VML surgery to track the fate of Ly6Clo monocytes 
during FTY720-mediated immunomodulation. Inspection of whole mount confocal images 
revealed a high frequency of LX+ cells in the muscle tissue (Figure 20d), demonstrating 
that labeled Ly6Clo monocytes were directly recruited from circulation to the injured tissue. 
Interestingly, LX+ cells were primarily negative for CX3CR1 expression, indicating that 
these cells may have differentiated into a cell type that is lower in CX3CR1 expression 
(such as macrophages) or been cleared by phagocytosis. More LX+ cells were observed 
around the defect in the muscle tissue of FTY720-treated animals (Figure 20d). 
 
Figure 20. Delivery of FTY720 increases Ly6Clo, CX3CR1hi monocytes in volumetric 
muscle injury. (a) Frequency of Ly6Clo and Ly6Chi monocyte subsets 3 days post-injury 
during delivery of FTY720 from PLGA thin films to VML injury in wildtype mice 
(monocytes gated on CD11b+SSClo). (b) Uninjured, contralateral spinotrapezius muscle 
from CX3CR1GFP/+ mice. (c) CX3CR1hi cells within peri-defect tissue at day 3 in mice 
treated with an FTY720-loaded or unloaded implant. (d) Distribution of LX+ cells around 
VML defects 3 days post-injury. Data presented as mean ± S.E.M. *p<0.05 compared to 
Ly6Clo monocytes in PLGA and no implant controls by two-way ANOVA. n=3-4 animals 
per group. 
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4.3.6   Local delivery of FTY720 increases accumulation of CD206+ alternatively 
activated macrophages in injured muscle 
To quantify cellular infiltration into the defect, we measured the relative size of the 
avascular region with high myeloid cellularity (CX3CR1+ cells). FTY720-treated animals 
had a larger percentage of the defect filled with CX3CR1+ cells (Figure 21a,b). We 
observed a similar, but insignificant, trend following quantification of the proportion of the 
defect filled with CD68+ and CD206+ cells (data not shown). Interestingly, we noticed 
cellular regions that were sparse in CX3CR1+ cells but contained numerous CD68+ 
CD206+ cells. Since we previously observed conversion of non-classical monocytes into 
alternatively activated macrophages (Chapter 3, Figure 10), we investigated whether 
FTY720 also increases the frequency of CD206+ macrophages in injured muscle. Animals 
treated with FTY720 had more CD68+CD206+ alternatively activated macrophages in 
peri-defect tissue 3 days post-injury (Figure 21c,d). Close interactions of macrophages and 
endothelial cells have been associated with enhanced vascular remodeling and 
arteriogenesis [189, 190]. Quantification of the distance between CD68+CD206+ 
macrophages and the nearest CD31+ blood vessel within damaged spinotrapezius muscles 
revealed that CD206+ macrophages were located closer to vasculature with FTY720 
treatment (Figure 21e).   
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Figure 21. FTY720 increases the frequency of CD68+CD206+ cells in injured muscle 
of CX3CR1GFP/+ mice. (a) Infiltration of CX3CR1+ and LX+ cells into the defect region 
in PLGA- and FTY720-treated mice 3 days post-injury. (b) Quantification of cellular 
infiltration in CX3CR1/LX bead/lectin-labeled muscles defects. (c, d) Density of 
CD68+CD206+ cells 3 days post-injury near muscle defects. (e) Quantification of the 
distance of CD68+CD206+ cells to the nearest CD31+ blood vessel 3 days post-injury. 
Data presented as mean ± S.E.M. *p<0.05 by two-tailed t-test. n=3-4 animals per group. 
Scale bars, 50µm. 
 
4.3.7   FTY720 immunomodulation promotes early wound healing and improved 
regenerated muscle quality   
To investigate whether FTY720-induced perivascular accumulation of CD206+ 
macrophages was associated with repair of injured skeletal muscle, we assessed wound 
healing parameters. By 3 days post-injury, local delivery of FTY720 was able to induce 
increased revascularization of the defect region (Figure 22a,b), as quantified by the density 
of area positive for CD31 immunostaining. Interestingly, the amount of revascularization 
in FTY720-treated animals was similar to animals with no implant (data not shown), 
indicating that PLGA may impair revascularization. Increased collagen deposition within 
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the defect area, as measured by imaging the second harmonic generation (SHG) signal, was 
observed in FTY720-treated animals (Figure 22c), coinciding with a significantly 
decreased non-collagenous void area (Figure 22d).  
 
Figure 22. Delivery of FTY720 promotes muscle healing 3 days post-injury in 
CX3CR1GFP/+ mice. (a) CD31 immunostaining to visualize defect area vascularization in 
PLGA- and FTY720-treated mice 3 days post-injury and (b) quantification of CD31+ 
vessel density. (c) Collagen deposition within the defect region visualized by two-photon 
microscopy and (d) quantification of the non-collagenous void area. 
 
At day 7 post-injury, injured muscles were imaged with two-photon confocal 
microscopy for immunostained desmin and SHG collagen signal. Images were rendered 
using 3D imaging processing software to generate quantitative volumes of desmin and 
collagen signal. FTY720-treated animals displayed a lower volume ratio of collagen to 
desmin compared to PLGA animals (Figure 23a,b), indicating less interstitial fibrosis. 
Furthermore, control animals displayed highly aligned collagen fibrils compared to 
uninjured muscle, which is a hallmark of fibrotic scarring [191]. Regenerated fiber 
diameter was significantly higher in animals treated with FTY720 compared to PLGA only 
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(Figure 23c,d), and comparable to that observed in uninjured spinotrapezius muscle. 
Taken together, these findings demonstrate that immunomodulatory biomaterial strategies 
that coordinate inflammatory, angiogenic, and fibrotic processes can improve skeletal 
muscle repair.  
 
Figure 23. Local immunomodulation with FTY720 improves muscle repair 7 days 
post-injury in wildtype mice.  (a) FTY720-treated mice have larger and more desmin+ 
muscle fibers (detected by immunostaining) that more closely recapitulates the structure of 
an uninjured contralateral control, as well as less dense and aligned collagen (detected by 
two-photon microscopy) compared to PLGA controls. (b) FTY720-treated mice have a 
reduced volume ratio of collagen to desmin.  (c-d) FTY720-treated mice have regenerated 
muscle fibers with a larger diameter. Data presented as mean ± S.E.M. Statistical analyses 
were performed using two-tailed t-tests. *p<0.05, n=3-4 animals per group. 
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4.4   Discussion 
In the present work, we have demonstrated that local delivery of the S1PR agonist 
FTY720 from PLGA thin films enhances accumulation of CD206+ alternatively activated 
macrophages and promotes vascularization of ischemic or traumatically injured skeletal 
muscle. The immunomodulatory effects of FTY720 are likely mediated in part through 
recruitment of non-classical monocytes, as their removal from circulation with clodronate 
liposomes impaired generation of alternatively activated macrophages. Perivascular 
localization of CX3CR1hi monocytes in response to FTY720 delivery during the acute 
inflammatory phase after skin injury, and perivascular accumulation of CD206+ 
macrophages in injured muscle suggests that pro-regenerative myeloid cells may position 
themselves near the vasculature. FTY720 promoted multimodal tissue repair of 
traumatically injured muscle, including early collagen deposition, enhanced re-
vascularization and muscle fiber regeneration, and reduced fibrotic deposition.  
While macrophages are key mediators of the host response to implanted materials 
and govern the integration of implants into host tissue [101, 192], the role that their 
monocytic precursors play in regulating implant outcome has been largely unexplored. In 
our studies, around 45% of monocytes surrounding PLGA implants were Ly6Clo/int. In 
previous work [54], we demonstrated that around 40% of monocytes around heparin-
containing PEG hydrogels were Ly6Clo/int. While lymphocyte, granulocyte, and 
macrophage accumulation are impacted by the type of material implanted [193], future 
studies are needed to determine how different classes of materials impact infiltration of 
monocyte and macrophage subsets. Delivery of FTY720 from a PLGA material increased 
the frequency of Ly6Clo non-classical monocytes 3 days after volumetric muscle loss in 
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the spinotrapezius muscle (Figure 20a). Interestingly, we observed model-specific 
differences in the effect of FTY720 on monocyte recruitment, as we detected a decrease in 
CX3CR1hi non-classical monocytes 3 days after arteriole ligation (Figure 17b). While this 
merits further investigation, one possibility is that the progression of inflammation is 
expedited during ischemic injury because of the need to rapidly restore blood supply and 
oxygen transport. CX3CR1 may also mark a slightly different myeloid population than 
those distinguished by Ly6C expression, as extravasated CX3CR1+ cells may also include 
dendritic cells and natural killer cells [194]. 
 Macrophages are the primary source of angiogenic growth factors such as VEGF 
[69] and robust vascularization is associated with increased macrophage presence in and 
around biomaterial implants [143, 184]. M2-polarized macrophages (IL-4- or IL-10-
stimulated) are considered pro-angiogenic both in vitro and in vivo [174, 195, 196], though 
recent studies have demonstrated that M1-polarized macrophages may also play key roles 
in angiogenesis [41, 57]. Hydrogel vascularization in response to growth factor delivery 
(platelet-derived growth factor and fibroblast growth factor) in the cornea was 
accompanied by accumulation of macrophages that produce both M1- and M2-associated 
mRNA transcripts, such as Tnfa and Arg1, respectively [143]. CD206 is expressed on bone 
marrow-derived macrophages that have been alternatively activated through exposure to 
IL-4 in vitro (also called M2a macrophages) [41]. The present work provides additional 
evidence that alternatively activated macrophages are associated with expansion of 
vascular networks, as muscles treated with FTY720 displayed increased vessel density 
(Figure 18d, Figure 22b), which coincided with increased numbers of M2-like CD206+ 
cells (Figure 21d). FTY720 likely acts on both immune cells and the endothelium, as loss 
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of S1PR3 in hematopoietic or parenchymal cells impairs FTY720-induced arteriogenic 
remodeling [9].  
Adoptively-transferred non-classical monocytes selectively differentiate into 
CD206+ macrophages in injured skin (Chapter 3, [197]); therefore, we also explored 
whether FTY720 affects accumulation of alternatively activated macrophages. FTY720 
increased the frequency of both F4/80+CD206+ macrophages in wounded skin (Figure 
15b) and the number of perivascular CD68+CD206+ macrophages in injured muscle 
(Figure 18b, Figure 21e). Previously, we have also detected more M2-like macrophages 
within mandibular bone defects 3 weeks after implantation of FTY720-loaded polymer 
nanofibers [184]. Monocytes and macrophages can position themselves strategically by 
remodeling blood vessels within inflamed tissue [23, 189, 190]. Crosstalk between the 
vasculature and immune cells may provide instructional cues for alternative activation of 
macrophages [185]. In vitro, CX3CR1hi monocytes preferentially associated with 
endothelial cell networks (Figure 14), and in vivo, exhibit closer homing to inflamed 
vasculature in the presence of FTY720 (Figure 13c). While further studies are needed, it 
is possible that the vasculature provides microenvironmental cues that educate non-
classical monocytes to convert into alternatively activated macrophages via signaling with 
the endothelium [185]. Increased perivascular positioning of alternatively activated 
macrophages in FTY720-treated animals coincided with increased density of vasculature 
in injured muscle (Figure 18d, Figure 22b) compared to PLGA control animals.  
Similarly, during chronic arterial occlusion, CD163+ macrophages are clustered in the 
perivascular space at sites of collateral growth in remodeling vasculature [198]. 
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Consequently, both the phenotype of monocytes and macrophages, as well as their spatial 
distribution is likely an important feature when assessing their function. 
In addition to promoting vascularization, FTY720 also supported overall healing of 
traumatically injured skeletal muscle (Figure 22d, Figure 23). Alternatively activated 
macrophages can promote muscle repair by providing a source of regenerative growth 
factors such as IGF-1 [199] and promoting satellite cell differentiation into mature 
myotubes [4, 73]. Macrophages control collagen deposition from fibroblasts in an IL-4ra-
dependent manner [45], a process that is vital to wound healing within the skin. Assessment 
of the defect area via SHG imaging of collagen showed that FTY720 results in increased 
collagen content and a smaller defect area 3 days post-injury (Figure 22c,d). By 7 days 
post-injury, regenerated fiber diameter was significantly higher in FTY720-treated animals 
and the collagen architecture more closely mimicked that of native uninjured muscle 
(Figure 23).  Future studies should focus on whether monocytes and macrophages are 
absolutely required for FTY720-mediated repair, and if so, which repair processes they 
primarily target. Taken together, these results indicate that incorporation of FTY720 into 
biomaterial implants can induce pro-regenerative immunomodulation and promote tissue 
revascularization and repair.  
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4.5   Materials and Methods 
4.5.1   Material fabrication 
Films were fabricated as previously described [9]. Briefly, 350 mg PLGA (50:50 
DLG 5E – Evonik Industries) was dissolved in 2ml dichloromethane in a glass scintillation 
vial via high-speed vortexing. For drug-loaded films, 1.75 mg of FTY720 (Cayman 
Chemical) was added at a 1:200 drug:polymer weight ratio, and mixed until completely 
incorporated. Polymer solutions were poured into Teflon-coated petri dishes and allowed 
to dry at -20°C for 7 days. Before use, films were lyophilized overnight to remove any 
traces of solvent. 
4.5.2   Dorsal skinfold window chamber and tracking of monocyte subsets 
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology or University of Virginia Institutional Animal Care and 
Use Committee. Male C57BL/6J or B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) mice 
(8-12 weeks) were fitted with sterile dorsal skinfold window chambers (APJ Trading Co) 
as previously described [9], and as described in Chapter 3 Materials and Methods. Two 
films were placed on top of the exposed subreticular dermis layer immediately after surgery 
(Day 0) and exposed tissue was sealed with a sterile glass window. Mice were euthanized 
72 hours after surgery via CO2 asphyxiation. The vasculature was immediately flushed with 
intracardiac infusion of saline follow by an intracardiac infusion of 4% paraformaldehdyde, 
prior to whole mounting of tissue and immunohistochemistry. For selective labeling of 
Ly6Clo monocytes, mice were administered 250µL of Fluoresbrite® Polychromatic Red 
latex beads intravenously one day prior to surgery (0.5µm, Polysciences -  diluted 1:25 in 
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sterile saline) via jugular vein injection. For selective labeling of Ly6Chi monocytes, mice 
were administered 100µL of clodronate liposomes per 10g of mouse body weight (Dr. Nico 
van Rooijen, clodronateliposomes.com) intravenously two days prior to surgery, followed 
by administration of latex beads 16 hours later (one day prior to surgery).  
4.5.3   Flow cytometry 
Prior to tissue collection, mice were euthanized via CO2 asphyxiation. The dorsal 
tissue circumscribing films was punched out with 6mm biopsy punches and pooled from 
both films within one animal. For characterization of myeloid cell composition in 
spinotrapezius muscles without an implant, a 6mm biopsy punch of muscle tissue centered 
on the defect was taken. For studies with an implant (unloaded or FTY720-loaded), the 
entire spinotrapezius muscle was collected. Tissue was digested with collagenase (1mg/ml) 
at 37°C for 45 minutes and further disaggregated with a cell strainer to create a single cell 
suspension. Single cell suspensions of tissues were stained for flow cytometry analysis in 
3% FBS according to standard procedures and analyzed on a FACS-AriaIIIu flow 
cytometer (BD Biosciences). The following antibodies were used for immunophenotyping 
of cells collected from dorsal tissue: APC-Cy7-conjugated anti-CD11b (BioLegend), APC-
conjugated anti-Ly6C (BioLegend), PE-Cy7-conjugated anti-GR-1 (BioLegend), APC-
conjugated anti-F4/80 (BioLegend), or PE-Cy7-conjugated anti-CD206 (BioLegend). 
Positivity was determined by gating on fluorescence minus one controls. Absolute 
quantification of cell numbers in blood and tissue was performed by adding 25µL of 
AccuCheck counting beads to flow cytometry samples (Thermo Fisher Scientific). The 
following antibodies were used for immunophenotyping of cells collected from muscle: 
BV510-conjugated anti-CD11b (BioLegend), PerCP eFluor-710-conjugated anti-CD115 
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(eBioscience), APC-Cy7 conjugated anti-CD11b (BioLegend), BV421-conjugated anti-
CD11c (BioLegend), APC conjugated anti-Ly6C (BioLegend), PE-Cy7 conjugated anti-
GR-1 (BioLegend), BV711-conjugated anti-CD64 (BioLegend), PE-conjugated anti-
MerTK (R&D Systems), APC-Cy7-conjugated anti-Ly6G (BioLegend), PE-Cy7-
conjugated anti-CD206 (BioLegend).  
4.5.4   Intravital image acquisition  
Mice were anesthetized with isofluorane, the glass window was removed, and 
dorsal tissue was superfused with saline to prevent desiccation. Up to two films were 
implanted into the window chambers on the day of surgery (day 0). To label perfused 
vasculature, mice were anesthetized with isoflurane and given a retro-orbital injection of 
high molecular weight TRITC-conjugated dextran (2 MDa; Life Technologies). For 
imaging, the anesthetized mouse was secured to the microscope stage in a custom adapter, 
the glass window was removed, and dorsal tissue was superfused with sterile saline. 
Intravital confocal microscopy was conducted with a 20X water immersion objective 
(NA=1.0) on a Zeiss LSM710 NLO microscope and z-stack images were acquired 
immediately proximal to the films. For 3D analysis in Imaris (Bitplane), images of 
708x708µm regions were acquired adjacent to the implant to visualize immune cell 
distribution in the close surrounding tissue. Cells expressing CX3CR1-GFP were identified 
in Imaris using the surface tool. CX3CR1+ surfaces were identified by smoothing with a 
2µm grain size and an automatic threshold on absolute intensity. Touching objects were 
split using a seed points diameter of 10µm. CX3CR1hi versus CX3CR1lo cells were 
discriminated by applying a filter to select surfaces with a high fluorescence intensity in 
the CX3CR1-GFP channel (above 150 max intensity). Vessels were identified in Imaris by 
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drawing a surface on the TRITC-dextran fluorescent channel with a 3µm grain size, 
manually-selected threshold value (determined based on each image), and manually-
selected volume filter to remove small debris. To calculate the distance between CX3CR1+ 
cells and the nearest blood vessel, a distance transformation was applied to TRITC-dextran 
vessel surfaces and the median position of each CX3CR1+ cell within this space was 
recorded. 
4.5.5   Angiogenesis assay with monocyte co-culture 
C166 murine yolk-sac endothelial cells (ATCC) were propagated in flasks coated 
with 0.1% gelatin (Stem Cell Technologies) using endothelial growth medium 
(Angioproteomie) and incubated at 37˚C and 5% CO2 atmosphere. Monocytes were 
isolated from bone marrow of male CX3CR1GFP/+ mice and sorted using a FACS-AriaIIIu 
to discriminate CX3CR1hi monocytes and CX3CR1lo monocytes. Endothelial tube forming 
assays were performed in 15-well angiogenesis slides (Ibidi) as follows. Wells were coated 
with BD MatrigelTM and seeded with C166 cells (7500 cells/ well) and CX3CR1hi or 
CX3CR1lo monocytes (2000 cells/well). After 20 hours, co-cultures were fixed and labeled 
with rhodamine-phalloidin. Images were captured using a Zeiss LSM 700 confocal (10x 
magnification) and Zen software (Zeiss). The centroid of each monocyte was identified 
and the distance to the nearest endothelial tube formation was calculated using a custom 
MATLAB code. For each vessel image, a random distribution of “cells” was overlaid on 
the image (equal to the number of monocytes in the original image) and the distance of the 
“random cells” to the nearest vessel was calculated. The experimental monocyte distance 
to vessel was then compared to the computer-generated randomized cell distance to vessel 
to determine whether the cells preferentially distribute themselves near vessel segments.  
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4.5.6   Spinotrapezius ischemia model 
Mice were anesthetized with an i.p. injection of ketamine⁄xylazine⁄atropine 
(60⁄4⁄0.2 mg⁄kg). Ligation surgeries were performed as previously described [190]. Briefly, 
a small incision was made on the dorsum above the lateral edge of the right spinotrapezius 
at the edge of the fat pad. The fascia was separated from the top of the muscle and the fat 
pad moved before isolating an anatomically reproducible feeding arteriole entering the 
muscle from below. This feeding arteriole was ligated with 10-0 nonabsorbable suture in 
two places and cut. The fat pad and fascia were moved back into position and the skin was 
closed with 8-0 non-absorbable suture. To allow visualization of vascular endothelium of 
arterioles in CX3CR1GFP/+ mice, anesthetized mice were administered an intra-jugular 
injection of labeled isolectin (IB4-Alexa Fluor 568; Life Technologies), which was allowed 
to circulate for 10 minutes. Anesthetized mice were euthanized via CO2 asphyxiation 72 
hours post-surgery. The vasculature was immediately flushed with an intracardiac infusion 
of adenosine (70 mg/L) in Ringer’s solution followed by an intracardiac infusion of 4% 
paraformaldehyde. 
4.5.7   Spinotrapezius volumetric muscle loss model and Ly6Clo monocyte labeling 
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology Institutional Animal Care and Use Committee. Male 
C57BL/6J (The Jackson Laboratory) or B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) 
(The Jackson Laboratory) of age 8-12 weeks old were used for all animal studies. A 1mm 
full thickness defect in the spinotrapezius muscle was created as follows. The dorsum of 
the mouse was shaved and hair removal cream applied to completely remove hair. Skin 
 86 
was sterilized with three washes of 70% ethanol and chlorhexidine. A longitudinal 1 inch 
incision (cranial to caudal) was made just after the bony prominence of the shoulder blade. 
The overlying fascia was dissected away and the spinotrapezius muscle identified. Using 
flat-tipped tweezers, the edge of the spinotrapezius was lifted up. The muscle was reflected 
and positioned against a sterile piece of wood. A 1mm biopsy punch was made through the 
muscle, using the wooden piece as support. The muscle was replaced and 1.5 mm implant 
placed over the punch defect. The incision was closed with mouse wound clips. 
In order to visualize cells within injured muscle originating as circulating Ly6Clo 
monocytes, CX3CR1GFP/+ mice were administered Fluoresbrite® Polychromatic Red latex 
beads (0.5µm, Polysciences) intravenously 1 day prior to surgery via jugular vein injection. 
Prior to injection, latex beads were diluted 1:25 in sterile saline as previously described 
[50]. Labeling was confirmed by retro-orbital blood draw immediately prior to surgery (1 
day after bead administration) and subsequent flow cytometry analysis. 
4.5.8   Whole mount immunohistochemistry 
For lectin-based labeling of the vasculature in CX3CR1GFP/+ mice, Alexa Fluor 568 
isolectin IB4 (1mg/mL, Life Technologies) was diluted (50µL of isolectin, 150µL saline) 
and administered by jugular vein injection 15 minutes prior to euthanasia. Post-euthanasia, 
mouse vasculature was perfused with warm saline followed by 4% PFA until tissues were 
fixed. Dorsal tissue and spinotrapezius muscles were explanted and permeabilized 
overnight with 0.1-0.2% saponin. The tissues were blocked overnight in 5-10% mouse 
serum. Tissues were incubated at 4˚C overnight in solution containing 0.1% saponin, 5% 
mouse serum, 0.5% bovine serum albumin, and the following conjugated fluorescent 
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antibodies: Alexa Fluor 594 or PE anti-CD31 antibody (BioLegend, eBioscience) or Alexa 
Fluor 568 isolectin IB4 (Life Technologies) for blood vessel visualization, Alexa Fluor 647 
anti-CD68 (AbD Serotec) for monocyte/macrophage visualization, and Alexa Fluor 488 
anti-CD206 (AbD Serotec) or Alexa Fluor 647 anti-CD206 (Biolegend). For desmin 
immunostaining in muscle, identical tissue processing procedures were followed and 
muscles were incubated overnight with Alexa Fluor 488 anti-desmin (1:200 dilution, 
Abcam) alone or in combination with PE anti-CD31 and Alexa Fluor 647 anti-CD206 
(1:200 dilution, BioLegend). Following immunostaining, tissues were washed 4 times for 
30 minutes each, mounted in 50/50 glycerol/phosphate buffered saline and imaged until 
fluorescence signal was lost (for dorsal tissue) or through the entire thickness of the muscle 
(~200 microns) on a Zeiss LSM 710 NLO confocal microscope or a Nikon confocal 
microscope. Acquisition parameters were kept identical across all animals.  
4.5.9   Imaging and quantification of whole mount immunohistochemistry  
For monocyte/macrophage quantification after arteriole ligation, 3-4 different 
fields of view (FOVs) per muscle containing a collateral arteriole with 
monocytes/macrophages evident were located manually. Full-thickness z-stack (2µm step 
size) volume renders of these FOVs were generated using a 20X oil immersion objective. 
Simultaneous visualization of CX3CR1-GFP cells with immunohistochemical markers is 
not possible due to leakage of GFP from the cells following permeabilization. Therefore, 
imaging of CX3CR1-GFP spinotrapezius muscles occurred immediately after perfusion 
fixation and further immunostaining was subsequently performed as described in the 
previous methods section. A threshold at which only the brightest CX3CR1GFP/+ cells 
(CX3CR1hi) were visible was applied to all images. Vessel-associated CD206+ and 
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CX3CR1hi cells were defined as cells falling within the 2-dimensional area of the vessel in 
question and within 50µm of the vessel border. ImageJ (NIH) imaging software was used 
to quantify vessel length and density. Arterioles were distinguished from venules by degree 
of lectin binding, vessel size, and morphology. Cell counts and green channel thresholding 
to designate CX3CR1hi cells were performed in Adobe Photoshop (Adobe Systems 
Incorporated).  
For 3D monocyte/macrophage quantification after VML muscle injury, 1 crop per 
animal of 332x332µm was taken from the area adjacent to the defect. Crops were chosen 
based on matching anatomical vessel morphology from both CX3CR1GFP/+ images and the 
subsequently stained CD206, CD68, and CD31 images. Cells co-expressing CD68 and 
CD206 were identified in Imaris using the surface tool. CD68+ surfaces were identified by 
smoothing with a 1.5µm grain size and an automatic threshold on absolute intensity. 
Touching objects were split using a seed points diameter of 13.8µm. Cells that co-
expressed two markers were identified by applying an additional filter to select surfaces 
with a high fluorescence intensity in the CD206 channel (above 17.7 mean intensity). 
Vessels were identified in Imaris by drawing a surface on the CD31 fluorescent channel 
with a 1.66µm grain size, manually-selected threshold value (determined based on each 
image), and manually-selected volume filter to remove small debris. To calculate the 
distance between CD68+CD206+ cells and the nearest blood vessel, a distance 
transformation was applied to CD31+ vessel surfaces and the median position of each 
CD68+CD206+ cell within this plane was recorded.  
For collagen imaging after VML injury, a two-photon chameleon laser (tuned to 
λ=810nm) and collection range of 380-420nm was utilized with acquisition parameters 
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kept identical across animals. Z-stacks were collected from the beginning to end of 
collagen signal visible across the entire x-y plane analyzed. Max intensity projections were 
generated from 3D confocal images for 2D analysis in Zen software (Zeiss). Quantification 
of vascularization and collagen deposition was performed in ImageJ software (NIH).  An 
elliptical region of interest (1.370mm high by 1.778mm wide) was centered over each 
defect and the image was thresholded to display only areas of positive fluorescence signal, 
with the same threshold applied to all images. The number of pixels positive for the 
fluorescence channel of interest was normalized to the total area of the region of interest. 
The percentage of cell infiltration was determined by tracing the border between lectin-
positive regions and the avascular zone. The area of this region was measured. A secondary 
trace between the cellular (CX3CR1+) region and acellular zone was made. The area of 
this region was measured and subtracted from first measurement to measure the region of 
cell infiltration into the defect. This value was normalized to the first measurement. Void 
area was measured by tracing the edges of collagen-positive signal and identifying void 
area as the area that is collagen-negative. 2D fiber diameter was determined by measuring 
the widest portion of each regenerated muscle fiber (determined based on the morphology 
of desmin-positive regions) within the defect region from the day 7 maximum intensity 
projections.  
4.5.10   Statistical analysis 
Data are presented as mean ± standard error of the mean (S.E.M.), unless otherwise 
noted. All statistical analysis was performed in GraphPad Prism software. For pairwise 
comparisons, unpaired t-test (according to experimental design) with Welch’s correction if 
variance was significantly different was used. For non-parametric test (performed for 
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intravital imaging analysis), a two-tailed Mann-Whitney test was used. For comparisons of 
more than two groups, one-way ANOVA with Dunnett’s post-test was used for multiple 
comparisons. For grouped analyses, two-way ANOVA with Sidak's post-test was used for 





5. QUANTITATIVE ANALYSIS OF THE TEMPORAL 
PROGRESSION OF INFLAMMATION AROUND ENGINEERED 
HYDROGELS 
5.1   Abstract 
Significant advances have been made in the development of materials that better 
mimic native tissues; however how these materials interact with the host immune system 
after implantation remains incompletely understood. In the current work, we explored the 
progression of inflammation around protease-degradable PEG hydrogels functionalized 
with bioadhesive RGD (Arg-Gly-Asp) peptides by using high-dimensional flow cytometry 
data paired with intravital image acquisition. Incorporation of RGD into PEG hydrogels 
did not impact the overall composition of innate immune cells adherent to the material 
surface after 1, 3, 7, and 14 days of subcutaneous implantation in mice. Hydrogel 
implantation significantly altered myeloid cell composition compared to uninjured tissue: 
during the acute inflammatory phase, monocytes and neutrophils were the primary cell type 
recruited to subcutaneously implanted hydrogels, while macrophages and dendritic cells 
predominated the later stages. Using intravital confocal microscopy, we visualized real-
time myeloid cell interactions with hydrogels implanted in dorsal skinfold window 
chambers. Myeloid cells moved at greater velocities around hydrogels compared to distal 
tissue, and velocity was further increased by RGD functionalization. These results shed 
light on the progression of inflammation in response to implantation of engineered 
hydrogels.  
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5.2   Introduction 
Significant advances have been made in the development of materials that better 
mimic native tissues through incorporation of biofunctionality [200-202], transplantation 
of exogenous cells [140, 203], and matching host tissue mechanical and structural 
properties [204, 205]. Hydrogel materials are particularly appealing because of their 
crosslinked matrix that resembles native tissues and their high water content, enabling cell 
and growth factor delivery [200]. Hydrogels derived from synthetic polymers such as 
poly(ethylene glycol) (PEG) serve as a building block for engineering desired biological 
responses by providing a matrix whose mechanical properties, structural composition, and 
bioactivity can be finely controlled [206]. While these advances have generated promising 
pre-clinical results [207-209], how biofunctional hydrogels interact with the host immune 
system after implantation remains incompletely understood. 
Implantation of a foreign material induces a physiological response that is both 
spatially and temporally regulated, and varies widely depending on the material properties 
[86]. Within 5 seconds of contact with whole blood, protein adsorption and platelet 
activation occurs on titanium oxide surfaces [87]. The composition and bioactivity of 
adsorbed proteins evolves over time and depends on the concentration of proteins in the 
surrounding microenvironment, their affinity for the material surface, and their 
conformation on the surface [88]. Immune cells recruited to the material interact with the 
surface through integrin ligation to adsorbed proteins such as complement proteins, 
fibrinogen, and fibronectin [100, 101]. Neutrophils are recruited within 16 hours after 
material implantation during the acute inflammatory phase [90], but may persist for as long 
as two weeks, as is the case for polymer microparticles implanted in the mouse peritoneum 
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[91]. Neutrophil activation and degranulation results in the release of proteolytic enzymes 
and reactive oxygen species that may contribute to material degradation [93], as well as 
initiate subsequent phases of inflammation [92].  
   Monocytes are recruited from circulation in response to mediators released from 
neutrophil granules that alter local chemokine production by endothelial cells and resident 
macrophages, as well as induce expression of intercellular adhesion molecules [94]. 
Extravasated monocytes differentiate into macrophages or dendritic cells (DCs) in 
response to M-CSF or GM-CSF, respectively [95]. Mononuclear phagocytes exhibit 
significant heterogeneity in vivo [95], with their phenotype being correlated with outcomes 
such as wound healing, vascularization, and implant integration. Blood monocytes exist in 
two principle subsets in both humans and rodents, including classical monocytes that are 
early pro-inflammatory responders during infection or injury and non-classical monocytes 
that patrol the resting endothelium and participate in reparative processes after injury [86]. 
Macrophages can similarly display a wide spectrum of different gene and protein 
expression patterns, that have been primarily classified as classically activated or “M1” 
macrophages and alternatively activated “M2” macrophages, although macrophages are 
extremely diverse and this nomenclature is likely an oversimplification [210].   Crosstalk 
with other immune cells, including apoptotic neutrophils [96] and paracrine signals derived 
from T helper cells [97], regulate the phenotype of monocytes and macrophages. We have 
previously demonstrated that biomaterial-based strategies that enhance recruitment of non-
classical monocytes and their subsequent differentiation into alternatively activated 
macrophages is associated with enhanced vascularization [197] and muscle repair after 
traumatic injury [72]. While immune cells are required for biomaterial-induced tissue 
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repair [97], persistent or dysfunctional inflammation has been associated with fibrosis 
[211], carcinogenesis [212], and implant failure [85, 213].  
In the current work, we explored the progression of inflammation around 
degradable PEG hydrogels functionalized with the bioadhesive ligand RGD (Arg-Gly-
Asp) by using high-dimensional flow cytometry data paired with intravital image 
acquisition. Cell-adhesive peptides such as RGD have been broadly used throughout the 
biomaterials field to enhance host cell interactions with materials that typically resist 
protein fouling [214]. Previous work has indicated that functionalization of hydrogels with 
RGD increases cell infiltration into the material and promotes vascularization [61, 215]. In 
the current work, we demonstrate that incorporation of RGD into PEG hydrogels does not 
impact the overall composition of innate immune cells adherent to the material surface at 
1, 3, 7, and 14 days post-implantation. We found that, compared to uninjured tissue, 
implantation of PEG hydrogels substantially increased infiltration of CD11b+ myeloid 
cells. During the acute inflammatory phase, monocytes and neutrophils were the primary 
cell type recruited to subcutaneously implanted hydrogels, while macrophages and 
dendritic cells predominated the later stages. Over the course of 14 days, monocyte and 
macrophage populations transitioned from a pro-inflammatory phenotype to an 
alternatively activated phenotype. Using intravital confocal microscopy in transgenic mice 
heterozygously expressing GFP under the CX3CR1 promoter, we visualized myeloid cell 
interactions with implanted hydrogels in real-time. The presence of a hydrogel increased 
the distance travelled and velocity of myeloid cells moving through interstitial tissue. RGD 
functionalization further increased the velocity of CX3CR1+ cells compared to control 
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hydrogels, and this effect was localized to the material surface. These results shed light on 
the progression of inflammation in response to implantation of engineered hydrogels.  
5.3   Results 
5.3.1   Temporal profile of the myeloid response to degradable PEG hydrogels 
We engineered degradable poly(ethylene glycol) (PEG) hydrogels using 20 kDa 4-
arm PEG macromers containing terminal maleimide groups (PEG-MAL) that can react 
with free cysteines on peptides or full-length proteins.  PEG-MAL macromers were 
crosslinked with the cysteine-flanked peptide GCRDVPMSMRGGDRCG (VPM) that 
contains a protease cleavage site (Figure 24a). In order to explore how adhesive peptide 
functionalization impacts myeloid cell recruitment, PEG-MAL macromers were 
functionalized with cysteine-terminated RGD or scrambled peptide control (RDG) prior to 
crosslinking. Combination of functionalized PEG-MAL with VPM rapidly forms a 
hydrogel (Figure 24b).  
 
Figure 24. Protease-degradable biofunctional PEG hydrogels. (a) 4-arm PEG-
maleimide macromers (20 KDa) were functionalized with RGD peptides and crosslinked 
with a cysteine-flanked protease sensitive crosslinker (VPM), forming a hydrogel. (b) 
Macroscopic photo of a PEG hydrogel. Scale bar, 5mm. 
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To investigate the kinetics of myeloid cell accumulation around PEG hydrogels, we 
injected hydrogel precursors (functionalized PEG-MAL and VPM crosslinker) into the 
subcutaneous space of mice, where the hydrogels polymerized in situ. Each mouse received 
two hydrogel implants: a control hydrogel containing RDG on the left side and a RGD-
functionalized hydrogel on the right side. At 1, 3, 7, or 14 days after implantation, the 
hydrogels were explanted and digested with collagenase to extract adherent cells for 
immunophenotyping by flow cytometry (Figure 25a). Macrophages were identified based 
on expression of both CD64 (FcγR1) and Mer tyrosine kinase (MerTK) (Figure 25b), 
which distinguishes macrophages from monocytes that express CD64, but not MerTK 
[151]. DCs were identified based on high expression of CD11c, which also corresponded 
to a population of cells that express high levels of major histocompatibility complex class 
II (MHCII) (data not shown). The remaining CD11b+ cells were composed of Ly6G+ 
neutrophils and CD64+ monocytes that were low in side scatter (SSC) (Figure 25b).  
After 1 day of implantation, CD11b+ myeloid cells were 39.5% of adherent cells 
collected from RGD hydrogels, and about 49.6% for RDG hydrogels (Figure 25c). This 
frequency varied over Days 3 through 14 from 61.8% to 72.9%, and was not sensitive to 
the presence of active adhesive ligand. Ly6G+ neutrophils were present at the highest 
frequency 1 day post-implantation (11.7% for RDG hydrogels, 4.1% for RGD hydrogels), 
and decreased to less than 1% of all cells by 7 days post-implantation (Figure 25d). 
CD64+SSClo monocytes decreased over the course of 14 days, with the highest frequency 
measured occurring at 1 day post-implantation (19.7% for RDG hydrogels, 18.6% for RGD 
hydrogels) (Figure 25e). By 14 days post-implantation, less than 3% of cells were 
monocytes. Conversely, MerTK+CD64+ macrophages increased over the time course 
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Figure 25. In vivo assessment of inflammatory response to PEG hydrogels implanted 
subcutaneously in mice. (a) One RGD hydrogel and one RDG (scrambled peptide control) 
hydrogel were injected within the subcutaneous space in mice. Hydrogels were explanted 
at 1, 3, 7, or 14 days after implantation for flow cytometry. (b) Adherent cells were 
collected from digested hydrogels and immunophenotyped by flow cytometry. Single cells 
were plotted as MerTK versus CD64. Macrophages were identified as MerTK+CD64. 
Among the remaining cells, dendritic cells were identified as CD11c+, neutrophils were 
identified as Ly6G+CD11b+, and monocytes were identified as CD64+CD11b+SSClo. 
Total frequency of (c) CD11b+ myeloid cells, (d) neutrophils, (e) monocytes, (f) 
macrophages, and (g) dendritic cells. (h) Explanted hydrogel weight over time. Data 
expressed as mean ± S.E.M. n=3-7 animals per group. 
 
measured (Figure 25f). While macrophages were less than 1% of total cells 1 day post-
implantation, macrophages were the most abundant cell population 14 days post-
implantation (38.1% for RDG hydrogels, 52.2% for RGD hydrogels). CD11c+ DCs were 
initially less than 7% of all cells 1 day post-implantation, but were the most abundant cell 
 98 
type measured at days 3 and 7 post-implantation (Figure 25g). At 14 days post-
implantation, the frequency of DCs dropped, (19.2% for RDG hydrogels, 11.9% for RGD 
hydrogels), perhaps due to increase in macrophages. No differences in the weight of 
hydrogels explanted at different time points was detected (Figure 25h). While the 
hydrogels are expected to degrade in vivo in response to protease production and decrease 
in total mass over time, an increase in the number (and mass) of adherent cells could 
explain why no changes in hydrogel weight occurred.  
5.3.2   Comparison of recruited cells and cells present in homeostatic subcutaneous 
tissue 
 In order to investigate how hydrogel implantation alters immune cell composition 
from resident populations present during homeostasis, we performed flow cytometry on 
resting tissue harvested from the subcutaneous space. The overall frequency of CD11b+ 
myeloid cells (9.6%) was significantly lower than cells collected from RGD-functionalized 
hydrogels at days 1-14 post-implantation (Figure 26a). The proportion of neutrophils was 
elevated compared to resting tissue 1 day after hydrogel implantation, but returned to 
baseline levels for the remainder of the study (Figure 26b). The proportion of monocytes 
was elevated above basal levels at days 1 and 3 post-implantation, but returned to baseline 
by 7 days (Figure 26c). The proportion of macrophages in resting subcutaneous tissue was 
greater than 1 day after hydrogel implantation (15.3% vs 0.9% out of CD11b+ cells), which 
was highest 14 days after implantation (77.2%) (Figure 26d). Although only a subset of 
CD11c+ DCs express CD11b, 42.6% of CD11b+ cells were also CD11c+ in uninjured 
tissue, which decreased to 15.8% 1 day after hydrogel implantation (Figure 26e). Overall,  
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Figure 26. Myeloid cells recruited to implanted hydrogels are phenotypically different 
from those present in uninjured subcutaneous tissue. (a) Overall frequency of CD11b+ 
myeloid cells in uninjured subcutaneous tissue (resting tissue) compared to 
subcutaneously-implanted RGD hydrogels at different time points. (b) Frequency of 
Ly6G+ neutrophils, (c) CD64+SSClo monocytes, (d) MerTK+CD64+ macrophages, and 
(e) CD11c+ dendritic cells expressed out of total CD11b+ cells. (f) Overall composition of 
CD11b+ myeloid cells in resting subcutaneous tissue. Data expressed as minimum, 25th 
percentile, median, 75th percentile, maximum. *p<0.05 by one-way ANOVA. n=3-7 
animals per group. 
 
CD11c+ DCs that also express high levels of MHCII (data not shown) are the most 
abundant subset of CD11b+ cells in resting subcutaneous tissue (Figure 26f). 
5.3.3   Pro-inflammatory monocyte and macrophage populations are replaced with anti-
inflammatory populations over the course of 14 days  
During inflammation, monocytes progressively lose Ly6C expression [8, 69]. 
While biomaterial implantation induces monocyte recruitment [85], the kinetics of 
recruited monocyte subsets remain unknown. Classical and non-classical monocyte subsets 
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were discriminated based on Ly6C expression (Figure 27a). At 1 day post-implantation, 
most monocytes were Ly6Chi (87.4% for RDG hydrogels, 83.8% for RGD hydrogels) 
(Figure 27a,b). By 3 days post-implantation, around half of all monocytes had converted 
to Ly6Clo, and over 90% of monocytes were Ly6Clo at 7 and 14 days post-implantation 
(Figure 27a,c). Interestingly, the Ly6Cint population increased in size from day 1 to day 3, 
but decreased thereafter (Figure 27d).  
 
Figure 27. Temporal evolution of monocytes around PEG hydrogels. (a) 
Representative flow cytometry dot plots of CD64+SSClo monocytes collected from 
explanted RDG (red) or RGD (blue) hydrogels. Quantification of the frequency of (b) 
classical Ly6Chi, (c) non-classical Ly6Clo, or (d) Ly6Cint monocytes, expressed as a 
frequency of total monocytes. Data expressed as mean ± S.E.M. n=3-7 animals per group. 
 
Recruited monocytes can differentiate into macrophages or dendritic cells. While 
IL-4 signaling induces M2a macrophage polarization in vitro [86], IL-4 signaling also plays 
key roles in the generation of foreign body giant cells and chronic inflammation in the 
context of non-degradable biomaterial implants [216]. To better understand the kinetics of 
different macrophage populations around degradable PEG hydrogels, we probed 
expression of the costimulatory molecule CD86 (expressed on M1-like macrophages [11]) 
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and the C-type lectin receptor CD206 (expressed primarily on M2a macrophages [41]). At 
1 day post-implantation, the total frequency of MerTK+CD64+ macrophages was very low 
and a majority of these macrophages were primarily CD86neg (Figure 28a). By 3 days post-
implantation, around 6% of all macrophages were CD86+CD206neg (Figure 28a, b), while 
the majority of macrophages were negative for both CD86 and CD206 (75.6% for RDG 
hydrogels, 78.0% for RGD hydrogels). The proportion of CD86+CD206neg macrophages 
decreased over the course of 14 days, while the proportion of CD86negCD206+ 
macrophages continued to increase, with a majority of macrophages displaying this 
phenotype by 14 days post-implantation (Figure 28a,c). Interestingly, macrophages 
harvested from uninflamed subcutaneous tissue are primarily CD86+CD206neg (44.8% of 
total macrophages) (Figure 28d). These results indicate that macrophages progressively 
lose CD86 expression and gain CD206 expression during the course of inflammation 




Figure 28. Temporal evolution of macrophages around PEG hydrogels. (a) 
Representative flow cytometry dot plots of MerTK+CD64+ macrophages collected from 
explanted RDG (red) or RGD (blue) hydrogels. Quantification of the frequency of (b) M1-
like CD86+CD206neg and (c) M2-like CD86negCD206+ macrophages, expressed as a 
frequency of total macrophages. (d) Representative dot plot of macrophages collected from 
uninjured subcutaneous tissue. Data expressed as mean ± S.E.M. n=3-7 animals per group. 
 
5.3.4   Myeloid cell recruitment to hydrogels functionalized with cyclic RGD 
We also explored whether hydrogel functionalization with a cyclic RGD peptide, 
for which the integrin αvβ3 has a 10-fold greater affinity than linear RGD [217], impacts 
bulk recruitment of myeloid cells. No differences in the overall frequency of neutrophils, 
monocytes, macrophages, or dendritic cells were detected between RDG- and cyclic RGD-
functionalized hydrogels 3 days after subcutaneous implantation (Figure 29a). There were 
also no differences in the frequencies of monocyte and macrophage subsets (Figure 29b,c), 
further supporting the finding that functionalization with RGD adhesive ligands does not 





Figure 29. Impact of functionalization with cyclic RGD on myeloid cell recruitment 
to PEG hydrogels. (a) Overall frequency of Ly6G+ neutrophils, CD64+SSClo monocytes, 
MerTKCD64+ macrophages, and CD11c+ dendritic cells 3 days after implantation of 
RDG- or cyclic RGD (cyRGD)-functionalized hydrogels. Frequency of (b) monocyte and 
(c) macrophage subsets. Data expressed as minimum, 25th percentile, median, 75th 
percentile, maximum. n=4-5 animals per group.  
 
5.3.5   High-dimensional analysis of temporal progression of inflammation around 
PEG hydrogels 
 To further explore myeloid cell heterogeneity within our data set, we performed t-
distributed stochastic neighbor embedding (tSNE) analysis, which is a non-linear 
dimensional reduction technique that has been applied to flow and mass cytometry data 
[218]. Manual gating of flow cytometry data is often biased and is limited by the ability to 
visualize only two dimensions simultaneously. Samples collected from RGD hydrogels at 
1 or 3 days post-implantation were downsampled, electronically barcoded, and combined 
into a single file for tSNE analysis. Each dot represents a single cell projected into low-
dimensional tSNE space. Cells taken from Day 1 hydrogel samples primarily segregate 
from cells taken from Day 3 hydrogel samples (Figure 30a), emphasizing the phenotypic 
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differences of these two time points. We manually gated on cells that were CD11b+ or 
CD11c+ to investigate the distribution of myeloid cells in tSNE space (Figure 30b). We 
found that spatial separation of samples from different time points occurred for both 
myeloid and non-myeloid cells, which is interesting given that our panel was selected to 
focus on myeloid subset discrimination. tSNE was able to separate manually gated myeloid 
cell subsets of neutrophils, monocytes, DCs, and macrophages that were identified using 
Figure 25b gating (Figure 30c). Overlay of manual gates indicates that most of the 
phenotypic diversity between Day 1 and 3 samples is likely due to shifts in the frequency 
of each myeloid cell subset. For example, the appearance of clusters 1 and 2 at Day 3 
(Figure 30a), is due to the absence of macrophages and DCs in Day 1 samples (Figure 
30c, Figure 25f,g). Cluster 4 is Ly6G+ neutrophils, and Day 1 and Day 3 neutrophils are 
located near each other, but the slight separation may reflect subtle phenotypic differences. 
Additionally, this tSNE map indicates that monocytes and DCs are the most heterogeneous 
for expression of the markers including in our analysis. Mapping the global expression of 
Ly6C highlights the reduction of Ly6C expression in monocytes present 3 days post-
implantation (Figure 30d). Conversely, tSNE regions associated with Day 3 samples 
displayed increased MHCII expression (Figure 30e).  
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Figure 30. High-dimensional analysis of temporal progression of inflammation 
around PEG hydrogels. (a) Application of tSNE to cells collected from subcutaneously 
implanted hydrogels 1 day post-implantation (red) or 3 days (green). tSNE map represents 
8 total samples (4 from each time point) and each dot represents a single cell projected 
from high-dimensional space onto the tSNE axes, which are in arbitrary units. Clusters 
were identified manually. (b) Manual gating of myeloid CD11c+ or CD11b+ cells and (c) 
Ly6G+CD11b+ neutrophils, CD64+CD11b+ monocytes (green), CD11c+MHCII+ 
dendritic cells (blue), and MerTK+CD64+ macrophages (orange). Cells not classified by 
manual gating are shown in gray. Expression of (d) Ly6C and (e) MHCII in tSNE space.   
 
Consistent with manual gating, we observed no global shifts in the distribution of cells 
collected from RDG or RGD hydrogels (Figure 31). These results support the quantitative 
analysis performed using biased manual gating and reveal heterogeneity that evolves 
temporally in myeloid cell subsets during hydrogel-induced inflammation.      
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Figure 31. High-dimensional analysis of myeloid response to adhesive ligand 
functionalization of PEG hydrogels. Application of tSNE to cells collected from 
subcutaneously implanted RDG- (red) or RGD- (blue) functionalized PEG hydrogels 1 or 
3 days post-implantation.  
 
5.3.6   Implantation of PEG hydrogels in mouse cutaneous wounds 
 While subcutaneous implantation likely induces minor tissue damage during 
hydrogel injection, this model does not mimic larger scale soft tissue injuries. In order to 
explore the inflammatory response to engineered hydrogels in the context of non-healing 
dermal wounds, we performed dorsal skinfold window chamber surgeries, which involves 
excising the epidermis and outer layers of the dermis, inducing a robust systemic 
inflammatory response [197]. Immediately after surgery, we placed a pre-cast hydrogel 
functionalized with RDG or RGD on the exposed subcutaneous layer of the dermis (Figure 
32a). At 3 days post-injury, we explanted the hydrogels from the dorsal tissue and 
immunophenotyped adherent cells by flow cytometry. Around 40% of total cells after 3 
days were Gr-1hiLy6Cint neutrophils (41.9% for RDG hydrogels, 44.1% for RGD 
hydrogels) (Figure 32b), which was much higher than the frequency of neutrophils 
detected 3 days after hydrogel implantation in the subcutaneous space (Figure 25d). 
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Around 20% of total cells were F4/80+ (22.8% for RDG hydrogels, 22.0% for RGD 
hydrogels), which is expressed on monocytes/macrophages. Similarly, in the subcutaneous 
space, around 20% of total cells were immunophenotyped as monocytes or macrophages 
(Figure 32b). These results indicate that the inflammatory environment surrounding 
implanted hydrogels impact the composition of hydrogel-adherent leukocytes.  
 
Figure 32. Implantation of PEG hydrogel is mouse dorsal skinfold window chambers. 
(a) One RDG- and one RGD-functionalized pre-formed hydrogel was placed on the 
exposed subcutaneous layer.  Scale bar, 2.5mm. (b) Adherent cells were 
immunophenotyped by flow cytometry 3 days after implantation. CD11b+ cells were 
identified as neutrophils based on Gr-1hiLy6Cint expression and monocytes/macrophages 
based on F4/80+ expression. (c) Monocyte/macrophage subsets were further characterized 
based on Ly6C expression. Data expressed as minimum, 25th percentile, median, 75th 





5.3.7   Intravital imaging of myeloid cell migration around PEG hydrogels 
While flow cytometry provides single cell information necessary for 
immunophenotyping, expression of selected surface markers do not necessarily reflect 
subtle changes in cell function. To explore the activity of myeloid cells around engineered 
hydrogels, we performed intravital confocal imaging in mice that heterozygously express 
GFP under the CX3CR1 promoter (CX3CR1GFP/+ mice). CX3CR1 is expressed primarily 
on monocytes, but also expressed on macrophages and some dendritic cells [194]. One day 
after surgery, we placed RDG or RGD-functionalized PEG hydrogels on the exposed 
subcutaneous layer of the dermis (Figure 33a). At 3 days post-surgery, we performed 
intravital laser scanning confocal microscopy and acquired 25-30 minute videos at the edge 
of each hydrogel or in tissue distal to both gels (Figure 33b). A fluorescent tag was 
incorporated into the hydrogels during fabrication to enable visualization of the material 
surface and identification of the hydrogel edge (Figure 33c).  
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Figure 33. Intravital assessment of myeloid cell migration around PEG hydrogels. (a) 
Dorsal skinfold window chambers were performed in CX3CR1GFP/+ mice. One RDG- and 
one RGD-functionalized hydrogel was placed on the exposed subcutaneous layer 1 day 
after surgery. At 3 days post-injury, intravital confocal microscopy was performed. (b) 
Time-lapse images were acquired near at the edge of each hydrogel and in tissue distal to 
both hydrogels that contained no gel. (c) Z-stacks acquired in each region; CX3CR1+ cells 
shown in green, fluorescently-tagged hydrogel shown in blue. Scale bar, 100µm. 
 
Using 3D image processing software, we tracked the migration of CX3CR1+ cells 
in real time (Figure 34a). We detected an increase in the average track length around both 
RDG (55.7±32.9μm) and RGD (53.9±29.1μm) hydrogels compared to tissue far away from 
either hydrogel (33.9±16.4μm), but no differences between the two hydrogel formulations 
(Figure 34b). Interestingly, we detected an increase in the mean and maximum velocity of 
CX3CR1+ cells around RGD hydrogels compared to both RDG hydrogels and tissue 
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without a hydrogel (Figure 34c,d). The velocity of cells moving around RDG hydrogels 
was also greater compared to distal tissue containing no hydrogel. The path straightness, 
which is the track displacement normalized to the track length, was lower on both RDG 
and RGD hydrogels compared to distal tissue (Figure 34e). These results indicate that 
CX3CR1+ myeloid cells migrate differently through interstitial space in close proximity to 
a hydrogel implant than in tissue lacking a material, and that functionalization of PEG 
hydrogels with RGD enhances cell velocity.  
 
Figure 34. Migration of CX3CR1+ cells around PEG hydrogels. (a) Representative 
renderings of cell tracks (top row) and displacement vectors (bottom row) generated during 
image processing to track cell migration. Scale bars, 100µm. (b) Track length (in µm), (c) 
mean velocity (in µm/minute), (d) maximum velocity (in µm/minute), and (e) track 
straightness (displacement normalized to the path length) of CX3CR1+ cells moving in 
tissue without a hydrogel or around hydrogels functionalized with RDG or RGD. Red bar 
indicates the mean. *p<0.05 compared to no gel, ^p<0.05 compared to RDG hydrogel by 
Kruskal-Wallis. n>219 cells across 3 mice.  
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To further explore the how adhesive ligand functionalization impacts the migration 
of CX3CR1+ cells, we classified cells by their shortest 3D distance from the hydrogel 
surface. More CX3CR1+ cells were found within 10μm of RGD-functionalized hydrogel 
surfaces than RDG surfaces (Figure 35a). This measurement was normalized to the total 
volume of the hydrogel within the acquired image due to variability in the surface area 
imaged. Most tracks were within 30μm of the hydrogel surface (69.6% for RGD hydrogels) 
(Figure 35b), but this is likely due to the fact that we were unable to image the entire tissue 
depth with sufficient time resolution, and therefore focused primarily on acquiring data at 
the hydrogel-tissue interface. The mean and maximum velocity of CX3CR1+ cells were 
greater around RGD hydrogels compared to RDG hydrogels only if the cells were located 
within 30μm of the hydrogel surface (Figure 35b,c). At greater distances (30-50μm and 
>50μm), cells were insensitive to the presence of adhesive ligand on the hydrogel. The 
velocity of cells greater than 30μm from the hydrogels was also compared to the velocity 
of cells in distal tissue (Figure 34b). Despite the insensitivity to adhesive ligand at further 
distances, CX3CR1+ cells still displayed higher velocities than in distal tissue 
(2.8±0.8μm/min for distal tissue, 3.6±1.1μm/min for RDG hydrogels >50μm, and 
3.9±0.9μm/min for RGD hydrogels >50μm). Taken together, these results suggest that 
RGD functionalization increases the velocity of myeloid cells that are within 30μm of the 
hydrogel surface, but the presence of a material has an effect on cell migration on longer 




Figure 35. Migration of CX3CR1+ cells as a function of distance from hydrogel 
surface. (a) Number of CX3CR1+ cells with 10µm of RDG- and RGD-functionalized 
hydrogels, normalized to the hydrogel volume contained in each image. (b) Mean and (c) 
maximum velocity (expressed in µm/minute) of CX3CR1+ cells, classified according to 
their minimum distance from the hydrogel surface. Red bar indicates the mean. *p<0.05 
compared to RDG hydrogel by Kruskal-Wallis. n>803 cells across 3 mice.   
 
CX3CR1 is differentially expressed on monocyte subsets, with non-classical 
monocytes being CX3CR1hi and classical monocytes being CX3CR1lo. We have previously 
demonstrated that approximately half of monocytes are non-classical by 3 days after 
window chamber surgery [197]. In order to explore whether migration is different between 
CX3CR1hi and CX3CR1lo cells, we classified half of all tracks as CX3CR1hi cells based on 
GFP fluorescence intensity. The remaining tracks were classified as CX3CR1lo and 
compared across migration metrics. The mean velocity was not different between 
CX3CR1hi and CX3CR1lo cells in all regions imaged (Figure 36a). Conversely, CX3CR1hi 
cells displayed an increase in total track length and a decrease in track straightness 
compared to CX3CR1lo cells in all regions imaged (Figure 36b,c). These measurements 
indicate that CX3CR1hi cells move greater distances than CX3CR1lo cells in interstitial 
tissue, but this motion is less directed and does not involve a change in velocity. 
Interestingly, the metrics that were insensitive to adhesive ligand presence (path length and 
straightness) were significantly different between CX3CR1hi and CX3CR1lo cells, while 
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the metrics that were sensitive to adhesive ligand presence (mean and maximum velocity) 
were not.  
 
Figure 36. Migration of CX3CR1lo and CX3CR1hi cells around PEG hydrogels. (a) 
Mean velocity (expressed in µm/minute), (b) track length expressed in µm), and (c) path 
straightness (the displacement normalized to the path length) of CX3CR1hi and CX3CR1lo 
cells.  *p<0.05 compared to RDG hydrogel by Kruskal-Wallis. n=219-876 cells across 3 
mice.   
 
5.4   Discussion 
The inflammatory response to biomedical implants plays a critical role in the long-
term success of the implant, including artificial hip replacements [219], pacemaker leads 
[213], and breast implants [220]. The global implantable medical devices market was 
estimated to be around 25 billion dollars in 2007, and is expected continue to rise [221]. 
While engineered hydrogels have been increasingly used for regenerative medicine 
applications [222], how these materials interface with the host immune system remains 
incompletely understood. Additionally, while adhesive ligand functionalization appears to 
alter the host response to non-degradable hydrogels [89], the host response to degradable 
hydrogels with or without adhesive ligands remains uncharacterized. In this study, we 
examined whether incorporation of integrin-targeted RGD peptides within protease-
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degradable PEG hydrogels impacts bulk cell recruitment to the material, as well as 
microscale cellular interactions at the hydrogel-tissue interface.  
The recruitment and activity of leukocytes plays key roles in biomaterial outcomes 
such as ability to promote tissue repair [97], vascularization [41], and fibrous encapsulation 
[223]. Myeloid cell recruitment to PEG hydrogels was characterized by early and robust 
monocyte recruitment, clearance of neutrophils by 3 days post-implantation, and sustained 
generation of macrophages and DCs (Figure 25). Scaffolds derived from cardiac 
extracellular matrix induced robust recruitment of monocytes/macrophages, dendritic cells, 
and T cells 1 week after volumetric muscle injury [97]. Loss of IL-4 signaling, T and B 
cells, or Rictor signaling (which drives polarization of T helper 2 cells), reduced generation 
of M2 macrophages and prevented scaffold-induced muscle regeneration [97]. While the 
current work focused on the myeloid response to PEG hydrogels, our data indicates that 
PEG hydrogels support generation of CD86negCD206+ without delivery of exogenous 
biomolecules (Figure 28). M2 macrophages have been associated with bone [184], skeletal 
muscle [72], nerve [144], and skin repair [162], indicating that PEG may be a desirable 
material to use for regenerative medicine applications. Alginate, a naturally occurring 
polysaccharide, induces sustained neutrophil recruitment (around 15% of cells at all time 
points) and a gradual increase in the frequency of macrophages (around 70% at day 14) 
over the course of 28 days of intraperitoneal implantation [223]. Loss of macrophages, but 
not neutrophils, completely abrogated fibrous encapsulation of alginate, with evidence that 
macrophages recruit fibrosis-potentiating B lymphocytes [223]. Consequently, future 
studies should investigate the interplay between innate and adaptive immune cells in 
response to implantation of PEG-based materials.  
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Immune cells recruited to a material interact with the surface through integrin 
ligation to adsorbed proteins such as complement components, fibrinogen, and fibronectin 
[100, 101]. Mass spectrometry analysis of adsorbed proteins collected from PEG hydrogels 
revealed that albumin is the most abundant protein after 30 minutes of subcutaneous 
implantation in mice, although complement component 3 (C3) and 8 (C8) were also 
detected [89]. Integrins are heterodimeric proteins composed of an alpha and a beta chain 
that pair in a cell type-specific manner to enable cell-matrix and cell-cell interactions [102]. 
Phagocytes (including neutrophils, monocytes, and macrophages) can express the β1, β2, 
and β3 chains, which dimerize to form integrins that include αLβ2 (LFA-1), αMβ2 (Mac-1), 
α5β1, and αVβ3 [102]. Functionalization of material surfaces with integrin ligands such as 
RGD and PHSRN (sequences derived from fibronectin and other ECM proteins) and 
GFOGER (derived from collagen) have been used to increase cell adhesion [224], but 
whether these ligands promote adhesion of specific immune cells remains unknown. 
Consistent with previous reports [61], we found that RGD functionalization of PEG 
hydrogels increases the overall number of myeloid cells at the material surface (Figure 
35a). However, incorporation of either a linear or cyclic RGD peptide did not alter the 
overall composition of biomaterial-adherent cells compared to a scrambled peptide control 
(Figure 25, Figure 29), suggesting that RGD does not promote adhesion of specific 
immune cell populations. RGD primarily interacts with αVβ3, although at least 8 out of the 
24 total can bind to RGD [225]. The affinity or expression of specific integrins on myeloid 
cells may be dependent on cell activation, as is the case is the case for Mac-1, whose 
expression increases in neutrophils and monocytes after local administration of TNF-αto 
the vasculature [104]. One interpretation of our results is that cells do not sense material-
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bound adhesive ligands during extravasation from the vasculature, which represents the 
primary recruitment event. Subsequently, RGD functionalization and integrin activation 
does not change the phenotype of cells that have already been recruited to the material 
surface, although subtle shifts in cell phenotype that are not captured by our flow cytometry 
analysis remain possible.  
Integrin signaling appears to play different roles in leukocyte migration, depending 
on the environment in which the cell is migrating. For example, monocytes utilize the 
integrin LFA-1) to crawl along the endothelium and extravasate into the tissue [49, 108]. 
Conversely, leukocyte migration through interstitial space is not integrin-dependent and 
instead involves amoeboid-like flowing and squeezing motions [108]. The critical 
parameter appears to be whether the cell comes in contact with a 2D barrier, such as the 
endothelium. Biomaterials provide a unique context to migrating cells, where the surface 
serves as a 2D barrier, but materials that are porous or have topographical features may be 
interpreted by cells as an analogous environment to interstitial space. In the current study, 
we demonstrate that CX3CR1+ myeloid cells move at greater speeds near hydrogels 
presenting integrin ligands (Figure 34). This effect appears to be primarily localized to the 
material surface, as there was no detectable difference in migration speed between RDG- 
and RGD-functionalized materials at distances greater than 30μm (Figure 35). Previous 
work has demonstrated that integrins (particularly Mac-1) are required for macrophage 
adhesion to complement proteins adsorbed to biomaterial surfaces [100]. Additionally, 
integrin signaling appears to play key roles in mediating the function of biomaterial-
associated leukocytes, as blockade of Mac-1 in macrophages reduces pro-inflammatory 
cytokine production and reduces fibrous encapsulation [109]. Delayed exposure of RGD 
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using a caged peptide system reduced fibrous capsule thickness around non-degradable 
PEG hydrogels [61]. Fibrous encapsulation primarily occurs around non-degradable 
materials; however, previous work demonstrated that degradable materials can induce a 
transient and modest fibrotic response that disappears as the material degrades [226].  
Future studies are required to better understand the role of adhesive ligand 




5.5   Materials and Methods 
5.5.1   Poly(ethylene glycol) hydrogel fabrication 
Four-arm poly(ethylene glycol) (PEG, 20 kDA molecular weight) end-functionalized 
with maleimide (>95% purity, Laysan Bio) at 4.5% weight/volume was used for all 
hydrogel formulations. PEG macromers were functionalized with RGD peptide 
(GRGDSPC), cyclic RGD peptide (Arg-Gly-Asp-D-Phe-Cys, Peptides International), or 
RDG scrambled peptide control (GRDGSPC), and crosslinked with the cysteine-flanked 
peptide VPM (GCRDVPMSMRGGDRCG) (AAPPTec) in 0.5M MES buffer, pH 5.5. The 
final concentration of RGD or RDG was 1.0mM and the final concentration of VEGF was 
10µg/mL. The crosslinker concentration was based on the concentration of non-reacted 
maleimide groups remaining on PEG macromers. To generate pre-formed hydrogels for 
intravital imaging, the hydrogel was cast in a 4mm diameter circular silicon mold. After 
crossslinking, hydrogels were incubated at 37˚C for 15 minutes and then swelled in PBS 
for at least 30 minutes. For studies where hydrogels were fluorescently tagged, RDG or 
RGD was dissolved in sodium bicarbonate and tagged with Alexa Fluor 405 NHS Ester 
(Life Technologies) according to the manufacturer’s recommendation. Tagged RDG or 
RGD was combined with unlabeled peptide in a 1:3 ratio for conjugation to PEG-MAL.   
5.5.2   Subcutaneous implant model 
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology Animal Care and Use Committee. Male C57BL/6J mice 
(8-12 weeks) were used for subcutaneous implant studies. Mice were anesthetized with 
vaporized isoflurane at 5% concentration and maintained under anesthesia at 1-3%. The 
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animal’s dorsal skin was shaved, depilated, and sterilized with chlorhexidine and 70% 
isopropanol. All animals received a single dose of sustained release buprenorphine 
(1.2mg/kg injected intraperitoneally) prior to implantation. A 23G needle was first inserted 
into the subcutaneous space where hydrogels were to be implanted. Hydrogel precursors 
were mixed in a tube and rapidly pulled into a 31G insulin syringe for subcutaneous 
injection.  One hydrogel (25μL volume) was placed on each side of the spine (two total 
hydrogels per animal). Animals were euthanized by CO2 inhalation for flow cytometry 
analysis at 1, 3, 7, or 14 days post-implantation. 
5.5.3   Dorsal skinfold window chamber model 
Male C57BL/6J or B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) mice (8-12 
weeks) were used for dorsal skinfold window chamber studies. A sterile dorsal skinfold 
window chambers (APJ Trading Co) was placed on the mouse dorsum as previously 
described [227]. Briefly, mice were anesthetized with vaporized isoflurane at 5% 
concentration and maintained under anesthesia at 1-3%. The dorsal skin was shaved, 
depilated, and sterilized with 70% ethanol and chlorhexidine. One of the window chamber 
titanium frames was fitted on the underside of a double-layered skin fold on the back of 
the mouse. A 12mm diameter circular area of epidermis and dermis was removed from the 
top of the skinfold using surgical microscissors, revealing the underlying vasculature. 
Sterile saline was superfused on the exposed tissue throughout surgery to prevent 
desiccation. The upper titanium frame was placed on the top side of the skinfold, secured 
to the underlying frame, and sutured to the surrounding tissue. The exposed subreticular 
dermis was flushed with sterile saline and sealed with a sterile glass window layer (a 
circular cover slip). For flow cytometry studies, two hydrogels (one RDG and one RGD, 
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15μL volume each) was placed on top of the exposed subcutaneous tissue immediately 
after surgery. For intravital imaging studies, one day after surgery (day 1), the cover slip 
was removed and two hydrogels were placed on top of the exposed tissue. The window 
chamber was resealed with a new sterile cover slip. Animals were euthanized by CO2 
inhalation for flow cytometry analysis at 3 days post-implantation. 
5.5.4    Immunophenotyping by flow cytometry 
Hydrogels were explanted from the subcutaneous space or window chamber, 
weighed, and placed in cold PBS containing calcium and magnesium. Hydrogels were 
washed for 30 minutes on a shaker to remove non-adherent cells.  Adherent cells were 
isolated by digesting hydrogels with collagenase type 1A (1mg/ml) at 37°C for 30 minutes 
and further disaggregated with a cell strainer to ensure a single cell suspension. Single cell 
suspensions were stained for flow cytometry analysis in 3% FBS/PBS according to 
standard procedures and analyzed on a FACS-AriaIIIu flow cytometer (BD Biosciences). 
The following antibodies were used for immunophenotyping: BV421- or BV510-
conjugated anti-CD11b (BioLegend), APC- or BV510-conjugated anti-Ly6C (BioLegend), 
PerCP-Cy5.5-conjugated anti-CD11c (Biolegend), PE-Cy7-conjugated anti-GR-1 
(BioLegend), APC-Cy7-conjugated anti-Ly6G (Biolegend), BV711-conjugated anti-CD64 
(BioLegend), PE-conjugated anti-MerTK (Biolegend), APC-Cy7-conjugated anti-F4/80 
(Biolegend), PE-Cy7- or BV605-conjugated anti-CD206 (Biolegend), FITC-conjugated 
anti-CD86 (Biolegend), PE-Cy7-conjugated anti-MHCII (Biolegend). Staining using BV 
dyes was performed in the presence of Brilliant Stain Buffer (BD Biosciences). Positivity 
was determined by gating on fluorescence minus one controls. Absolute quantification of 
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cell numbers was performed by adding 25μL of AccuCheck counting beads to flow 
cytometry samples (Thermo Fisher Scientific). 
5.5.5   High-dimensional tSNE analysis 
Prior to tSNE dimensional reduction, each flow cytometry sample was pre-gated to 
select single cells, and then downsampled to up to 1500 events in FlowJo Version 10.2. For 
samples that contained less than 1500 events, no downsampling was performed (the lowest 
number of single cells in a sample was 763). After downsampling, each sample was 
electronically barcoded so that all samples could be concatenated to into a single file for 
tSNE analysis. A composite tSNE map that utilized data points from all samples (8 total 
samples: 4 from Day 1 RGD hydrogels, 4 Day 3 RGD hydrogels). tSNE analysis was 
executed in FlowJo software using the following surface markers: CD11b, CD64, MerTK, 
CD11c, MHCII, Ly6C, Ly6G, CD86, and CD206. The following tSNE parameters were 
used: 1000 iterations, 30 perplexity, 200 Eta (learning rate), and 0.5 theta.  
5.5.6   Intravital confocal microscopy 
Mice were anesthetized with vaporized isoflurane at 5% concentration and 
maintained under anesthesia at 1-3%. The glass cover slip was removed and sterile saline 
was administered to the exposed dorsal tissue to prevent desiccation. The anesthetized 
mouse was secured to the microscope stage in a custom adapter placed on top of a heating 
block to maintain body temperature. Intravital confocal microscopy was performed using 
a 20X water immersion objective (NA=1.0) fixed to an inverter on a Zeiss LSM710 NLO 
microscope. Time-lapse z-stack images were acquired at each hydrogel edge. A step size 
of 5μm was used in the z-direction. Videos of 25-30 minutes were acquired at each 
 122 
location, with a time step of 30 seconds and a total of 2-3 videos acquired for each hydrogel, 
and one video acquired in distal tissue without a hydrogel.  
 
5.5.7    Intravital imaging analysis  
For 3D analysis in Imaris (Bitplane), time-lapse imageswere acquired adjacent to 
the implant to visualize immune cell distribution in the close surrounding tissue. Cells 
expressing CX3CR1-GFP were identified in Imaris using the surface tool. CX3CR1+ 
surfaces were identified by smoothing with a 2.77µm grain size and a threshold value of 
7.71 on absolute intensity. Touching objects were split using a seed points diameter of 
10.4µm with a quality threshold above 3.53. CX3CR1hi versus CX3CR1lo cells were 
discriminated by assigning half of all cells to each group based on maximum fluorescence 
intensity in the CX3CR1-GFP channel. The hydrogel surface was identified using the 
surface tool with a 10µm grain size and a manually selected threshold value on absolute 
intensity. To calculate the distance between cells and the hydrogel surface, a distance 
transformation was applied to the hydrogel surface and the minimum distance of each cell 
was recorded. To track cell activity over time, cells were identified in Imaris using the spots 
tool. Estimated diameter was set to 8.00µm with background subtraction enabled and an 
automatic threshold on quality. Tracks were selected for analysis if they lasted at least 300 
seconds. Tracks were set to a maximum distance of 10.0 µm and a max gap size of 3µm. 
Because statistical comparisons were made on a single-cell basis, an equal number of cells 
was used for analysis of each video. The minimum number of detected track was 73. 
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5.5.8   Statistical analysis 
Data are presented as mean ± standard error of the mean (S.E.M.), unless otherwise 
noted. For box and whiskers plots, whiskers represent the minimum and maximum; box 
represents the 25th to 75th percentile, with a line denoting the median. All statistical analysis 
was performed in GraphPad Prism software. For comparisons of two groups, paired or 
unpaired t-test (according to experimental design) was used. For grouped analyses, two-
way ANOVA with Sidak's post-test was used for multiple comparisons. For intravital 
imaging data, a non-parametric Mann-Whitney test (for comparing two groups) or a 
Kruskal-Wallis test with Dunn’s test for multiple comparisons (for comparing more than 







6. VASCULAR ENDOTHELIAL GROWTH FACTOR DELIVERY 
FROM DEGRADABLE HYDROGELS ALTERS MYELOID 
CELL RECRUITMENT 
6.1   Abstract 
Revascularization of biosynthetic matrices to support survival of endogenous or 
transplanted cells is a major challenge in tissue engineering and regenerative medicine. The 
innate immune system plays key roles in facilitating vascularization by providing physical 
and biochemical cues to endothelial cells. In the current work, we investigated myeloid cell 
recruitment to protease-degradable poly(ethyelene glycol) (PEG) hydrogels delivering 
vascular endothelial growth factor (VEGF) and functionalized with RGD adhesive 
peptides. VEGF delivery from degradable hydrogels alters bulk myeloid cell recruitment, 
particularly at later time points. Following subcutaneous hydrogel implantation in mice, 
we detected an increase in monocytes and dendritic cells, but a decrease in macrophages 
during VEGF delivery from PEG hydrogels, regardless of incorporation of RGD adhesive 
ligands. Monocyte phenotype was unaffected, but an increase in the proportion of 
CD86negCD206+ alternatively activated macrophages occurred in the presence of VEGF. 
In dorsal skinfold window chambers, we observed that myeloid cells move greater 
distances in tissue far from VEGF hydrogels compared to unloaded hydrogels. However, 
myeloid cells moved slower and shorter distances near the source of VEGF. These findings 
demonstrate the impact that VEGF incorporation and adhesive ligand functionalization 
have on the inflammatory response to hydrogel implantation, which will likely be 
important to the translation of angiogenic therapies.  
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6.2   Introduction 
A major challenge in tissue engineering and regenerative medicine is re-
vascularization of biosynthetic matrices and engineered vasculature is often limited in its 
capacity to support repair. Physiologically, most cells in the body are located within 100-
200µm of a capillary, which enables proper oxygenation and nutrient delivery [228]. After 
traumatic or ischemic injury, remodeling or expansion of existing vasculature represents a 
key step in restoring tissue function [170].  Numerous approaches aiming to revascularize 
ischemic tissues and enhance recovery have been proposed, but pro-angiogenic drugs have 
not translated clinically and therapeutic angiogenesis remains a major challenge. For 
example, delivery of vascular endothelial growth factor (VEGF) has been investigated, but 
high concentrations of native VEGF can lead to enhanced vascular leakage and abnormal 
restructuring of blood vessels, similar to the vascular dysfunction observed in cancer [229]. 
Conversely, controlled delivery of VEGF from engineered matrices enables sustained 
delivery at physiological doses, and supports functional re-vascularization [140, 201, 230]. 
A better understanding of the physiological effects of angiogenic growth factor delivery 
from biomaterials will enable improved therapies for treatment of cardiovascular diseases 
and large-scale traumatic injuries. 
The VEGF family of growth factors includes four isoforms, with VEGF-A playing 
the primary role in developmental, physiological, and pathological blood vessel growth 
[231]. VEGF-A (VEGF) is produced by many cell types, including activated platelets, 
fibroblasts, myeloid cells, and endothelial cells, in part in response to stabilization of the 
transcription factor hypoxia-inducible factor 1-alpha during low oxygen levels (HIF-1α) 
[166]. VEGF signals primarily through VEGFR2 on endothelial cells to induce cell 
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survival, migration, and proliferation [231], but also recruits accessory cells such as 
monocytes and macrophages through VEGFR1 [232]. Myeloid cells play multi-faceted 
roles in supporting vasculogenesis, angiogiogenesis, and arteriogenesis, both through 
direct interaction with the vasculature and through paracrine signaling. Genetic mutation 
of colony stimulating factor receptor 1 (CSFR1), which is essential for normal development 
of the mononuclear phagocyte system leads to the formation of aberrant and immature 
vascular networks [7, 23]. During development, macrophages position themselves near the 
endothelium to help bridge tip cells from different vessel segments and create nascent 
fusion sites within vascular networks [23]. Post-developmentally, macrophages play a 
reparative role by physically pulling endothelial cells together after vascular rupture and 
facilitating repair [233].  
Monocytes and macrophages display significant heterogeneity in vivo, enabling 
them to perform extremely varied and tissue-specific functions [95]. During homeostasis, 
blood monocytes are composed of classical and non-classical subsets [16], while 
macrophage heterogeneity is primarily determined by the tissue of residence [21]. 
Following injury, classical monocytes are the first monocytic responders, followed by their 
conversion into or direct recruitment of non-classical monocytes that produce anti-
inflammatory and wound healing mediators [8]. Macrophages derived from monocytes or 
locally-proliferating tissue resident populations display a wide spectrum of activation states 
that are primarily determined by paracrine signals from other leukocytes, endothelial cells, 
and stromal cells [147]. Macrophage phenotype has been described on a spectrum ranging 
from “M1” classically activated macrophages to “M2” alternatively activated 
macrophages, although this nomenclature is likely an oversimplification of macrophages 
 128 
in vivo, where phenotype and function is extremely varied. Both non-classical monocytes 
and alternatively activated macrophages present during the later stages of inflammation 
have been associated with revascularization and tissue repair. Loss of NR4A1, a nuclear 
factor that is critical for development of non-classical monocytes, impairs revascularization 
after myocardial infarction [234]. Loss of IL-4 receptor α, which plays a major role in 
alternative activation of macrophages, prevents proper endothelial cell-matrix interactions 
during skin repair, leading to abnormal vascular morphology and hemorrhage [45]. 
Additionally, while most research has focus on the role of monocytes and macrophages in 
vascularization, neutrophils and dendritic cells may also provide important functions [235, 
236].  
Given the role of myeloid cells in supporting vascularization [55] and the role that 
VEGF signaling plays in their recruitment [56], the objective of this study was to 
investigate innate immune cell recruitment to synthetic hydrogels delivering VEGF. 
Previous work has indicated that incorporation of adhesive ligands such as Arg-Gly-Asp 
(RGD) into hydrogels enhances VEGF-induced vascularization [61]. Therefore, we also 
explored how RGD functionalization impacts cell recruitment during VEGF delivery. We 
fabricated protease-degradable poly(ethylene-glycol) (PEG) hydrogels with covalently-
tethered VEGF and functionalized with RGD, which has been previously used to 
vascularize bone defects and transplanted islets [140, 237]. These matrices were implanted 
in the subcutaneous space of mice to assess the composition of adherent myeloid cells by 
high-dimensional flow cytometry. We also explored the migration of myeloid cells around 
VEGF hydrogels implanted in dorsal skinfold window chambers using real-time intravital 
confocal microscopy. We hypothesized that delivery of VEGF from PEG hydrogels would 
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enhance recruitment of myeloid cells that support vascularization, including monocytes 
and alternatively activated macrophages.  
6.3   Results 
6.3.1   VEGF-tethered PEG hydrogels for on demand angiogenic growth factor delivery 
We engineered degradable poly(ethylene glycol) (PEG) hydrogels for on demand 
VEGF delivery by conjugating VEGF-A165 (VEGF) to 4-arm PEG macromers (20 kDa) 
containing terminal maleimide groups (PEG-MAL). VEGF has a thiol-containing free 
cysteine that can react with PEG-MAL, forming a PEG-VEGF conjugate. After VEGF 
conjugation, PEG-VEGF was reacted with a cysteine-terminated RGD adhesive peptide or 
a scrambled peptide control (RDG).  Functionalized macromers were crosslinked with the 
cysteine-flanked peptide GCRDVPMSMRGGDRCG (VPM) that contains a cleavage site 
for proteases such as matrix metalloproteinases (Figure 37). Protease-mediated 
degradation of the hydrogel matrix enables VEGF delivery, which occurs gradually over 
two weeks when implanted subcutaneously [238].   Previous work has demonstrated that 
VEGF conjugated to PEG-MAL matrices remains bioactive, promoting endothelial cell 




Figure 37. On demand VEGF delivery from protease-degradable PEG hydrogels. 4-
arm PEG-maleimide macromers (20 KDa) were functionalized with cysteine-containing 
VEGF and RGD peptides. Functionalized macromers were crosslinked with a protease 
sensitive crosslinker (VPM), forming a hydrogel. Degradation of the hydrogel matrix 
results in VEGF delivery.  
 
6.3.2   Effects of VEGF delivery and adhesive ligand presentation on myeloid cell 
recruitment   
While VEGF is chemotactic for myeloid cells [56], the effects of biomaterial-
delivered VEGF on the inflammatory response remains unknown. To investigate the 
kinetics of myeloid cell accumulation around degradable PEG hydrogels delivering VEGF, 
we mixed functionalized PEG-MAL and VPM crosslinker and immediately injected the 
pre-hydrogel solution into the subcutaneous space of mice, where hydrogels formed in situ. 
Each mouse received two hydrogels that were either unloaded or loaded with 250ng of 
VEGF: a control hydrogel containing RDG and a RGD-functionalized hydrogel on the 
opposite flank. After 3, 7, or 14 days of implantation, the hydrogels were explanted, 
digested with collagenase to extract adherent cells, and immunophenotyped by flow 
cytometry (Figure 38a). Macrophages were identified based on co-expression of MerTK 
and CD64, DCs were identified based on high expression of CD11c, neutrophils were 
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identified as Ly6G+CD11b+ cells, and monocytes were identified among the remaining 
cells as CD64+CD11b+SSClo (Chapter 6, Figure 25b).  
We compared data collected from animals with VEGF-loaded hydrogel implants to 
data collected from animals receiving unloaded hydrogels (Chapter 6, Figure 25). The 
frequency of CD11b+ myeloid cells was similar across all groups, indicating that neither 
VEGF nor RGD adhesive ligand impact the overall recruitment of myeloid cells (Figure 
38b). In all groups, Ly6G+ neutrophils were present at the highest frequency 1 day post-
implantation, and decreased by 7 days post-implantation (Figure 38c). While the average 
percentage of neutrophils was higher in both VEGF hydrogel formulations (0.10±0.11% 
for unloaded RGD hydrogel vs. 5.30±7.85% for VEGF-loaded RGD hydrogel), we 
detected no significant differences by ANOVA. The frequency of CD64+SSClo monocytes 
was higher for RDG- and RGD-functionalized VEGF hydrogels compared to unloaded 
hydrogels at 14 days after implantation (Figure 38c). We also detected fewer 
MerTK+CD64+ macrophages around both VEGF hydrogel formulations compared to 
unloaded hydrogels at day 14, but not at earlier time points (Figure 38e,g). While the 
frequency of CD11c+ DCs decreased from day 7 to day 14 around unloaded hydrogels, no 
decrease was observed around VEGF hydrogels (Figure 38f), and the frequency of DCs 
was higher around VEGF hydrogels at day 14 (Figure 38h). These results indicate the 
VEGF delivery from PEG hydrogels primarily impacts the composition of myeloid cells at 
later time points (day 14), and that RGD presentation does not impact bulk cell recruitment 
both in the absence and presence of VEGF. 
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Figure 38. In vivo effect of VEGF delivery from PEG hydrogels on inflammatory cell 
recruitment. (a) Each mouse received unloaded or VEGF-loaded hydrogel subcutaneous 
implants. One RGD and one RDG (scrambled peptide control) hydrogel were injected in 
the subcutaneous space above each rear flank. Hydrogels were explanted at 3, 7, or 14 days 
after implantation. Adherent cells were collected from digested hydrogels and 
immunophenotyped by flow cytometry. Total frequency of (b) CD11b+ cells, (c) 
neutrophils, (d) monocytes, (e) macrophages, and (f) dendritic cells. Representative flow 
cytometry dot plots from day 14 from which (g) macrophages and (h) dendritic cells were 
identified. Data expressed as mean ± S.E.M. *p<0.05 compared to unloaded RDG 
hydrogel, ^p<0.05 compared to unloaded RGD hydrogel by one-way ANOVA at the 
indicated time point. n=3-11.  
 
6.3.3   Effect of VEGF delivery and adhesive ligand presentation on accumulation of 
monocyte/macrophage subsets 
Non-classical monocytes, characterized by low expression of Ly6C [16], and 
alternatively activated macrophages, characterized by high expression of CD206 [41], have 
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been associated with vascularization after ischemic injury [8, 154]. We explored the effect 
of PEG hydrogel-delivered VEGF on accumulation of pro-angiogenic monocyte and 
macrophage subsets in vivo. Consistent with previous findings in other inflammatory 
contexts [8, 69], we found that monocytes recruited to all hydrogel formulations 
progressively lost Ly6C expression from day 3 to day 7 post-implantation (Figure 39a). 
By day 14, more than 93% of all monocytes were Ly6Clo (Figure 39b), and there was no 
effect on monocyte composition in response to VEGF delivery or RGD presentation. The 
proportion of macrophages that were CD86+CD206neg (M1-like) was highest for all 
hydrogel formulations at 3 days post-implantation (between 2% and 7%), but was not 
significantly different between the groups (Figure 39c). The proportion of inflammatory 
CD86+CD206neg macrophages decreased over 14 days of implantation, while the 
proportion of CD86negCD206+ macrophages increased from day 3 to day 14 (Figure 39d). 
At 14 days post-implantation, we detected a greater proportion of CD86negCD206+ 
macrophages around RGD-functionalized VEGF hydrogels compared to unloaded RGD 
hydrogels (Figure 39d,e). Taken together, VEGF delivery from PEG hydrogels did not 
impact the composition of recruited monocytes at the tested time points, but increased 
accumulation of alternatively activated macrophages 14 days after implantation.  
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Figure 39. Temporal evolution of monocytes and macrophages around PEG 
hydrogels delivering VEGF. Quantification of the frequency of (a) classical Ly6Chi and 
(b) non-classical Ly6Clo monocytes, expressed as a frequency of total monocytes. 
Quantification of the frequency of (c) M1-like CD86+CD206neg and (d) M2-like 
CD86negCD206+ macrophages, expressed as a frequency of total macrophages. (e) 
Representative flow cytometry dot plots from day 14 of MerTK+CD64+ macrophages 
showing expression of CD86 and CD206. Data expressed as mean ± S.E.M. ^p<0.05 
compared to unloaded RGD hydrogel by one-way ANOVA at the indicated time point. 
n=3-11 animals per group. 
 
6.3.4   Intravital imaging of myeloid cell migration around VEGF-releasing hydrogels 
In order to explore the migration patterns of myeloid cells around engineered 
hydrogels, we performed intravital confocal microscopy in CX3CR1GFP/+ mice (Figure 
40a; Chapter 6, Figure 33). Mice underwent dorsal skinfold window chamber surgery 
and, immediately after surgery, we placed a pre-cast hydrogel functionalized with RDG or 
RGD on the exposed subcutaneous layer of the dermis. Each animal received two 
hydrogels that were either unloaded or loaded with 150ng of VEGF.  Utilizing 3D image 
processing, we tracked the migration of CX3CR1+ cells in real time around hydrogels 
functionalized with adhesive ligands and/or VEGF (Figure 40b). No gross differences in 
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the frequency of CX3CR1+ cells were observed between different hydrogel formulations, 
which is consistent with the flow cytometry analysis of monocyte subsets from 
subcutaneously implanted hydrogels (Figure 39a,b).  
 
Figure 40. Intravital imaging of CX3CR1+ myeloid cell migration around PEG 
hydrogels delivering VEGF. (a) Dorsal skinfold window chambers were performed in 
CX3CR1GFP/+ mice. One RDG- and one RGD-functionalized hydrogel was placed on the 
exposed subcutaneous layer 1 day after surgery. Each animal received either unloaded or 
VEGF-loaded hydrogels. At 3 days post-injury, intravital confocal microscopy was 
performed. (b) Time-lapse images were acquired at the edge of each hydrogel and in tissue 
distal to both hydrogels. Representative renderings of cell displacement vectors generated 
during image processing to track cell migration. Scale bars, 100µm. 
 
In tissue distal to implanted hydrogels, CX3CR1+ cells displayed a greater average 
track length in animals that received VEGF-loaded hydrogels (57.7±30.6μm) compared to 
unloaded hydrogels (40.4±22.0μm) (Figure 41a). Interestingly, in images taken at the 
hydrogel edge, CX3CR1+ cells displayed a lower track distance around VEGF-loaded 
hydrogels compared to unloaded hydrogels regardless of RGD functionalization (Figure 
41a). The mean velocity of CX3CR1+ cells moving through tissue far away from the 
hydrogels was also greater in animals receiving VEGF gels, but decreased when cells were 
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in close proximity to VEGF gels (Figure 41b).  No differences in mean velocity were 
detected between RDG- and RGD-functionalized VEGF hydrogels. The path straightness, 
which is the track displacement normalized to the track length, was lower in distal tissue 
of animals receiving VEGF gels, but increased as cells moved closer to VEGF hydrogels 
(Figure 41c). These measurements indicate that VEGF delivery from PEG hydrogels 
causes myeloid cells far away from the material to migrate faster, but reduces their 
migration around the hydrogel surface.  
 
Figure 41. Quantification of myeloid cell migration around PEG hydrogels delivering 
VEGF. (a) Track length (in µm), (b) mean velocity (in µm/minute), and (c) track 
straightness (the displacement normalized to the path length) of CX3CR1+ cells moving 
in tissue without a hydrogel or around hydrogels functionalized with RDG or RGD. Red 
bar indicates the mean. *p<0.05 compared to unloaded hydrogel or tissue, ^p<0.05 
compared to RDG hydrogel by Kruskal-Wallis. n>146 cells across 4 mice (2 mice received 
unloaded hydrogels, 2 mice received VEGF hydrogels). 
 
6.3.5   Effects of adhesive ligand incorporation on VEGF-induced vascularization  
To investigate whether adhesion plays a role in hydrogel vascularization, we co-
implanted hydrogels functionalized with VEGF and RDG or RGD immediately adjacent 
to each other in window chambers. Whole mount immunohistochemistry was used to 
visualize new microvessels and alternatively activated macrophages via CD31 and CD206 
staining, respectively (Figure 42a). To quantify the extent of vascularization, we selected 
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the region of greatest vessel density within each hydrogel and measured the length of 
CD31+ blood vessels. VEGF hydrogels functionalized with RGD increased the total length 
of blood vessels associated with implanted hydrogels compared to RDG control gels 
(Figure 42b). In high-power images, we observed that regions of CD206+ cell infiltration 
were associated with hydrogel degradation and vascular ingrowth into the hydrogel 
(Figure 42c). Consequently, incorporation of integrin ligands into PEG hydrogels 
delivering VEGF facilitates vessel growth. 
 
Figure 42. Effect of RGD incorporation on vascularization in response to VEGF 
delivery from PEG hydrogels. (a) Immunohistochemistry for CD31 (red) and CD206 
(green) was performed 7 days after implantation of VEGF-loaded hydrogels in dorsal 
skinfold window chambers. Collagen was visualized using second harmonic generation 
with multiphoton microscopy (blue). Scale bar, 1mm. (b) Quantitative analysis of blood 
vessel length normalized to the analysis region’s area. (c) Regions of vascular ingrowth 
and hydrogel degradation (white arrow). Scale bar, 100µm. Data expressed as mean ± 
S.E.M. *p<0.05 by paired t test. n=6 animals per group. 
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6.4   Discussion 
    Cardiovascular diseases are the main source of mortality in the US and around the 
world, with peripheral arterial disease being present in 12% of the adult population and 
presenting a major risk factor for adverse cardiovascular events [239]. Delivery of 
angiogenic growth factors represents a promising strategy to enhance endogenous 
angiogenic and arteriogenic programs; however, controlled delivery of proteins such as 
VEGF is critical, as supraphysiological doses can result in pathological vessel formation 
characterized by excessive leakiness and poor perfusion [229]. Immune cells play key roles 
in vascularization during development and after injury, both through physical contacts [23, 
233] and providing paracrine signals to endothelial cells [55]. In the current study, we 
examined how VEGF delivery from engineered hydrogels impacts the kinetics of myeloid 
cell recruitment and migration.  
 Monocytes express VEGFR1, enabling them to migrate towards gradients of 
VEGF, and we detected that they also express VEGFR2 (Chapter 3, Figure 12g). We 
explored myeloid cell migration through interstitial space using intravital confocal 
microscopy of dorsal skinfold window chambers in CX3CR1GFP/+ mice. The path length of 
CX3CR1+ cells was nearly twice as long in tissue distal to VEGF hydrogels compared to 
unloaded hydrogels (Figure 41a). This finding is consistent with cells displaying enhanced 
migration in response to a chemokine gradient. Interestingly, we detected no difference in 
the average speed of distal cells. In close proximity to implanted hydrogels, CX3CR1+ 
cells displayed decrease both in path length and mean velocity near VEGF hydrogels, 
regardless of RGD incorporation (Figure 41a,b). Previous work has demonstrated that 
neutrophils migrating towards a site of infection slow down as they approach the infection 
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loci [240]. Our findings suggest that myeloid cells similarly slow down and move shorter 
distances in close proximity to exogenously delivered VEGF. During VEGF delivery, path 
length was greater around PEG hydrogels functionalized with RGD compared to RDG; 
however, both were lower compared to unloaded hydrogels (Figure 41a). Migration speed 
was insensitive to adhesive ligand functionalization in the presence of VEGF. In the 
context of vascularization, VEGF and adhesive ligand incorporation into hydrogels has 
been demonstrated to be synergistic [238], but this effect may not be mediated through 
leukocyte recruitment. Endothelial cells in particular may be sensitized to VEGF signaling 
during ligation to integrins αvβ3 [241] and α1β1 [242], and thus may be the primary 
mediators of cooperation between VEGF and integrin signaling. 
Transgenic activation of VEGF production by the liver results in recruitment of 
Ly6Chi monocytes that convert in situ to Ly6Clo monocytes within 3 days [56]. In the 
present work, we saw no differences in the composition of monocytes (Ly6Chi or Ly6lo) 
around VEGF hydrogels (Figure 39a,b), despite an increase in the overall frequency of 
monocytes (Figure 38d). These results are particularly surprising given that circulating 
non-classical monocytes express higher levels of VEGF receptors compared to classical 
monocytes (Figure 12g). We previously demonstrated that non-classical monocytes 
differentiate into alternatively activated macrophages (Chapter 3). We observed parallel 
increases in the proportion of non-classical Ly6Clo monocytes and CD86negCD206+ 
alternatively activated macrophages. However, we did not see enhancement of Ly6Clo 
monocytes around VEGF hydrogels at any time points, which had more CD86negCD206+ 
macrophages 14 days post-implantation (Figure 39d). It is possible that our temporal 
resolution was not sufficient to detect differences in monocyte recruitment in these studies, 
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or that changes in macrophage phenotype occurred independently of changes to monocyte 
recruitment. We also detected an increase in CD11c+ DCs around VEGF hydrogels 
compared to unloaded hydrogels after 14 days (Figure 38f). VEGF inhibits DC maturation 
and may be a mechanism by which tumors suppress the immune system [243]. 
Interestingly, tumors also selectively recruit plasmacytoid DCs, but exclude monocyte-
derived DCs, which contributes to dysregulated angiogenesis [236].  While we were unable 
to discriminate DC subsets in the current studies, an interesting future direction would be 
to investigate whether hydrogel-delivered VEGF recruits DCs that more closely resemble 
those present during physiological or pathological vascular remodeling.  
 Consistent with previous work [61], vascularization occurred more robustly when 
VEGF hydrogels were functionalized with RGD compared to a scrambled peptide control 
(Figure 42b). Regions of vascular ingrowth into the material were associated with 
infiltration of CD206+ cells and hydrogel degradation (Figure 42c). The protease-sensitive 
crosslinker we used in these studies is degraded by matrix metalloproteinase (MMP)-1 and 
MMP-2 [139], which can be produced by myeloid cells, including macrophages [244]. In 
addition to matrix remodeling, macrophages may support stabilization of vasculature 
induced by biomaterial-delivered VEGF. Encapsulation of VEGF within PEG hydrogels 
generates disorganized and leaky blood vessels, but co-delivery of macrophage colony-
stimulate factor 1 (M-CSF1) promotes vascular stabilization [143]. The current work seeks 
to limit the side effects of VEGF by tethering it to the matrix, and delivering low doses 
during the course of inflammation; however, incorporation of macrophage-targeted factors 
could further enhance or improve the quality of vascularization induced by VEGF in our 
system.  
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 This work demonstrates that VEGF delivery from protease-degradable PEG 
hydrogels alters bulk myeloid cell recruitment, particularly at later time points. Following 
subcutaneous hydrogel implantation, we detected an increase in monocytes and dendritic 
cells, but a decrease in macrophages during VEGF delivery, regardless of incorporation of 
RGD adhesive ligands. Monocyte phenotype was unaffected, but an increase in the 
proportion of CD86negCD206+ alternatively activated macrophages occurred in the 
presence of VEGF. In dorsal skinfold window chambers, we observed that myeloid cells 
move greater distances in tissue far from VEGF hydrogels compared to unloaded 
hydrogels. However, myeloid cells move slower and shorter distances near the source of 
VEGF. These findings demonstrate the impact that VEGF incorporation and adhesive 
ligand functionalization have on the inflammatory response to hydrogel implantation, 
which will likely be important to the translation of angiogenic therapies.  
  
 142 
6.5   Materials and Methods 
6.5.1   Hydrogel fabrication 
Four-arm poly(ethylene glycol) (PEG, 20 kDA molecular weight) end-functionalized 
with maleimide (>95% purity, Laysan Bio) at 4.5% weight/volume was used for all 
hydrogel formulations. Recombinant human VEGF-A165 (Invitrogen) was covalently 
tethered to PEG macromers for 30 minutes on ice in PBS, pH 7.4. PEG macromers were 
also functionalized with RGD peptide (GRGDSPC) or RDG scrambled peptide control 
(GRDGSPC), and crosslinked with the cysteine-flanked peptide VPM 
(GCRDVPMSMRGGDRCG) (AAPPTec) in 0.5M MES buffer, pH 5.5. The final 
concentration of RGD or RDG was 1.0mM and the final concentration of VEGF was 
10µg/mL. Crosslinker concentration was based on the concentration of non-reacted 
maleimide groups remaining on PEG macromers. To generate pre-formed hydrogels, the 
hydrogel was cast in a 4mm diameter silicon mold. After crossslinking, hydrogels were 
incubated at 37˚C for 15 minutes and then swelled in PBS for at least 30 minutes. 
6.5.2   Subcutaneous implant model and flow cytometry 
All animal procedures were conducted according to protocols approved by the 
Georgia Institute of Technology Animal Care and Use Committee. Male C57BL/6J mice 
(8-12 weeks) were used for subcutaneous implant studies. Mice were anesthetized with 
vaporized isoflurane at 5% concentration and maintained under anesthesia at 1-3%. The 
animal’s dorsal skin was shaved, depilated, and sterilized with chlorhexidine and 70% 
isopropanol. All animals received a single dose of sustained release buprenorphine 
(1.2mg/kg injected intraperitoneally) prior to implantation. One hydrogel (25μL volume) 
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was placed on each side of the spine (two total hydrogels per animal). Each animal received 
unloaded or VEGF hydrogels, with one hydrogel containing RGD and the other containing 
RDG. Animals were euthanized by CO2 inhalation for flow cytometry analysis at 3, 7, or 
14 days post-implantation. Hydrogels were explanted from the subcutaneous space, 
weighed, and washed for 30 minutes in cold PBS containing calcium and magnesium. 
Adherent cells were isolated by digesting hydrogels with collagenase type 1A (1mg/ml) at 
37°C for 30 minutes. Single cell suspensions were stained for flow cytometry analysis in 
3% FBS/PBS according to standard procedures and analyzed on a FACS-AriaIIIu flow 
cytometer (BD Biosciences). Staining using BV dyes was performed in the presence of 
Brilliant Stain Buffer (BD Biosciences). Positivity was determined by gating on 
fluorescence minus one controls. Absolute quantification of cell numbers was performed 
by adding 25μL of AccuCheck counting beads to flow cytometry samples (Thermo Fisher 
Scientific).  
6.5.3   Dorsal skinfold window chamber model 
Male B6.129P-Cx3cr1tm1Litt/J mice (CX3CR1GFP/+) mice (8-12 weeks) were used 
for dorsal skinfold window chamber studies. A sterile dorsal skinfold window chambers 
(APJ Trading Co) was placed on the mouse dorsum as previously described [227]. Briefly, 
mice were anesthetized with vaporized isoflurane at 5% concentration and maintained 
under anesthesia at 1-3%. The dorsal skin was shaved, depilated, and sterilized with 70% 
ethanol and chlorhexidine. One of the window chamber titanium frames was fitted on the 
underside of a double-layered skin fold on the back of the mouse. A 12mm diameter 
circular area of epidermis and dermis was removed from the top of the skinfold using 
surgical microscissors, revealing the underlying vasculature. Sterile saline was superfused 
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on the exposed tissue throughout surgery to prevent desiccation. The upper titanium frame 
was placed on the top side of the skinfold, secured to the underlying frame, and sutured to 
the surrounding tissue. The exposed subreticular dermis was flushed with sterile saline and 
sealed with a sterile glass window layer (a circular cover slip). One day after surgery (day 
1), the cover slip was removed and two hydrogels (unloaded or VEGF-loaded) were placed 
on top of the exposed tissue. The window chamber was resealed with a new sterile cover 
slip.  
6.5.4   Intravital confocal microscopy and analysis 
Mice were anesthetized with vaporized isoflurane at 5% concentration and 
maintained under anesthesia at 1-3%. The glass cover slip was removed and sterile saline 
was administered to the exposed dorsal tissue to prevent desiccation. The anesthetized 
mouse was secured to the microscope stage in a custom adapter placed on top of a heating 
block to maintain body temperature. Intravital confocal microscopy was performed as 
described in Chapter 5 with a 20X water immersion objective fixed to an inverter on a 
Zeiss LSM710 NLO microscope. Time-lapse z-stack images were acquired at each 
hydrogel edge, with a time step of 30 seconds and a total of 2-3 videos acquired for each 
hydrogel, and one video acquired in distal tissue without a hydrogel. To track cell migration 
over time, cells were identified in Imaris software using the spots tool. Estimated diameter 
was set to 8.00µm with background subtraction enabled and an automatic threshold on 
quality. Tracks were selected for analysis if they lasted at least 300 seconds. Tracks were 
set to a maximum distance of 10.0µm and a max gap size of 3µm. Because statistical 
comparisons were made on a single-cell basis, an equal number of randomly selected cells 
was selected from each video and used for analysis. 
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6.5.5   Whole mount immunohistochemistry and quantification 
Post-euthanasia, mouse vasculature was perfused with warm saline followed by 4% 
PFA until tissues were fixed. Dorsal tissue was explanted, leaving implanted hydrogels 
intact. Tissue was permeabilized overnight with 0.1% saponin and tissues were blocked 
overnight in 10% mouse serum. Tissues were incubated at 4˚C overnight in solution 
containing 0.1% saponin, 5% mouse serum, 0.5% bovine serum albumin, and the following 
conjugated fluorescent antibodies: Alexa Fluor 594 (BioLegend, eBioscience) for blood 
vessel visualization, Alexa Fluor 647 anti-CD68 (AbD Serotec) for monocyte/macrophage 
visualization, and Alexa Fluor 647 anti-CD206 (Biolegend). Following immunostaining, 
tissues were washed 4 times for 30 minutes each, mounted in 50/50 glycerol/phosphate 
buffered saline and imaged until fluorescence signal was lost on a Zeiss LSM 710 NLO 
confocal microscope. Acquisition parameters were kept identical across all animals. For 
quantification of blood vessel density, CD31+ blood vessels were manually traced and 
analyzed by a blinded observer. Using ImageJ software (NIH), a region of fixed size was 
selected on the area of greatest vascular density within the hydrogel (identified by 
incorporation of a fluorescent tag) and the length of blood vessels was normalized to the 
region’s area. 
6.5.6   Statistical analysis 
Data are presented as mean ± standard error of the mean (S.E.M.), unless otherwise 
noted. All statistical analysis was performed in GraphPad Prism software. For comparisons 
of two groups, a two-tailed paired t-test was used. For comparisons of more than two 
groups analyses, one-way ANOVA with Tukey's post-test was used for multiple 
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comparisons. For intravital imaging data, a non-parametric Mann-Whitney test (for 
comparing two groups) or a Kruskal-Wallis test with Dunn’s test for multiple comparisons 





7. CONCLUSIONS AND FUTURE DIRECTIONS5,6 
7.1   Overall Summary 
The work presented in this thesis represents a significant contribution to the fields 
of biomaterials and regenerative medicine by demonstrating that modulation of monocyte 
and macrophage accumulation around biomaterial implants can enhance vascularization 
and tissue repair. This work expands understanding of the relationship between blood 
monocyte subsets and alternatively activated macrophages, as well as identifies potential 
targets by which to modulate myeloid cell recruitment.   
In Aim 1, non-classical monocytes were identified as biased progenitors of 
alternatively activated macrophages during inflammation induced by cutaneous wounding. 
Blood monocytes exist in two primary subpopulations, characterized as classical 
inflammatory or non-classical. Through the use of cell fate tracking techniques, the 
relationship between circulating monocyte subsets and wound macrophages can be studied. 
Utilizing fluorescent bead- and CD45.1/CD45.2-based labeling of blood monocyte subsets, 
we demonstrated that non-classical monocytes are directly recruited to soft tissue injury 
and selectively give rise to alternatively activated macrophages. Reduction of non-classical 
monocytes with clodronate liposomes impaired generation of alternatively activated 
                                                
5Portions of this chapter adapted from: Ogle ME, Segar CE, Sridhar S, Botchwey EA, 
Monocytes and macrophages in tissue repair: Implications for immunoregenerative 
biomaterial design. Exp Biol Med (241) pp. 1084-97. Copyright © 2016. Reprinted by 
permission of SAGE publications. 
6Portions of this chapter adapted from: San Emeterio CL, Olingy CE, Chu Y, Botchwey 
EA. Selective recruitment of non-classical monocytes promotes skeletal muscle repair. 
Biomaterials. 2017;117:32-43. License No. 4098910025385 
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macrophages, while adoptive transfer of non-classical monocytes increased the frequency 
of donor-derived wound healing macrophages compared to adoptive transfer of classical 
monocytes.  
Taken together, these results highlight a previously unknown role for blood-derived 
non-classical monocytes as contributors to alternatively activated macrophages. The 
significance of this work includes identification of a novel therapeutic target for enhancing 
accumulation of cells that support repair and improve host responses to implanted 
materials. Harnessing myeloid cell functions for regenerative medicine applications 
requires an understanding of the cues that direct the localization and fate of these cells. 
While monocytes and macrophages appear during the first few days after injury, their 
effects can be long-lived and have critical impacts on tissue repair [147].  
In Aim 2, we demonstrated that delivery of FTY720 from polymer films enhances 
recruitment of alternatively activated macrophages and skeletal muscle repair after 
ischemic or traumatic injury. Mononuclear phagocytes play key roles in regulating post-
injury processes of vascularization, re-organization of tissue architecture, and regulating 
the activities of stem and parenchymal cells. We used intravital confocal microscopy in 
dorsal skinfold window chambers to demonstrate that FTY720 delivery promoted 
perivascular accumulation of non-classical monocytes during the acute inflammatory 
phase. Immunohistochemistry and flow cytometry were used to demonstrate that FTY720 
promoted subsequent accumulation of CD206+ alternatively activated macrophages. 
Mouse models of ischemic and volumetric muscle injuries were treated with FTY720-
loaded materials to investigate how FTY720-mediated immunomodulation impacts 
revascularization and tissue repair. During early wound healing, FTY720 enhanced the 
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density of CD31+ blood vessels and collagen within the defect area. In the later stages of 
repair, FTY720 improved muscle fiber regeneration and reduced fibrotic collagen 
deposition.   
These findings indicate that biomaterials delivering immunomodulatory factors that 
target S1P receptors, such as FTY720, can enhance accumulation of pro-regenerative 
myeloid subsets. The significance of this work is demonstration that FTY720-mediated 
immunomodulation accelerates revascularization and enhances non-fibrotic muscle tissue 
repair after injury. While granulation tissue formation and its subsequent remodeling into 
mature extracellular matrix is crucial for the restoration of functional tissue in the 
volumetric void, a fibrotic response often progresses faster than a myogenic response 
[245]. Interventions that tune acute inflammatory responses may be more efficacious at 
enhancing repair than those that directly target parenchymal cells, although this requires 
further investigation.   
In Aim 3, the progression of inflammation around protease-degradable PEG 
hydrogels functionalized with bioadhesive RGD peptides and vascular endothelial growth 
factor (VEGF) was explored using high-dimensional flow cytometry data paired with 
intravital image acquisition. Incorporation of RGD into PEG hydrogels did not impact the 
overall composition of innate immune cells adherent to the material surface after 1, 3, 7, 
and 14 days of subcutaneous implantation in mice. Hydrogel implantation significantly 
altered myeloid cell composition compared to uninjured tissue: during the acute 
inflammatory phase, monocytes and neutrophils were the primary cell type recruited to 
subcutaneously implanted hydrogels, while macrophages and dendritic cells predominated 
the later stages. Using intravital confocal microscopy, we visualized real-time myeloid cell 
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interactions with hydrogels implanted in dorsal skinfold window chambers. Myeloid cells 
moved at greater velocities around hydrogels compared to distal tissue, and velocity was 
further increased by RGD functionalization.  
While synthetic hydrogels such as those derived from PEG are extensively used 
throughout the biomaterials field for cell and growth factor delivery, the innate immune 
response to engineered hydrogel matrices remains incompletely understood. The 
significance of this work is demonstration that degradable PEG hydrogels induce 
recruitment of anti-inflammatory myeloid populations without exogenous biomolecule 
delivery. Delivery of VEGF alters myeloid cell recruitment and further enhances 
accumulation of alternatively activated macrophages, which could have important 
implications for the clinical translation of pro-angiogenic therapies. Additionally, these 
findings shed light on how myeloid cells interpret signals presented by engineered 
hydrogels, included covalently-tethered VEGF and RGD presentation.  
7.2   Engineering smarter immunoregenerative materials  
In the current work, we explored how biomaterial-based delivery of FTY720 and 
VEGF impact myeloid cell recruitment into the surrounding tissue. This was motivated in 
part by the knowledge that monocyte subsets differentially expressed receptors for these 
chemokines, including S1PR3 and VEGFR2. Future work in this area should focus on the 
following topics: 1) Optimized delivery vehicle for FTY720 and 2) Delivery of other 
biomolecules to target monocyte/macrophage activities.  
A PLGA thin film was selected for delivery of FTY720 because of our extensive 
experience with encapsulating sphingolipid signaling molecules and controlling release 
 151 
kinetics in vivo [9, 53, 246]. Additionally, PLGA is approved by the FDA for various drug 
delivery and biomedical applications [247], and can be readily combined with other 
therapies such as in coatings on bone allografts [192]. However, other biomaterial delivery 
vehicles may provide enhanced support of vascularization and tissue repair, as well as 
greater control over the kinetics and mechanism of delivery. While PLGA promotes 
production of inflammatory mediators such as TNF-α by macrophages [248] and impairs 
early revascularization of muscle defects [72], we observed that non-classical monocytes 
and alternatively activated macrophages accumulate around degradable PEG hydrogels in 
the absence of additional biomolecules. To incorporate the small molecule FTY720 into a 
porous matrix, our lab has recently utilized heparin-PEG hydrogels loaded with albumin 
that sequesters FTY720 within the material  [249]. The use of aqueous materials would 
also enable co-delivery of proteins and cells. An immediate future direction would be to 
explore how co-delivery of FTY720 and VEGF from hydrogel materials impacts vascular 
remodeling. These studies would be particularly interesting from both an immunology 
perspective, in which FTY720-mediated monocyte/macrophage recruitment could help 
stabilize VEGF-induced vascularization [23], and a vascular biology perspective, in which 
extensive literature has documented the role of sphingolipid signaling in vascular 
maturation through direct signaling on endothelial cells [250, 251].  
Generally, biomolecules can regulate monocyte and macrophage function by 
modulating the following biological processes: 1) recruitment of monocytes and 
macrophages from blood or surrounding tissue, 2) monocyte/macrophage polarization 
state, and 3) macrophage proliferation. In addition to FTY720 or S1P, recruitment can be 
controlled by local delivery of chemokines that selectively target monocytes and 
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macrophages, such as MCP-1, SDF-1, or CX3CL1. For example, SDF-1 delivery from 
heparin-PEG hydrogels can selectively enhance recruitment of non-classical monocytes, 
but not classical monocytes, by exploiting their relative overexpression of CXCR4 [54]. 
Given our findings regarding the localization of CX3CR1hi cells near the endothelium, it 
would be extremely interesting to explore the effect of CX3CL1 (fractalkine) delivery on 
monocyte recruitment and tissue repair. Delivery of M-CSF, which promotes 
monocyte/macrophage proliferation, from PEG hydrogels enhances macrophage 
accumulation in the cornea and supports more mature vascularization than VEGF [143]. 
Release of polarizing cytokines such as IL-4 enhances M2 macrophage generation and 
promotes peripheral nerve regeneration [144]. While a strong therapeutic benefit on 
vascularization was not observed, sequential delivery of IFN-γ and IL-4 was used to guide 
the kinetics of macrophage polarization  in vivo [57]. As more strategies emerge to target 
myeloid cells, it will be of interest for the field to identify which approaches (such as 
targeting recruitment, polarization, or proliferation) generate the most robust functional 
outcomes in the context of a specific therapeutic application.  
7.3   Expansion of macrophage classifications 
Biomaterial-mediated delivery of FTY720 promoted accumulation of CD206+ 
macrophages in injured skin and muscle, which correlated with tissue repair outcomes such 
as vascularization and muscle regrowth. While our studies were an informative first step, 
futures studies should focus on expanding our characterization of macrophage subsets. 
Given the extreme heterogeneity of macrophages and the many different factors to which 
they can respond, single surface markers are likely insufficient to accurately distinguish 
macrophage subsets. Incorporation of additional analysis techniques such as cytokine 
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production, transcription factor dependence, and gene expression would enable better 
assessment of the roles specific macrophages play in repair [210].  
In addition to the phenotypic complexity presented by the wide range of polarizing 
cues, macrophages have different developmental origins, which can contribute to 
heterogeneity between organs [21]. While some macrophages are the descendants of 
circulating monocytes and are replenished at steady state and during inflammation by 
blood-derived monocytes [13, 26],  other macrophages are derived from embryonic sources 
and self-maintain locally in tissues throughout adulthood in a manner analogous to stem 
cells [14, 27, 28]. Specifically, populations of tissue macrophages of the heart, lung, brain, 
skin, and liver are derived prenatally [14, 29-31]. Some injury contexts, such as TH2-linked 
infection, can increase local tissue macrophage populations specifically through 
proliferation as opposed to monocyte recruitment from the blood [27].  
Monocyte-derived alternatively activated macrophages have a unique gene 
expression profile compared to tissue resident alternatively activated macrophages, 
upregulating genes important during inflammation such as Socs2, IL-31ra, Ccl17, Ch25h, 
Jag2, and Ccl22 [252].  Monocyte-derived alternatively activated macrophages also 
specifically drive the differentiation of CD4+ T cells to Foxp3+ regulatory T cells [252]. 
These observations could have particular importance for skeletal muscle repair, in which 
Foxp3+ regulatory T cells are crucial to healing [253]. While distinguishing monocyte-
derived and tissue resident populations is challenging, this may be critical to understanding 
the phenotypic and functional diversity of macrophages. 
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7.4   Innate immune cell interactions with adaptive immunity  
Most of the literature exploring host response to biomaterials has focused on innate 
immunity because these constitute the majority of cells that are recruited to implanted 
materials [85]. However, a role for adaptive immune responses to material implantation 
and tissue repair is being increasingly appreciated [97]. For example, implantation of 
alginate microspheres induces recruitment of B cells within the first week of implantation 
[223]. While macrophages are sufficient for the complete fibrotic response, macrophage 
paracrine factors are responsible for recruiting B cells that potentiated fibrosis [223]. 
Additionally, loss of T cells increased fibrosis, suggesting they may play a regulatory role 
in preventing implant fibrous encapsulation. Recent work indicated that implantation of 
scaffolds derived from extracellular matrix modify systemic immune homeostasis by 
inducing expression of IL-4 in lymph nodes [97]. Macrophage polarization towards a 
regenerative phenotype did not occur in the absence of TH2 signals derived from T cells, 
which functionally impaired regeneration of volumetric muscle injury. Future work should 
more closely examine the interplay between the innate and adaptive branches of immunity 
in tissue repair and host responses to material implantation in order to better understand 
whether macrophages are absolutely required, or just participate, in these processes. 
7.5   Extension of findings to other medical applications 
The work presented in this thesis investigated myeloid cell trafficking during soft 
tissue injury and material implantation. Given the broad roles that myeloid cells play in 
injury and pathology, investigation of the presented immunomodulatory materials for 
treatment of other injuries and disease contexts is of great interest. We found differences 
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in the effects of FTY720 on myeloid cells between ischemic and traumatic injuries within 
the same tissue, so it is likely that different tissues undergoing injury will have unique 
immunological responses and needs.    
Given the promising results we reported in the spinotrapezius arteriole ligation 
model, future studies could explore FTY720-mediated immunomodulation in the murine 
hindlimb ischemia model, which is the most common preclinical model of peripheral 
arterial disease (PAD). PAD is present in 12% of the adult population and represents a 
major risk factor for cardio- and cerebrovascular events [239]. Pro-angiogenic therapies 
have been largely unsuccessful in clinical translation in part due to the high doses required 
for effect and the pathophysiological side effects on  the vasculature [229]. Delivery of 
factors such as FTY720 alone or in combination with VEGF in a mouse model of hindlimb 
ischemia would provide important insights into whether simultaneous targeting of the 
immune system can enhance the efficacy of therapies for treatment of vascular diseases.  
  Another application that would be extremely interesting to investigate modulation 
of monocyte/macrophage activities is during cancer progression. Non-classical monocytes 
have been shown to restrict cancer metastasis by ingesting tumor material [254], while 
tumor-associated macrophages display an alternatively activated phenotype that supports 
dysfunctional tumor angiogenesis and deactivation of anti-tumor adaptive immune 
responses [255]. Consequently, tumors represent a context where the anti-inflammatory 
activities of mononuclear phagocytes may be overactive. While biomaterials-based 
approaches to anti-cancer therapy have focused on nanoparticle-based drug delivery, 
particles have previously been used to modulate monocyte trafficking, with success in 
treatment of inflammatory diseases [127]. Perturbing monocyte and macrophage function 
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in the context of cancer could reveal unexpected functions that would guide the design of 
future therapies. 
7.6   Conclusions 
By investigating the recruitment of myeloid cells to implanted biomaterials, we 
revealed several key findings: 1) Non-classical monocytes differentiate into wound healing 
macrophages within cutaneous wounds, 2) Biomaterial-delivered FTY720 enhances 
wound healing macrophage accumulation, vascularization, and non-fibrotic repair during 
muscle injury, 3) Both PEG hydrogel implantation and RGD functionalization enhance the 
speed of myeloid cells migrating within skin injuries, and 4) Degradable PEG hydrogels 
promote accumulation of alternatively activated macrophages, which is further enhanced 
by VEGF delivery. These findings identify non-classical monocytes and alternatively 
activated macrophages as therapeutic targets for strategies attempting to overcome 
challenges facing biomaterials, including proper integration into host tissue, 
vascularization, and circumventing fibrosis.  Taken together, these results provide 
previously unknown insight into the value of leveraging endogenous populations of pro-
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